Refine
Year of publication
- 2024 (7)
- 2023 (8)
- 2022 (52)
- 2021 (69)
- 2020 (84)
- 2019 (89)
- 2018 (92)
- 2017 (84)
- 2016 (84)
- 2015 (75)
- 2014 (58)
- 2013 (38)
- 2012 (61)
- 2011 (52)
- 2010 (28)
- 2009 (39)
- 2008 (13)
- 2007 (12)
- 2006 (32)
- 2005 (42)
- 2004 (39)
- 2003 (31)
- 2002 (17)
- 2001 (25)
- 2000 (27)
- 1999 (21)
- 1998 (13)
- 1997 (14)
- 1996 (5)
- 1995 (16)
- 1994 (13)
Document Type
- Article (763)
- Doctoral Thesis (275)
- Postprint (89)
- Conference Proceeding (36)
- Review (34)
- Other (30)
- Monograph/Edited Volume (9)
- Habilitation Thesis (5)
- Preprint (2)
- Master's Thesis (1)
Is part of the Bibliography
- yes (1244) (remove)
Keywords
- inflammation (23)
- obesity (18)
- oxidative stress (15)
- insulin (14)
- type 2 diabetes (14)
- Biomarker (13)
- LC-MS/MS (13)
- cancer (12)
- carotenoids (12)
- insulin resistance (12)
- FGF21 (10)
- selenium (10)
- sphingolipids (10)
- α-amylase/trypsin inhibitors (10)
- Insulin resistance (9)
- acid sphingomyelinase (9)
- ceramide (9)
- cytokines (9)
- Adipositas (8)
- Caenorhabditis elegans (8)
- Manganese (8)
- Selen (8)
- metabolic syndrome (8)
- protein (8)
- Oxidative stress (7)
- adipose tissue (7)
- metabolism (7)
- retinol (7)
- Geschmack (6)
- Mitochondria (6)
- NASH (6)
- Obesity (6)
- Pregnancy (6)
- Prunus avium L. (6)
- SDS-PAGE (6)
- Solanaceae (6)
- Vitamin A (6)
- aging (6)
- cholesterol (6)
- diet (6)
- disease (6)
- epigenetics (6)
- polyphenols (6)
- pregnancy (6)
- retinol-binding protein 4 (6)
- taste (6)
- vitamin A (6)
- zinc (6)
- Aging (5)
- Arsenolipids (5)
- C. elegans (5)
- DNA methylation (5)
- Dexamethasone (5)
- Energiestoffwechsel (5)
- Entzündung (5)
- Epigenetics (5)
- Fetal programming (5)
- HPLC (5)
- LC–MS/MS (5)
- NAFLD (5)
- Sphingolipids (5)
- Sphingosine 1-phosphate (5)
- Type 2 diabetes (5)
- adiponectin (5)
- biomarker (5)
- cardiovascular disease (5)
- coffee by-products (5)
- diabetes (5)
- genes (5)
- linagliptin (5)
- liver (5)
- mass spectrometry (5)
- mitochondria (5)
- plasma (5)
- probiotics (5)
- type 2 diabetes mellitus (5)
- wheat (5)
- Adipose tissue (4)
- Arsenic-containing fatty acids (4)
- Arsenic-containing hydrocarbons (4)
- C-reactive protein (4)
- Cardiovascular diseases (4)
- Carotenoids (4)
- DNA damage (4)
- Emulsion (4)
- Endothelin (4)
- Flower buds (4)
- GDF15 (4)
- Hypertension (4)
- Inflammation (4)
- Insulin (4)
- Mass spectrometry (4)
- Metabolisches Syndrom (4)
- PUFA (4)
- Placenta (4)
- SDS PAGE (4)
- Sphingosine-1-phosphate (4)
- Typ-2-Diabetes (4)
- Vitamin E (4)
- Zinc (4)
- adipogenesis (4)
- brain (4)
- cell-based assay (4)
- cells (4)
- chronic kidney disease (4)
- copper (4)
- database (4)
- electrochemistry (4)
- epidemiology (4)
- glutathione peroxidase (4)
- gut microbiota (4)
- lipid metabolism (4)
- lutein (4)
- macrophages (4)
- malnutrition (4)
- manganese (4)
- metabolomics (4)
- micronutrients (4)
- neurodegeneration (4)
- protein modification (4)
- proteinuria (4)
- resistin (4)
- transcriptomics (4)
- weight loss (4)
- Abscisic acid (3)
- Acid sphingomyelinase (3)
- African indigenous vegetables (3)
- Alterung (3)
- Arabica coffee beans (3)
- BMI (3)
- Bilophila wadsworthia (3)
- Bioavailability (3)
- Bittergeschmack (3)
- Boron exposure (3)
- Diabetes (3)
- Diabetic nephropathy (3)
- Doehlert design (3)
- Dormancy (3)
- Drug delivery (3)
- Ernährung (3)
- Fettstoffwechsel (3)
- GCN2 (3)
- Glucosinolates (3)
- Hepatocytes (3)
- Insulinresistenz (3)
- Kidney (3)
- MALDI-TOF-MS (3)
- Mendelian randomization (3)
- Meta-analysis (3)
- Methylmercury (3)
- Mitochondrien (3)
- NZO (3)
- Neurotoxicity (3)
- Nrf2 (3)
- Nutrition (3)
- Selenium (3)
- Skeletal muscle (3)
- Sphingosine kinase (3)
- Stability (3)
- Toxicity (3)
- Verhalten (3)
- acid ceramidase (3)
- activated carbon (3)
- adiposity (3)
- age (3)
- antioxidants (3)
- bioavailability (3)
- biofortification (3)
- bitter taste (3)
- chronic diseases (3)
- coffee processing (3)
- colorectal cancer (3)
- diabetic nephropathy (3)
- differentiation (3)
- elevated plus-maze (3)
- energy metabolism (3)
- fatty acid metabolism (3)
- fatty acids (3)
- fibrosis (3)
- food choice (3)
- gallbladder cancer (3)
- glucocorticoid receptor (3)
- goblet cells (3)
- heart (3)
- high-sodium (3)
- homeostasis (3)
- iCheck (3)
- infection (3)
- kidney transplantation (3)
- lifestyle (3)
- liver metabolism (3)
- mitochondrial dysfunction (3)
- model (3)
- mortality (3)
- non-alcoholic fatty liver disease (3)
- nutrition (3)
- omega-3 fatty acids (3)
- open-field (3)
- p53 (3)
- plant volatiles (3)
- polymorphism (3)
- post-natal (3)
- pre-natal (3)
- prevention (3)
- prostaglandin E2 (3)
- protein restriction (3)
- proteome (3)
- red meat (3)
- redox state (3)
- refinement (3)
- saliva (3)
- sample preparation (3)
- sarcopenia (3)
- selenoprotein P (3)
- sphingomyelin (3)
- sphingosine (3)
- sphingosine-1-phosphate (3)
- sulfotransferase (3)
- survival (3)
- tocopherols (3)
- transformation products (3)
- transthyretin (3)
- type 2 (3)
- vascular calcification (3)
- vegetables (3)
- 1-Hydroxymethylpyren (2)
- 1-aminodecylidene bis-phosphonic acid (2)
- AMD (2)
- Ageing (2)
- Akt pathway (2)
- Amino acids (2)
- Amylase (2)
- Anemia (2)
- Apoptosis (2)
- Arabica coffee (2)
- Arabidopsis (2)
- Arsenic (2)
- BMI change (2)
- Beer (2)
- Birth weight (2)
- Blood (2)
- Blood pressure (2)
- BoNT (2)
- BoNT/B uptake (2)
- Boric acid (2)
- Botulinum neurotoxin (2)
- COVID 19 (2)
- CRISPR editing validation (2)
- CVD (2)
- Caco-2 intestinal barrier model (2)
- Caco-2/HT-29-MTX-model (2)
- Caenorhabitis elegans (2)
- Camellia sinensis (2)
- Carotenoid (2)
- Carotinoide (2)
- Cattle (2)
- Ceramide (2)
- Ceramides (2)
- Cereals (2)
- Christentum (2)
- Chrysopidae (2)
- Circadian rhythm (2)
- Clinical (2)
- Cohort studies (2)
- Copper (2)
- Cow-side assay (2)
- Curcumin (2)
- Cytotoxicity (2)
- DNA adducts (2)
- DNA damage response (2)
- DPP-4 inhibitors (2)
- Development (2)
- Differenzierung (2)
- Donors (2)
- Dopamine (2)
- E-2 (2)
- ET-1 (2)
- Endothelial cells (2)
- Endothelin-1 (2)
- Energy metabolism (2)
- Epidemiologie (2)
- Ernährungsfaktoren (2)
- Ernährungsgewohnheit (2)
- Ethanol (2)
- FTY720 (2)
- Ferritin (2)
- Fettgewebe (2)
- Fettsäuren (2)
- Fluorescence (2)
- Food labeling (2)
- Foxp3 (2)
- GI-GPx (2)
- GPx activity (2)
- Genotoxicity (2)
- Genregulation (2)
- Gestational diabetes (2)
- Gestational diabetes mellitus (2)
- Global DNA methylation (2)
- Glucose homeostasis (2)
- Glutathionperoxidase (2)
- HEK293 (2)
- HRMS (2)
- Hemoglobin (2)
- HepG2 (2)
- Hypermethylation (2)
- IGF-1 (2)
- IL-8 transcription (2)
- In vitro blood-brain barrier model (2)
- Inflammatory bowel disease (2)
- Insulin secretion (2)
- Iron deficiency anemia (2)
- Islam (2)
- Isoflavone (2)
- Judentum (2)
- Jurkat cells (2)
- Kaffee (2)
- Körperzusammensetzung (2)
- LC-MRM-MS (2)
- LC/HRMS (2)
- Labile zinc (2)
- Lebensstil (2)
- Leber (2)
- Linagliptin (2)
- Lipid metabolism (2)
- Lipidomics (2)
- Lymphocytes (2)
- M1/M2 differentiation (2)
- MALDI-TOF/MS (2)
- MRSA (2)
- Makrophagen (2)
- Maus (2)
- Meat (2)
- Mediterranean diet (2)
- Mercaptursäure (2)
- Mercuric mercury (2)
- Metabolomics (2)
- Method comparison (2)
- Microarray (2)
- Modified mycotoxins (2)
- Mortality (2)
- Mycotoxins (2)
- NAFLD/MAFLD (2)
- Nahrungssulfonate (2)
- Neutrophils (2)
- Nitric oxide (2)
- PTH (2)
- PXR (2)
- Pak choi (2)
- Palmitate (2)
- Parkinson disease (2)
- Pesticides (2)
- Phenole (2)
- Phenological modelling (2)
- Phenylpropanoids (2)
- Plackett–Burman design (2)
- Polymorphismus (2)
- Polyphenole (2)
- Post mortem chemistry (2)
- Prediabetes (2)
- Prostaglandin E2 (2)
- Proteasome (2)
- Protein oxidation (2)
- Protein restriction (2)
- Proteom (2)
- RBP4 (2)
- RRR (2)
- Rats (2)
- Redoxregulation (2)
- Religiöses Leben (2)
- Renal failure (2)
- Reticulocytes (2)
- Review (2)
- S-XRF (2)
- SCFA (2)
- SFA (2)
- SIMS techniques (2)
- Sarcopenia (2)
- Se (2)
- Selenoproteine (2)
- Skeletal muscle cells (2)
- Skin nanocarrier (2)
- Skin penetration (2)
- Small for gestational age (2)
- Smpd1 (2)
- Solanum lycopersicum (2)
- Speisegebot (2)
- Stoffwechsel (2)
- Stress response (2)
- Sulforaphan (2)
- Sulfotransferase (2)
- TAS2R (2)
- TEM (2)
- TLR signaling (2)
- Tandem mass spectrometry (2)
- Technical enzymes (2)
- Tenebrio molitor larvae (2)
- Thiomersal (2)
- Thioredoxin (2)
- Trace elements (2)
- Typ-2-Diabetes mellitus (2)
- VGCC (2)
- Vitamin K (2)
- Vollkorn (2)
- Whey protein (2)
- Xylanase (2)
- Zinc homeostasis (2)
- accumulation (2)
- acute kidney injury (2)
- adipose tissue dysregulation (2)
- aflatoxin B1 (2)
- ageing (2)
- albuminuria (2)
- alkylierte polyzyklische aromatische Kohlenwasserstoffe (2)
- all-cause mortality (2)
- angiotensin receptor blockers (2)
- anorexia (2)
- anthropometric measures (2)
- anti-genotoxicity (2)
- anti-inflammatory nutrition (2)
- anti-oxidant activity (2)
- anti-oxidative capacity (2)
- anxiety-like behavior (2)
- apoptosis (2)
- appetite (2)
- ascorbate (2)
- atherosclerosis (2)
- autophagy (2)
- base excision repair (incision activity) (2)
- batch process (2)
- behavior (2)
- benzylic alcohol (2)
- benzylischer Alkohol (2)
- beta-cell (2)
- binding (2)
- biological pest control (2)
- birth weight (2)
- bisphosphonates (2)
- bitter (2)
- bitter taste receptors (2)
- body weight gain (2)
- botulinum toxin (2)
- bound phenolic compounds (2)
- brain insulin signaling (2)
- c. elegans (2)
- calcination (2)
- calcium (2)
- cancer cachexia (2)
- cancer chemoprevention (2)
- cancer epidemiology (2)
- cardiovascular diseases (2)
- carotenoid (2)
- carotenoid biosynthesis (2)
- cellular bioimaging (2)
- cerami-des (2)
- ceramides (2)
- cereal meals (2)
- chaperones (2)
- chronic fatigue (2)
- chronic psychosocial stress (2)
- chronic subordinate colony housing (CSC) (2)
- circadian clock (2)
- clusterin (2)
- coenzyme-a (2)
- coffee (2)
- colon carcinogenesis (2)
- continuous process (2)
- copper-related disorders (2)
- copy number analyses (2)
- coronary heart disease (2)
- cortisol (2)
- cyclooxygenase (2)
- cysteine alkylation (2)
- cytokine (2)
- depressive-like behavior (2)
- design of experiment (2)
- determinants (2)
- diabetes mellitus (2)
- dietary patterns (2)
- dietary restriction (2)
- digestive enzymes quantification (2)
- dogs (2)
- dormancy (2)
- drug delivery (2)
- eNOS (2)
- eicosanoids (2)
- endothelin (2)
- endurance exercise (2)
- energy homeostasis (2)
- energy-metabolism (2)
- enzymology (2)
- equine (2)
- erythropoiesis (2)
- ethanol (2)
- exercise (2)
- exposome (2)
- exposome‐ wide association study (2)
- expression (2)
- extraction (2)
- fatigue reduction diet (2)
- fatty liver (2)
- feeding (2)
- fetal origins hypothesis (2)
- fetal programming (2)
- flavonoids (2)
- flower buds (2)
- food frequency questionnaire (2)
- force-field (2)
- forebrain (2)
- fractionation (2)
- fruit (2)
- functional inhibitors of acid sphin-gomyelinase (2)
- gene expression (2)
- genetically modified BoNT (2)
- glomerular filtration rate (2)
- glucagon (2)
- glucose intolerance (2)
- glucosinolates (2)
- glutathione (2)
- glycaemic control (2)
- growth behavior (2)
- growth restriction (2)
- gwas (2)
- hallervorden-spatz-syndrome (2)
- halophytes (2)
- hepatic steatosis (2)
- high protein diet (2)
- homologous recombination deficiency (2)
- homology-directed repair (2)
- hsp-70 (2)
- human excised skin (2)
- hydrolysis (2)
- hypertension (2)
- immunology (2)
- in vitro intestinal model (2)
- insulin signaling (2)
- insulin-resistance (2)
- interleukin-8 (2)
- intestinal microbiota (2)
- intestinal mucins (2)
- intestinal zinc resorption (2)
- ion-exchange chromatography (2)
- keratinocytes (2)
- kidney (2)
- kupffer cells (2)
- laminitis (2)
- later health (2)
- legumes (2)
- leptin (2)
- life-span (2)
- lipid peroxidation (2)
- lipidomics (2)
- liver fibrosis (2)
- loci (2)
- low birth weight (2)
- lung infection (2)
- lymphoma (2)
- lysosomal hydrolases (2)
- lysosome (2)
- maintenance of genomic integrity (2)
- mass index (2)
- meal timing (2)
- melatonin (2)
- membrane fusion (2)
- menadione (2)
- mercapturic acid (2)
- meta-analysis (2)
- metabolic disorders (2)
- metabolic stress (2)
- metabolic syndrom (2)
- method comparison (2)
- mice lacking (2)
- microarray (2)
- microcomputed tomography (2)
- microvascular complications (2)
- microwave assisted digestion (2)
- middle adulthood (2)
- mitochondria homeostasis (2)
- mitochondrial function (2)
- mobility-mass spectrometry (2)
- monensin (2)
- monitoring (2)
- mouse (2)
- mucus layer (2)
- multiple-pest infestation (2)
- muscarinic acetylcholine receptor (2)
- myalgic encephalomyelitis (2)
- myocardial infarction (2)
- myopathy (2)
- n-acetyl-cysteine (2)
- nanogels (2)
- nanoparticles (2)
- nanotoxicology (2)
- native American ancestry (2)
- neurodegenerative diseases (2)
- neurotoxicity (2)
- neurotoxins (2)
- nitric oxide (2)
- non-alcoholic fatty liver disease (NAFLD) (2)
- nonalcoholic steatohepatthis (2)
- nut allergenic proteins (2)
- nutrient transport (2)
- nutrients (2)
- nutritional characteristics (2)
- nuts (2)
- odd chain fatty acids (2)
- offspring (2)
- older persons (2)
- organic compounds adsorption (2)
- overweight (2)
- parchment (2)
- particle characterization (2)
- patterns (2)
- pea (2)
- peptide biomarkers (2)
- peptides markers (2)
- phagocytosis (2)
- phenolics (2)
- physical activity (2)
- pink1 (2)
- plasma measurements (2)
- platelets (2)
- pneumonia (2)
- poly(ADP-ribosyl)ation (2)
- polyenoic fatty acids (2)
- population-specific risk marker (2)
- prediction (2)
- proliferation (2)
- prospective study (2)
- prostaglandins (2)
- proteasome (2)
- protein extraction (2)
- proteomic analysis (2)
- proteostasis (2)
- provitamin A (2)
- purification (2)
- rapid test kit (2)
- rat (2)
- rat hepatocytes (2)
- redox regulation (2)
- redox-metabolites (2)
- reducing agents (2)
- relative quantification (2)
- reliability (2)
- renal disease (2)
- repetitive elements (2)
- replacement (2)
- reversed-phase chromatography (2)
- risk (2)
- rotes Fleisch (2)
- s-glutathionylation (2)
- saline agriculture (2)
- salt (2)
- secondary plant metabolites (2)
- seeds (2)
- selenite (2)
- selenoneine (2)
- selenoproteins (2)
- serine palmitoyltransferase (2)
- serum (2)
- sex (2)
- signal transduction (2)
- size (2)
- skeletal muscle (2)
- skin penetration (2)
- sorghum (2)
- soy protein (2)
- spent coffee grounds (2)
- sphingolipid de novo synthesis (2)
- sphingolipid metabolism (2)
- sphingosine kinase (2)
- stable-isotope labeling (2)
- status markers (2)
- stroke (2)
- suppress VLDL secretion (2)
- tacrolimus formulation (2)
- targeted proteomics (2)
- tetanus toxin (2)
- tritrophic system (2)
- tryptic digestion (2)
- ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) (2)
- ungeradkettige Fettsäuren (2)
- validity (2)
- valorization (2)
- variants (2)
- veterinary drugs (2)
- vicious cycle (2)
- visfatin (2)
- voltage-dependent calcium channels (2)
- weight gain (2)
- wheat cultivars (2)
- zinc binding (2)
- (2E)-Hexadecenal (1)
- (2E)-hexadecenal (1)
- (2E)-hexadecenoic acid (1)
- (9Z)-neoxanthin (1)
- 1-Methoxy-3-indolylmethyl glucosinolate (1)
- 1-Phenylethanol (1)
- 1-hydroxy methyl pyrene (1)
- 1-hydroxymethylpyrene (1)
- 1-phosphate (1)
- 11 beta-hydroxysteroid dehydrogenase 2 (1)
- 2-Phenylethanol (1)
- 20S (1)
- 20S proteasome (1)
- 25-OH vitamin D (1)
- 2D-LC-MS/MS (1)
- 2k1c renovascular hypertension (1)
- 3,4-didehydroretinol (1)
- 3,5-Dimethoxytoluene (1)
- 3-Methylhistidin (1)
- 3-methylhistidine (1)
- 3D breast cell model (1)
- 3D tissue model (1)
- 5-gliadin (1)
- 6-Shogaol (1)
- 6-shogaol (1)
- 7 macrophages (1)
- ACE I/D polymorphism (1)
- ACE inhibitors (1)
- ADPKD (1)
- AGE (1)
- AMPK (1)
- AOAC (1)
- APC (1)
- APOM protein (1)
- ARPE-19 cells (1)
- ASI-3 (1)
- Abrus precatorius (1)
- Acute coronary syndrome (1)
- Acute renal failure (1)
- Adioponectin (1)
- Adipocytes (1)
- Adipozyt (1)
- Adult height (1)
- Advanced fetal programming hypothesis (1)
- Advanced glycation end products (1)
- Advanced glycation end-products (1)
- Advanced glycation endproducts (1)
- Aflatoxin B1 (1)
- Age (1)
- Agonisteninteraktion (1)
- Akkermansia muciniphila (1)
- Akt (1)
- Akt signaling (1)
- Akt/PKB (1)
- Aktivkohle (1)
- Alcohol dependence (1)
- Aldehyddehydrogenase (1)
- Alkohol (1)
- Alkoholdehydrogenase (1)
- Alkoholkonsum (1)
- Allergenic food (1)
- Allicin (1)
- Alltagsbedingungen (1)
- Allyl isothiocyanate (1)
- Alpine metamorphism (1)
- Alternative to animal testing (1)
- Alternativmethoden (1)
- Alveolar epithelial cells (1)
- Amaranth (1)
- Amaranthaceae (1)
- Anaphylaxie (1)
- Angiotensin converting enzyme inhibitor (1)
- Ankle-brachial index (1)
- Anorexia (1)
- Antibeschlag-Additive (1)
- Antibiotics (1)
- Antibiotikaresistenz (1)
- Antimicrobial drugs (1)
- Antioxidant capacity (1)
- Antioxidants (1)
- Anxiety (1)
- Anxiety Sensitivity Index (1)
- Aortic valve (1)
- Apgar score (1)
- Apple polyphenoloxidase (1)
- Arabica Kaffeebohnen (1)
- Arbuscularmycorrhizal fungi (1)
- Arsenic speciation (1)
- Arsenite (1)
- Arsenolipid (1)
- Arsenosugar (1)
- Aryl-hydrocarbon receptor (1)
- Asian subjects (1)
- Aspergillus (1)
- Aspirin (1)
- Assay High-resolution mass spectrometry (1)
- Assay hochauflösende Massenspektrometrie (1)
- Assays (1)
- Astrocytes (1)
- Astrozyten (1)
- Atemwegserkrankungen (1)
- Atherosclerosis (1)
- Athletes (1)
- Augmentation (1)
- Ausdauerleistung (1)
- Autophagie Lysosomale System (1)
- Autotaxin (1)
- B cells (1)
- BALB/c-3T3 cells (1)
- BBsome (1)
- BIOCROSS (1)
- BMP4 (1)
- BPA (1)
- BRAF (1)
- Baked products (1)
- Ballaststoffe (1)
- Barriere (1)
- Bbs4 (1)
- Be-10 dating (1)
- Beef (1)
- Benzylisothiocyanat (1)
- Beryllium (1)
- Beta-Oxidation (1)
- Beta-Oxydation (1)
- Beta-Zelle (1)
- Beta-amylase (1)
- Beta-lactoglobulin (1)
- BfR MEAL Study (1)
- Bifidobacterium (1)
- Bile Acids (1)
- Bioaktivität (1)
- Biocompatibility (1)
- Biological Assay (1)
- Biomarkers (1)
- Bioreactor (1)
- Biotransformation (1)
- Bioverfügbarkeit (1)
- Biparietal diameter (1)
- Birds of prey (1)
- Bisphenol A (1)
- Bitter (1)
- Bittergeschmacksrezeptoren (1)
- Bitterrezeptoren (1)
- Blood flow resistance (1)
- Blood platelets (1)
- Blood protein adducts (1)
- Blood-cerebrospinal fluid barrier (1)
- Blood-liquor barrier (1)
- Blut-Hirn-Schranke (1)
- Body composition (1)
- Body weight (1)
- Body-Mass-Index (1)
- Botulinumtoxine (1)
- Brain development (1)
- Brassica (1)
- Brassica carinata (1)
- Brassica oleracea var. sabellica (1)
- Brassica rapa ssp. chinensis (1)
- Brassica vegetables (1)
- Brassicaceae (1)
- Breast cancer (1)
- Brood size (1)
- Brown adipose tissue (1)
- Brustkrebs (1)
- CAR (1)
- CD, DLS (1)
- CEHC (1)
- CKD (1)
- COPD (1)
- CRC (1)
- CRISPR/Cas9 (1)
- CXCL10 (1)
- CXCR2 (1)
- CYP3A4 (1)
- Cachexia (1)
- Caco-2 (1)
- Calculated free 25-hydroxyvitamin D (1)
- Calorimetry (1)
- Cameroon (1)
- Cancer prevention (1)
- Cannabidiol (CBD) (1)
- Cardiac function (1)
- Cardiac ischemia/reperfusion (1)
- Cardiac rehabilitation (1)
- Cardiovascular (1)
- Cardiovascular effects (1)
- Carobballaststoff (1)
- Carotene supplementation (1)
- Case-control study (1)
- Casein (1)
- Catabolism (1)
- Catechin (1)
- Catechins (1)
- Cell culture materials (1)
- Cell proliferation (1)
- Cellular bioavailability (1)
- Cellular damage response (1)
- Cellular uptake (1)
- Cellulose acetate phthalate (1)
- Chad (1)
- Chaperone (1)
- Chemerin (1)
- Chemotherapy resistance (1)
- Childhood nephrotic syndrome (1)
- Chlorogensäure (1)
- Chlorophyllide a oxygenase (1)
- Chlorophylls (1)
- Chloroplast (1)
- Cholesterol (1)
- Chronic diseases (1)
- Chronic kidney disease (1)
- Chylomicron (1)
- Clinical study (1)
- Clinical trials (1)
- Clostridium difficile (1)
- Coagulation (1)
- Cognition (1)
- Colitis (1)
- Colitis ulcerosa (1)
- Collagen (1)
- Colon cancer (1)
- Colonic microbiota (1)
- Colonkanzerogenese (1)
- Colorectal cancer (1)
- Colorectal carcinomas (1)
- Comet assay (1)
- Complications in diabetes (1)
- Connective tissue growth factor (1)
- Contaminants (1)
- Contamination (1)
- Contrast induced acute kidney injury (1)
- Control region (1)
- Core-multishell nanocarriers (1)
- Coronary angiography (1)
- Corticotropin-Releasing Factor Receptor Type 1 (1)
- Corticotropin-Releasing Factor Rezeptor Typ 1 (1)
- Cortisol Maternal cortisol (1)
- Cortisol vertical bar metabolism (1)
- Costs (1)
- Covalent modification (1)
- Coxsackie and Adenovirus Receptor (1)
- Coxsackie- und Adenovirus Rezeptor (1)
- Crop quality (1)
- Cross-sectional studies (1)
- Cu NP-incorporated MI-dPG coating (1)
- Cyp2b1 (1)
- Cyp3a11 (1)
- CypP450 (1)
- Cystic fibrosis (1)
- Cytokines (1)
- DAF-16 (1)
- DAF-16 transcription factor (1)
- DAIH (1)
- DASH study (1)
- DASH-Studie (1)
- DDP-4 inhibition (1)
- DNA integrity (1)
- DNA repair (1)
- DNA-Addukte (1)
- DNMT inhibitor (1)
- DNMT1 (1)
- DPP-4 inhibition (1)
- DPP-4 inhibitor (1)
- DPP-IV inhibitor (1)
- DPP4 (1)
- DPP4 inhibition (1)
- Dairy biomarkers (1)
- Darmbakterien (1)
- Darmbakterium (1)
- Darmerkrankung (1)
- Darmkrebs (1)
- Darmkrebsdiagnostik (1)
- Darmlänge (1)
- Daucus (1)
- Decontamination (1)
- Delinquency (1)
- Demographic transitions (1)
- Dendritic cells (1)
- Dendritic core-multishell nanocarriers (1)
- Dengue (1)
- Depression (1)
- Derivatisation (1)
- Derivatization (1)
- Dermal delivery (1)
- Dermal drug delivery (1)
- Desensibilisierung (1)
- Determinants (1)
- Developmental programming (1)
- Diabetes incidence (1)
- Diabetes mellitus Typ 2 (1)
- Diabetes-related vascular complications (1)
- Diabetic cardiomyopathy (1)
- Diacylglycerol (DAG) (1)
- Diagnostic (1)
- Diallyl disulfide (1)
- Diarrhoea (1)
- Dichlorofluorescein assay (1)
- Dickdarmkanzerogenese (1)
- Dickdarmkrebs (1)
- Dietary Fibre (1)
- Dietary compliance (1)
- Dietary fat composition (1)
- Dietary fat replacement (1)
- Dietary sulfonates (1)
- Differential Gene Expression (1)
- Dipeptidyl peptidase 4 inhibitor (1)
- Dipeptidyl peptidase IV (1)
- Dipeptidyl peptidase-4 inhibition (1)
- Dipeptidylpeptidase-4 (1)
- Disease (1)
- Distal tubules (1)
- Diät (1)
- Dog growth (1)
- Dogs (1)
- Dolichol lipids (1)
- Domestic cat (1)
- Domestic cooking (1)
- Dopaminergic neurons (1)
- Dopaminergic system (1)
- Drug delivery systems (1)
- Drug metabolism (1)
- EBI3 (1)
- EDC (1)
- ENaC (1)
- EPIC-Potsdam study (1)
- ER stress (1)
- ER-stress (1)
- EST (1)
- ETA (1)
- ETB (1)
- ETB receptor-deficient mouse (1)
- Edible insects (1)
- Eicosanoid (1)
- Electrochemistry (1)
- Electron paramagnetic resonance spectroscopy (1)
- Elektrochemie (1)
- Elemental blood serum concentration (1)
- Ellagsäure (1)
- Emulsifying properties (1)
- Enantio-selective reduction (1)
- Endocannabinoide (1)
- Endocrine disruption (1)
- Endodormancy (1)
- Endosomal sorting (1)
- Endothelfunktion (1)
- Endothelial dysfunction (1)
- Endothelial nitric oxide synthase (1)
- Endothelin receptor antagonists (1)
- Endothelin-1 transgenic mice (1)
- Endothelzelle (1)
- Energiehaushalt (1)
- Energy expenditure (1)
- Energy intake (1)
- Energy requirement (1)
- Enteric polymer (1)
- Enterolignanen (1)
- Enterolignans (1)
- Environmental (1)
- Enzyme (1)
- Epigallocatechingallat (1)
- Epigenetic (1)
- Epigenetik (1)
- Epstein-Barr Virus-induziertes Gen 3 (1)
- Equine metabolic syndrome (1)
- Equines (1)
- Equol (1)
- Erdnussallergie (1)
- Ernährungsmuster (1)
- Erosion kinetics (1)
- Escherichia coli (1)
- Et-1 (1)
- Ethyl cellulose (1)
- Eudragit (R) (1)
- Eudragit (R) RS (1)
- Eudragit L 100 (1)
- Euphorbia mauritanica (1)
- Euphorbiaceae (1)
- Europe (1)
- Evaluation tool (1)
- Excretion (1)
- Exercise tests (1)
- Experimental autoimmune encephalomyelitis (EAE) (1)
- Extraction (1)
- Extrudate (1)
- FASN (1)
- FISH (1)
- FOXO1 (1)
- FVB/NJ Maus (1)
- FVB/NJ mouse (1)
- Fabaceae (1)
- Factor-Xa (1)
- Faecal bacteria (1)
- Farber disease (1)
- Fast and slow fibers (1)
- Fat infiltration in muscle (1)
- Fat-free mass (1)
- Fattening pigs (1)
- Fatty acid hydroperoxides (1)
- Fetal development (1)
- Fettinfiltration im Muskel (1)
- Fettleibigkeit (1)
- Fettsucht (1)
- Fettwahrnehmung (1)
- Fettzelle (1)
- Fetuin-A (1)
- Fibroblast growth factor 21 (1)
- Fibrosis (1)
- Fingolimod (1)
- Firefly luciferase inhibition (1)
- First trimester (1)
- Flavonoid (1)
- Flavonoid glycosides (1)
- Flavonoide (1)
- Flavonoids (1)
- Floral scent compound (1)
- Flowering (1)
- Fluorescence lifetime imaging microscopy (1)
- Fluorescence screening (1)
- Foal (1)
- Foaming properties (1)
- Folientunnel (1)
- Food (1)
- Food Chain (1)
- Food analysis (1)
- Food authentication (1)
- Food choice (1)
- Food composition (1)
- Food labelling (1)
- Food safety (1)
- Food-exchange model (1)
- Forensic science (1)
- Forster resonance energy transfer (FRET) (1)
- Frailty (1)
- Frailty criteria (1)
- Frataxin (1)
- Free radicals (1)
- Free vitamin D (1)
- Freeze-fracturing (1)
- Fremdstoffmetabolismus (1)
- Fruits (1)
- Functionality (1)
- Furosemide (1)
- G protein-coupled receptors (1)
- G-Protein gekoppelte Rezeptoren (1)
- G-Protein-gekoppelte Rezeptoren (1)
- G-protein coupled receptors (1)
- GADD45A and GADD45G (1)
- GC gene (1)
- GC-MS (1)
- GC-globulin (1)
- GLP-1 (1)
- GLUT1 XbaI gene polymorphism (1)
- GLUT8 (1)
- GOAT (1)
- GPCR (1)
- GPX (1)
- GPx2 (1)
- Gallensäuren (1)
- Gallensäurenbindung (1)
- Garlic (1)
- Gastrointestinal tract (1)
- Gene Array (1)
- Gene Chip (1)
- Gene expression (1)
- Gene polymorphism (1)
- Genetics (1)
- Genetik (1)
- Genexpression (1)
- Geriatric patients (1)
- Gerontologie (1)
- Geschlecht (1)
- Geschmacksrezeptor (1)
- Getränkeauswahl (1)
- Getränkeautomat (1)
- Gewicht (1)
- Gewichtserhalt (1)
- Gewichtsreduktion (1)
- Gewichtsverlust (1)
- Ghrelin (1)
- Gliadin and glutenin fractions (1)
- Global (1)
- Glp1r(-/-) mice (1)
- Glucagon (1)
- Glucocorticoid receptor (1)
- Glucose intolerance (1)
- Glucose metabolism disorders (1)
- Glucose tolerance (1)
- Glucosehomöostase (1)
- Glucosetransport (1)
- Glucosinolate breakdown product (1)
- Glukoseintoleranz (1)
- Glukosestoffwechselstörungen (1)
- Glukosinolaten (1)
- Glutathion-Peroxidase (1)
- Glutathione (1)
- Gluten (1)
- Glycation (1)
- Glycemia (1)
- Glycerophospholipids (1)
- Grave’s orbitopathy (1)
- Grüner Tee (1)
- Gut microbiota (1)
- HAMP (1)
- HNRNPA1 (1)
- HOG (1)
- HOMA (1)
- HPLC-ESI-QTOF (1)
- HPLC/HR-ESMS (1)
- HPLC/ICPMS (1)
- HPMCP (1)
- HSD11B2[CA]n polymorphism (1)
- HSP70 (1)
- HaCaT cells (1)
- Hafer (1)
- Halophyten (1)
- Hautmodell (1)
- Head circumference (1)
- Health care expenditure (1)
- Health-promoting compounds (1)
- Heart failure (1)
- Heart weight (1)
- Heat aggregation (1)
- Heat shock protein 90 (1)
- Heat shock proteins (1)
- Heavy metals (1)
- Heme (1)
- Hepatic insulin resistance (1)
- Hepatic stellate cells (1)
- Hepatotoxicity (1)
- Hepatotoxizität (1)
- Herd size (1)
- Herd type (1)
- Heritabilität (1)
- Herzinfarkt (1)
- Herzkreislauferkrankungen (1)
- Heterocyclic aromatic amines (1)
- Heterogeneity (1)
- High pressure - low temperature treatments (1)
- High resolution microscopy (1)
- High-resolution mass spectrometry (1)
- Histologie (1)
- Hoch-Protein Diät (1)
- Hochfettdiät (1)
- Homocystein (1)
- Homologiemodellierung (1)
- Honey (1)
- Honeydew honey (1)
- Hormone (1)
- Hormonersatztherapie (1)
- Hormones (1)
- Horse (1)
- Host-plant suitability (1)
- Human (1)
- Human differentiated neurons (1)
- Human nutritional intervention (1)
- Hungerhormon (1)
- Hydroxycinnamic acids (1)
- Hydroxymethylfurfural (1)
- Hydroxymethylpyren (1)
- Hyperglycaemia (1)
- Hypertonie (1)
- Hyphenated techniques (1)
- Hypoxia (1)
- IBD (1)
- ICP-MS (1)
- ICP-QQQ-MS (1)
- IDH1 (1)
- IRAK (1)
- IgE (1)
- Imiquimod (1)
- Immediate-early-Gen (1)
- Immunhistochemie (1)
- Inactivation (1)
- Indigenous African leafy vegetables (1)
- Indole (1)
- Indoor farming (1)
- Induced pluripotent stem cells (1)
- Inductively (1)
- Inductively coupled plasma mass spectrometry (1)
- Infarct size (1)
- Inflammaging (1)
- Inflammatory skin disease (1)
- Influenza virus (1)
- Inhalation (1)
- Inorganic mercury (1)
- Insulin sensitivity (1)
- Insulin signaling (1)
- Insulin signalling (1)
- Insulin-induzierte Hypoglykämie (1)
- Insulinsekretion (1)
- Insulinsensitivität (1)
- Intergenerational effects (1)
- Interleukin-1 (1)
- Intestinal absorption (1)
- Intimahyperplasie (1)
- Intimal Hyperplasia (1)
- Intraperitoneal administration (1)
- Iodization (1)
- Ischemia/reperfusion (1)
- Isoprostane (1)
- Isotope ratios (1)
- Isotope-dilution (1)
- Isotope-dilution analysis (1)
- IκB (1)
- Jod (1)
- K-RAS (1)
- K-ras (1)
- Kachexie (1)
- Kaede (1)
- Kaffeenebenprodukte (1)
- Kaffeeproteine (1)
- Kaffeeverarbeitung (1)
- Kalorienrestriktion (1)
- Kalzium (1)
- Kanzerogenese (1)
- Kardiovaskuläre Erkrankungen (1)
- Kardiovaskuläre Krankheit (1)
- Katalase (1)
- Kernrezeptor (1)
- Kidney weight (1)
- Kinetik (1)
- Knock-out (1)
- Kokultur (1)
- Kolokalisation (1)
- Kolonkrebs (1)
- Konsum (1)
- Kontaktallergie (1)
- Kontrollierte klinische Studie (1)
- Kopfsalat (1)
- Kosakonia radicincitans (1)
- Krebs (1)
- Kunststoff-Additive (1)
- Kupfer (1)
- Kupfferzellen (1)
- Kurzkettige Fettsäuren (1)
- Kynurenine (1)
- Körperfett (1)
- Körpergewichsterhalt (1)
- Körpergewicht (1)
- Körpergewichtsregulation (1)
- Körpergewichtsverlust (1)
- Körpermasse (1)
- LC (1)
- LC-MS (1)
- LC-MS-MS (1)
- LC/MS/MS (1)
- LC/MS/MS; Quantification of allergenic plant traces (1)
- LEDs (1)
- LNA- clamp-PCR (1)
- LNA-clamp-PCR (1)
- LPA(3) receptor subtype (1)
- LRP8 (1)
- Labormäuse (1)
- Langerhans Zellen (1)
- Langerhans cells (1)
- Lebensmittelkette (1)
- Leg length (1)
- Legume (1)
- Lemna paucicostata (1)
- Life science (1)
- Light quality (1)
- Lignan-converting bacteria (1)
- Lignan-umwandelnde Bakterien (1)
- Lipase (1)
- Lipasen (1)
- Lipid (1)
- Lipid droplet proteome (1)
- Lipidstoffwechsel (1)
- Lipolysis (1)
- Liquid chromatography-tandem mass spectrometry (1)
- Liquid-liquid extraction (1)
- Lithiumion battery (LIB) (1)
- Liver fat (1)
- Liver fibrosis (1)
- Liver injury (1)
- Long term health (1)
- Long-term cellular toxicity (1)
- Loop diuretics (1)
- Low birth weight (1)
- Low lean mass (1)
- Low muscle mass (1)
- Lu-Hf geochronology (1)
- Lupin (1)
- Lutein (1)
- Lutein ester (1)
- Luteinester (1)
- Lysophosphatidic acid (1)
- Lysophosphatidylcholines (1)
- MCHR-1 (1)
- MCT oil (1)
- MMF (1)
- MS quantification of leguminous additives (1)
- MSCs (1)
- MUFA (1)
- Macrovascular (1)
- Major adverse kidney event (1)
- Major royal jelly proteins (1)
- Mangan (1)
- Manganese . C. elegans (1)
- Manganism (1)
- Marker (1)
- Marker peptides (1)
- Massenspektrometrie (1)
- Mauritanicain (1)
- Measured free 25-hydroxyvitamin D (1)
- Meat peptide biomarker (1)
- Mediationsanalyse (1)
- Mediterranean Diet (1)
- Medizinprodukt (1)
- Membrane (1)
- Menderes Massif (1)
- Mesoangioblasts (1)
- Meta-analyses (1)
- Metabolically benign (1)
- Metabolism (1)
- Metabolismus (1)
- Metabolom (1)
- Metabolome analysis (1)
- Metals (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methylation (1)
- Methylglyoxal (1)
- MiSpEx* (1)
- Mice (1)
- Micellar caseins (1)
- MicroRNAs (1)
- Microbial degradation (1)
- Microbiome (1)
- Microdialysis (1)
- Microelements (1)
- Microsatellite instability (1)
- Microsomal (1)
- Microvascular complications (1)
- Migration (1)
- Mikrobiologie (1)
- Mikrobiota (1)
- Mikronährstoffe (1)
- Mikrosomal (1)
- Milcheinnahme (1)
- Mitochondrial respiration (1)
- Mitohormesis (1)
- Mixed lymphocyte culture (MLC) (1)
- Model (1)
- Modell (1)
- Modelling (1)
- Molecular structure (1)
- Molkenproteine (1)
- Monocyte (1)
- Moringa oleifera (1)
- Morphogenesis (1)
- Mortalität (1)
- Motor coordination (1)
- Motor neurons (1)
- Motorneurone (1)
- Multi-Methods (1)
- Multi-method (1)
- Multi-mycotoxin analysis (1)
- Multiple herbivory (1)
- Multiple sclerosis (1)
- Multiplex platforms (1)
- Muskelproteinumsatz (1)
- Muskelschwund (1)
- Mycobacterium tuberculosis (1)
- Myoblasts (1)
- Myocardial infarction (1)
- Myocardial ischemia (1)
- Myogenic differentiation (1)
- Myoglobin (1)
- Myrrhe (1)
- Myzus persicae (1)
- NF-?B (1)
- NF-kB (1)
- NF-kappa B (1)
- NF-κB (1)
- NF1 (1)
- NMR-based metabolomics (1)
- NR3C1 gene (1)
- Nachkommen (1)
- Nahrung der Zukunft (1)
- Nahrungsbestandteile (1)
- Nahrungsfette (1)
- Nahrungsmittelallergie (1)
- Nahrunsgergänzungsmittel (1)
- Nanoparticle uptake (1)
- Nanoparticles (1)
- Nanotoxicology (1)
- Natriuretic peptides (1)
- Neisseria gonorrhoeae (1)
- Neoglucobrassicin (1)
- Neointima (1)
- Nephropathie (1)
- Nephropathy (1)
- Netzwerke (1)
- Neurodegeneration (1)
- Neurodevelopmental toxicity (1)
- Neurone (1)
- Neuronen (1)
- Neurons (1)
- Neuropathie (1)
- Neuropathy (1)
- Neuropeptides (1)
- Neutral lipids (1)
- New World camelids (1)
- Nif2 (1)
- Non-esterified fatty acids (NEFA) (1)
- Nordic diet (1)
- Novelose (1)
- Nuclear receptor (1)
- Nucleus tractus solitarii (1)
- Nukleosidaddukt (1)
- NutriAct family study (1)
- Nutritional counseling (1)
- Nährstoffe (1)
- OCFA (1)
- Oats (1)
- Occurrence data (1)
- Ocular delivery (1)
- Odorant compounds (1)
- Offending (1)
- Offspring (1)
- Oligomere (1)
- Olivenöl (1)
- Omega-3 Fettsäuren (1)
- Omega-Hydroxylation (1)
- Omega-Hydroxylierung (1)
- Oncogenes (1)
- Ontogenetic development (1)
- Ontogeny (1)
- Optogenetik (1)
- Organic and conventional type of production (1)
- Organic arsenic (1)
- Organic carbonates (1)
- Organic mercury (1)
- Other livestock (1)
- Outcome (1)
- Oxidativer Stress (1)
- Oxidized proteins (1)
- OxyR (1)
- Oxylipin (1)
- Oxylipins (1)
- PBCEC (1)
- PBPK (1)
- PBTK (1)
- PCR-DHPLC (1)
- PCaaC38:6 (1)
- PGC1 alpha (1)
- PGC1a (1)
- PHGPx (1)
- PKM2 (1)
- PPARalpha (1)
- PRM/Alf Maus (1)
- PRM/Alf mouse (1)
- PTEN (1)
- Pancreatic cells (1)
- Pannexin 1 (1)
- Parenthood (1)
- Paternal exposure (1)
- Paternal programming; (1)
- Paternal, maternal, sex differences (1)
- Pea flour (1)
- Pea protein isolate (1)
- Peptides (1)
- Permeability (1)
- Peroxidatic and resolving cysteine (1)
- Peroxiredoxin (1)
- Peroxynitrite (1)
- Personalised medicine (1)
- Pest infestation (1)
- Pest-pest interaction (1)
- Pflanzliches Lignan (1)
- PhIP (1)
- Pharbitis nil cv. Violet (1)
- Pharmacokinetics (1)
- Phase II Enzyme (1)
- Phenol-amino-adducts (1)
- Phosphatidylcholines (1)
- Phosphatidylinositols (1)
- Phospholipids (1)
- Photosynthesis (1)
- Physical activity (1)
- Physicochemical properties (1)
- Physiologie (1)
- Pig (1)
- Pilot-Studie (1)
- PlGF (1)
- Plant allergen (soy, sesame, lupine) (1)
- Plant authentication (1)
- Plant growth promoting bacteria (1)
- Plant lignan (1)
- Plasma (1)
- Plasma concentration (1)
- Plasmalogens (1)
- Platelets (1)
- Polyamine (1)
- Polymeric nanoparticle (1)
- Polymeric nanoparticles (1)
- Polyphenols (1)
- Polyubiquitination (1)
- Ponderostat (1)
- Pooling analysis (1)
- Post-translational modifications (1)
- Post-translational protein modification (1)
- Postharvest processing (1)
- Preadipozyt (1)
- Precision medicine (1)
- Precision prognostics (1)
- Preeclampsia (1)
- Pregnane X Receptor (1)
- Preinterventional biomarker (1)
- Presystemic metabolism (1)
- Preterm birth (1)
- Preterm delivery (1)
- Prevention (1)
- Primary care (1)
- Principal component analysis (1)
- Procyanidins (1)
- Proliferation (1)
- Prostaglandin (1)
- Prostaglandin receptor EP4 (1)
- Prostaglandine (1)
- Proteasomal system (1)
- Proteasome and lysosome (1)
- Protein (1)
- Protein Modifizierung (1)
- Protein aggregates (1)
- Protein functionality and modification (1)
- Protein-Wechselwirkungen (1)
- Proteine (1)
- Proteinmodifizierung (1)
- Proteolysis (1)
- Proteome (1)
- Proteostase (1)
- Proteostasis (1)
- Prävention (1)
- Pseudomonas aeruginosa (1)
- Psoriasis (1)
- Pulmonary arterial hypertension (1)
- Pulse wave velocity (1)
- Punktmutation (1)
- Purification (1)
- Pyrrolizidine alkaloids (1)
- QSAR (1)
- QTL (1)
- Quality appraisal (1)
- Quantification of peptides (1)
- RAW 264 (1)
- RBP (1)
- RNA Sequencing (1)
- RNA Sequenzierung (1)
- RNAseq (1)
- ROS (1)
- Radiocontrast media-induced nephropathy (1)
- Raman spectroscopy (1)
- Ratte (1)
- Rauchen (1)
- Reactive Oxygen Species (1)
- Reaktive Sauerstoffspezies (1)
- Recycling (1)
- Redox (1)
- Redox control (1)
- Redox homeostasis (1)
- Redox regulation (1)
- Reduktase (1)
- Reference intervals (1)
- Refinement (1)
- Regionality (1)
- Regulatory T cells (Treg) (1)
- Reh (1)
- Relaxin (1)
- Reliability (1)
- Renin-angiotensin system (1)
- Renin-angiotensin-aldosterone system (1)
- Reportergen-Assay (1)
- Resistance (1)
- Resistant starch (1)
- Retinoblastoma (1)
- Retinol (1)
- Retinol-Bindungsprotein 4 (1)
- Retinol-binding protein 4 (1)
- Retinopathie (1)
- Rezeptoren (1)
- Rezeptorscreening (1)
- Rheologie (1)
- Risikobewertungen (1)
- Risikoeinschätzung (1)
- Risk (1)
- Risk factor (1)
- Risk prediction (1)
- Risk prediction model (1)
- Risk score (1)
- Root exudates (1)
- Rosa x level (1)
- Rye (1)
- S1P receptors (1)
- S1P(3) receptor (1)
- SCID mice (1)
- SEC-HPLC (1)
- SELENOH (1)
- SGK-1 (1)
- SNARE proteins (1)
- SREBP-1c (1)
- SSCP (1)
- ST-1071 (1)
- ST-1893 (1)
- ST-1894 (1)
- ST-968 (1)
- SU5416 (1)
- SULT1A1 (1)
- SULT1A2 (1)
- SVM (1)
- Saccharomyces boulardii (1)
- Safety (1)
- Salicin (1)
- Saline Landwirtschaft (1)
- Salzgeschmack (1)
- Sarkopenie (1)
- Schilddrüse (1)
- Schilddrüsenautoimmunerkrankungen (1)
- Schlaganfall (1)
- Schwerkraft (1)
- Se-methylselenoneine (1)
- Seafood (1)
- Seasonality (1)
- Secondary metabolites (1)
- Selenonein (1)
- Selenoneine (1)
- Selenoprotein (1)
- Selenosugar 1 (1)
- Senescence (1)
- Sensorik (1)
- Serine and trypsin protease (1)
- Serotonin (1)
- Set-Point (1)
- Sex ratio at birth (1)
- Sexual dimorphism (1)
- Shan He Jian Fei Granules (SHJFG) (1)
- Short chain dehydrogenase (1)
- Short stature (1)
- Side effects (1)
- Signal transduction (1)
- Signaling pathways (1)
- Signalübertragung (1)
- Single nucleotide polymorphism (1)
- Skelettmuskel (1)
- Skelettmuskelalterung (1)
- Skin (1)
- Skin barrier disruption (1)
- Skin model (1)
- Slatted floor (1)
- Small molecules (1)
- Small selenium species (1)
- Smooth muscle cells (1)
- Sojabohne (1)
- Solanum scabrum (1)
- Speciation (1)
- Species differences (1)
- Spectrophotometry (1)
- Speichel (1)
- Spelt (1)
- Spermienmotilität (1)
- Sphingomyelin (1)
- Sphingosine 1-phosphate (S1P) (1)
- Sphingosine 1phosphate (1)
- Sphingosine kinase-1 (1)
- Sphingosine-1-phosphate lyase (1)
- Spirulina (1)
- Sport (1)
- Spurenelement (1)
- Stammzelle (1)
- Stereotypien (1)
- Stickstoffmonoxid (1)
- Stillbirth (1)
- Stoffwechselkäfig (1)
- Stroke (1)
- Stromal cell-derived factor-1 (1)
- Structural changes (1)
- Study protocol (1)
- Styrol (1)
- Substratverwertung (1)
- Sucrose (1)
- Sulfid (1)
- Sulfonate (1)
- Sulfoquinovose (1)
- Superoxiddismutase (1)
- Susceptibility-genes (1)
- Suszeptibilitätsgene (1)
- Swine (1)
- Synbiotika (1)
- Synthesis (1)
- Säugetiere ; Fettgewebe ; Zelldifferenzierung ; Genexpression (1)
- Säuglingsnahrung (1)
- Süßgeschmack (1)
- Süßrezeptor (1)
- Süßstoff (1)
- T helper 17 cells (1)
- T2D (1)
- TAVI (1)
- TEAC (1)
- TET (1)
- TFA (1)
- TGF-beta (1)
- TGF-beta 1 (1)
- TNF alpha (1)
- TRPV5 (1)
- TRPV6 (1)
- TTC (1)
- TTR (1)
- Tagetes (1)
- Tas1r1 (1)
- Tas2r (1)
- Tas2rs (1)
- Taurocholate (1)
- Tea leaves (1)
- Technofunctional properties (1)
- Teecatechin (1)
- Testicle (1)
- Tetranychus urticae (1)
- Th17 (1)
- Thai population (1)
- Thermal and nonthermal treatment (1)
- Thermal processing (1)
- Thin layer chromatography (1)
- Thio-arsenosugar-glycerol (1)
- Thio-dimethylarsinic acid (1)
- Thiol (1)
- Thiol-dependent peroxidase (1)
- Thiolmodifikation (1)
- Thioredoxin reductase (1)
- Three phase partitioning (1)
- Thrifty phenotype (1)
- Thyroid hormone (1)
- Tierarzneimittel (1)
- Tierschutz (1)
- Tight Junction (1)
- Tight Junctions (1)
- ToF-SIMS (1)
- ToF-SIMS imaging (1)
- Tocopherol (1)
- Tocotrienol (1)
- Tocotrienols (1)
- Total arsenic (1)
- Total diet study (1)
- Toxicokinetics (1)
- Toxikokinetik (1)
- TraceAge (1)
- Trans-Fettsäuren (1)
- Trans-epoxy-fatty acid (1)
- Transactivation assay (1)
- Transcatheter Aortic Valve Implantation (1)
- Transcriptomics (1)
- Transformation product (1)
- Transformationsprodukt (1)
- Transforming growth factor beta (1)
- Transkriptionsfaktor (1)
- Transkriptom (1)
- Transmembrane asymmetry (1)
- Transmission (1)
- Transplantation (1)
- Triglyceride secretion (1)
- Trunk length (1)
- Tumor (1)
- Tumor necrosis factor alpha (1)
- Tumour suppressor genes (1)
- Tween40 micelles (1)
- Twister (TM) (1)
- Twister TM (1)
- Typ 2 Diabetes (1)
- Type-2-diabetes (1)
- UDP-glucuronosyltransferase (1)
- UV light (1)
- Ubiquitin Proteasom System (1)
- Ulcerative colitis (1)
- Umbilical artery Doppler (1)
- Umbrella review (1)
- Uncoupling proteins (1)
- Unprepared and (1)
- Urinary ET-1 (1)
- Urine excretion (1)
- Uruguay River (1)
- VCAM-1 (1)
- VOC (1)
- Validation (1)
- Vascular stiffness (1)
- Vegan (1)
- Verhaltensstudien (1)
- Versuchstierkunde (1)
- Very low birth weight infant (1)
- Veterinary drugs (1)
- Vineatrol (R) 30 (1)
- Vitamin A supplementation (1)
- Vitamin C (1)
- Vitamin D (1)
- Vitamin D binding protein (1)
- Vitamin D deficiency (1)
- Vitamin D insufficiency (1)
- Vitamin D-binding protein (1)
- Vitellogenin (1)
- Volatile compound (1)
- WAT (1)
- Warburg effect (1)
- Water and salt retention (1)
- Weight change (1)
- Wheat (1)
- Whey proteins (1)
- Wiederkäuer (1)
- Wnt pathway (1)
- Wnt-Signalweg (1)
- World Cancer Research Fund/American Institute for Cancer Research Recommendations (1)
- Xenobesity (1)
- Y:X chromosome ratio (1)
- YB-1 (1)
- Yolk (1)
- Zellkulturen (1)
- Zelllinien (1)
- Zellproliferation (1)
- Zink (1)
- Zinypr-1 (1)
- Zirkadianer Rhythmus (1)
- Zoonoses (1)
- Zwillingsstudie (1)
- Zytokine (1)
- [N-15]Anthranilic acid (1)
- [N-15]Indole (1)
- a-tocopherol (1)
- absorption (1)
- accretionary wedge (1)
- acetate (1)
- activation (1)
- activity-regulated cytoskeleton-associated protein (1)
- acute inflammation (1)
- ad libitum consumption (1)
- ad libitum-Verzehr (1)
- adipocyte (1)
- advanced glycation endproducts (1)
- agonists interaction (1)
- air pollution (1)
- air-dried (1)
- air-fried (1)
- akute Entzündung (1)
- alcohol (1)
- alcohol dehydrogenase (1)
- alcohol intake (1)
- alcylated polycyclic aromatic hydrocarbons (1)
- aldehyde dehydrogenase (1)
- alkylated polycyclic aromatic hydrocarbons (1)
- allometric model (1)
- alpha-Catenin (1)
- alpha-SMA (1)
- alpha-Tocopherol (1)
- alpha-tocopherol (1)
- alpha-tocopherol transfer protein (Ttpa) (1)
- alternative zu Tierversuchen (1)
- amaranth (1)
- amino acid score (1)
- amino acids (1)
- amitriptyline (1)
- amylase activity (1)
- analytical methods (1)
- anaphylaxis (1)
- and nutrition (1)
- angiotensin (1-7) (1)
- angiotensin II (1)
- animal welfare (1)
- anti-inflammatory therapy (1)
- antibacterial aerosol (1)
- antibacterial effect (1)
- antibakterielles Aerosol (1)
- anticancer (1)
- antidiabetic drug (1)
- antifogging additives (1)
- antioxidant activity (1)
- antioxidant defense systems (1)
- antioxidant potential (1)
- antioxidative capacity (1)
- antioxidative phenolic ingredients (1)
- anxiety sensitivity (1)
- aphids (1)
- appetite regulation (1)
- arabinoxylan (1)
- aroma quality (1)
- aromatic amines; sulfotransferases; mutagenicity; bioactivation (1)
- aromatische Amine; Sulfotransferasen; Mutagenität; Bioaktivierung (1)
- arsenic (1)
- arsenolipids (1)
- artificial (1)
- astrocytes (1)
- asymmetric dimethylarginine (1)
- asymmetric dimethylarginine (ADMA) (1)
- asymmetrisches Dimethylarginin (1)
- atmospheric deposition (1)
- auditory neurons (1)
- autofluorescence (1)
- autoimmunity (1)
- autophagy flux (1)
- autophagy lysosomal system (1)
- b-Catenin (1)
- barrier (1)
- behavioral experiments (1)
- behaviour (1)
- benzylic sulfate (1)
- benzylic sulfuric acid ester (1)
- benzylischer Schwefelsäureester (1)
- benzylisches Sulfat (1)
- benzylisothiocyanate (1)
- beta-Lactoglobulin (1)
- beta-carotene (1)
- beta-carotene hydroxylase (1)
- beta-cell loss (1)
- beta-cells (1)
- beverage (1)
- bifidobacterium (1)
- bile acids (1)
- bioactive peptides (1)
- bioactivity (1)
- biomarkers (1)
- biomarkers of renal failure (1)
- biotransformation (1)
- birds of prey (1)
- birthweight (1)
- bladder cancer cells (1)
- blood banking (1)
- blood biomarker (1)
- blood pressure (1)
- blood-brain barrier (1)
- blood– brain barrier (1)
- blood– cerebrospinal fluid barrier (1)
- body composition (1)
- body mass (1)
- body weight (1)
- body weight loss (1)
- body weight maintenance (1)
- bone (1)
- bone mineral density (1)
- brain-gut axis (1)
- branched chain amino acids (1)
- braunes Fettgewebe (1)
- breast cancer (1)
- broiler chicks (1)
- brown adipose tissue (1)
- browning (1)
- burn injury (1)
- c-Fos (1)
- cachexia (1)
- caenorhabditis elegans (1)
- caffeic acid derivatives (1)
- calbindin D9k (1)
- calcitriol (1)
- calcium imaging (1)
- calcium transport (1)
- caloric restriction (1)
- cancer cells (1)
- cancer stem cells (1)
- canine osteoarthritis (1)
- cannabidiol (CBD) (1)
- capillary blood (1)
- caquexia (1)
- carbon sequestration (1)
- carcinogenesis (1)
- cardiac progenitor migration and differentiation (1)
- cardiokine (1)
- cardiometabolic diseases (1)
- cardiovascular risk (1)
- carob fibre (1)
- carota L (1)
- carotene (1)
- carotenoids bioavailability (1)
- catFISH (1)
- catalase (1)
- cell cuture (1)
- cell cycle (1)
- cell line (1)
- cell migration (1)
- cell transformation assay (1)
- cell wall deficient mutant (1)
- cell-based in vitro assay (1)
- cellular uptake (1)
- central nervous system (1)
- chemokines (1)
- chick embryo (1)
- children (1)
- chimpanzee (1)
- chlorbenzol (1)
- chlorogenic acid (1)
- chlorophylls (1)
- chronic and acute inflammation (1)
- chronic disease (1)
- chronic renal failure (1)
- chronic renal failure in children (1)
- chronisch-entzündliche Darmerkrankungen (1)
- cilium (1)
- circulation (1)
- classification (1)
- click chemistry (1)
- clinical prediction rule (1)
- clinical sample (1)
- clinical studies (1)
- clinical trial (1)
- cocoa processing (1)
- cocoa proteins (1)
- coffee proteins (1)
- cold atmospheric pressure plasma (1)
- collagen I (1)
- colocalisation study (1)
- colon cancer (1)
- colon cancer diagnosis (1)
- color (1)
- color preference (1)
- color vision (1)
- colorectal carcinoma (1)
- colorectal neoplasm (1)
- colostrum (1)
- colour (1)
- commensal (1)
- comparison (1)
- complication (1)
- complications (1)
- constitutive androstane receptor (1)
- construct validity (1)
- contrast-induced nephropathy (1)
- core (1)
- cost-effectiveness analysis (1)
- coupled plasma mass spectrometry (1)
- cow-side assay (1)
- crop (1)
- curcumin (1)
- cystic fibrosis (1)
- cytotoxicity (1)
- d-Loop (1)
- dairy intake (1)
- decision tree (1)
- decitabine (1)
- deep-fried (1)
- dendritic cell (1)
- dendritic polyglycerol (1)
- depression (1)
- desensitization (1)
- diatoms (1)
- dichlorbenzol (1)
- dichlorobenzene (1)
- diet score (1)
- diet selection (1)
- diet-disease association (1)
- dietary antioxidants (1)
- dietary choices (1)
- dietary citric acid (1)
- dietary factors (1)
- dietary fibre (1)
- dietary guidelines (1)
- dietary lipids (1)
- dietary sulfonates (1)
- dietary supplements (1)
- disproportional intrauterine growth retardation (1)
- distal convoluted tubule (1)
- distress (1)
- diurnal rhythm (1)
- diätetische Antioxidantien (1)
- dog (1)
- domestic cooking (1)
- dosage recommendation (1)
- drug design (1)
- drug metabolism (1)
- drug-resistant bacteria (1)
- dysfunction (1)
- e-Zigarette (1)
- e-cigarette (1)
- eating (1)
- echocardiography (1)
- egg yolk (1)
- electronic drug delivery system (EDDS) (1)
- electronic nicotin delivery system (ENDS) (1)
- ellagic acid (1)
- emotionality (1)
- emulsion (1)
- endocannabinoids (1)
- endocrine disruption (1)
- endothelabhängige flussinduzierte Vasodilatation (1)
- endothelial cell (1)
- endothelial function (1)
- endothelin-converting enzyme (1)
- energy (1)
- energy expenditure (1)
- energy harvest (1)
- environmental DNA (1)
- environmental impact (1)
- enzyme assays (1)
- enzyme induction (1)
- enzymes (1)
- epigallocatechin gallate (1)
- equol (1)
- essential oils (1)
- etanercept (1)
- etiology (1)
- exercise performance (1)
- experimental antigen-induced encephalomyelitis (1)
- expression analysis (1)
- extinction (1)
- extra-cellular matrix (1)
- extraction and characterization methods (1)
- factor structure (1)
- fasting blood glucose (1)
- fat metabolism (1)
- fat perception (1)
- fat-soluble vitamin (1)
- fatigue (1)
- fatty acid synthesis (1)
- fatty pancreas (1)
- female (1)
- fermentation (1)
- fermentation-related enzymes (1)
- fetal programing (1)
- fetal sex (1)
- fiber (1)
- filter paper (1)
- fingolimod (1)
- first trimester (1)
- flavonoid (1)
- fluorescent probe (1)
- fluvial terraces (1)
- foal (1)
- food (1)
- food allergy (1)
- food groups (1)
- food safety (1)
- foot and mouth disease (HFMD) (1)
- fortification (1)
- frailty (1)
- frataxin (1)
- free radicals (1)
- free zinc (1)
- fruit metabolites (1)
- functional diversity (1)
- functional properties (1)
- funktionelle Variabilität (1)
- future food (1)
- fígado (1)
- garnet (1)
- gender (1)
- gene (1)
- gene regulation (1)
- gene-lifestyle interaction (1)
- genetic variants (1)
- genetics (1)
- genomics (1)
- gerontology (1)
- geschützter Anbau (1)
- gestational diabetes mellitus (GDM) (1)
- girths and breadths (1)
- glasswort (1)
- gliptins (1)
- glomerular arterioles (1)
- glucose homeostasis (1)
- glucose transport (1)
- glycation (1)
- glycemic control (1)
- glycemic control during pregnancy (1)
- glycogen synthase kinase-3 (1)
- gold nanostars (1)
- grafische Modelle (1)
- graphical models (1)
- gravity (1)
- green tea (1)
- green tea phenols (1)
- greenhouse gas emissions (1)
- groEL (1)
- growth (1)
- gut length (1)
- hTAS2R10 (1)
- haemodialysis (1)
- hand (1)
- haplotype (1)
- health (1)
- health span (1)
- healthy subjects (1)
- heart tube (1)
- heart-type fatty acid binding protein (1)
- heat shock proteins (1)
- heath potentials (1)
- heme (1)
- hemodialysis (1)
- hepatic impairment (1)
- hepatocellular carcinoma (1)
- hepatotoxicity (1)
- heptadecanoic acid (C17:0) (1)
- heritability (1)
- heterocyclic aromatic amine (1)
- heterocyclic aromatic amines (1)
- heterocyclisches aromatisches Amin (1)
- heterologe Expression (1)
- heterologous expression (1)
- heterozyklische aromatische Amine (1)
- high fat diet (1)
- high salt (1)
- high-density lipoprotein (HDL) (1)
- high-fat diet (1)
- high-resolution imaging (1)
- hippocampus (1)
- homocysteine (1)
- homology modelling (1)
- hormones (1)
- human body composition (1)
- human diet (1)
- human follicular fluid (1)
- human health (1)
- human liver microsomes (1)
- human milk (1)
- hunger hormone (1)
- hydroxymethylfurfural (1)
- hydroxymethylpyrene (1)
- hyperglycemia (1)
- hypotension (1)
- hypoxic pulmonary vasoconstriction (1)
- hypoxische pulmonale Vasokonstriktion (1)
- immediate early gene (1)
- immune (1)
- immune response (1)
- immune system (1)
- immune-inflammatory biomarkers (1)
- immunoblot (1)
- immunohistochemistry (1)
- immunomodulator (1)
- impaired glucose tolerance (1)
- in silico (1)
- in situ chemical reduction (1)
- in vitro blood-brain barrier model (1)
- in vivo (1)
- incident type 2 diabetes (1)
- increases (1)
- index (1)
- indigenous leafy vegetables (1)
- indoor farming (1)
- induced pluripotent stem cells (1)
- induction (1)
- induzierte pluripotente Stammzellen (1)
- inflamação (1)
- inhalative Applikation (1)
- inhibitory cytokines (1)
- inorganic mercury (1)
- insect proteins (1)
- insulin signalling (1)
- insulin-induced hypoglycemia (1)
- insulina (1)
- insulinresistance (1)
- integrated stress response (1)
- integrins (1)
- intercropping (1)
- interleukin-1 (1)
- interleukin-35 (1)
- interventions (1)
- intesinal disease (1)
- intestinal (1)
- intestinal epithelial cells (1)
- intestinal inflammation (1)
- intestinal model (1)
- intestinale Epithelzellen (1)
- intestinale Mikrobiota (1)
- intrauterine (1)
- intrauterine fetal growth (1)
- inulin (1)
- invasion (1)
- involuntary weight loss (1)
- iodine (1)
- ion chromatography (1)
- ion quantification (1)
- ionophore antibiotics (1)
- iron (1)
- ischemia reperfusion injury (1)
- isoflavones (1)
- isothiocyanate (1)
- kale (1)
- kardiovaskuläres Risiko (1)
- ki-ras (1)
- kidney dysfunction (1)
- kidney injury molecule 1 (1)
- kinetics (1)
- knock-out (1)
- kolorektales Karzinom (1)
- kurzkettige Fettsäuren (1)
- körperliche Aktivität (1)
- laboratory animal sciences (1)
- laboratory mice (1)
- lactobacillus (1)
- lake sediments (1)
- land use (1)
- land-based aquaculture (1)
- langsame und schnelle Fasertypen (1)
- large for gestational age fetus (LGA) (1)
- large sample size studies (1)
- latex (1)
- lettuce (1)
- leucine (1)
- leukocyte-endothelial interaction (1)
- life style (1)
- lifestyle risk reduction (1)
- limb lengths (1)
- lineage commitment (1)
- linear gemischte Modelle (1)
- linear mixed models (1)
- lipases (1)
- lipid (1)
- lipid analysis (1)
- lipids (1)
- liposomes (1)
- litter decomposition (1)
- liver disease (1)
- liver regeneration (1)
- liver toxicity (1)
- long chain base (1)
- longevity (1)
- longitudinal analysis (1)
- low birth weight (LBW) (1)
- low molecular weight selenium species (1)
- low temperature (1)
- low-grade inflammation (1)
- lower nephron (1)
- lower respiratory tract infections (LRTIs) (1)
- lung cancer (1)
- lung inflammation (1)
- lupin (1)
- lutein ester (1)
- lutein esters (1)
- lycopene (1)
- lymphopenia (1)
- lysosomal storage disorders (1)
- lysozyme (1)
- lysozyme activity (1)
- mPGES (1)
- machine learning (1)
- macroarray (1)
- macrophage (1)
- macrovascular complications (1)
- macrófagos (1)
- macular pigment density (1)
- makrovaskuläre Komplikationen (1)
- male (1)
- malignant transformation (1)
- maligne Transformation (1)
- mare (1)
- maternal diet (1)
- maternale Ernährung (1)
- matrix metalloproteinases (1)
- maturity (1)
- mealworm (1)
- measles virus (1)
- mediation analysis (1)
- mediterrane Ernährung (1)
- membrane analysis (1)
- membrane lipids (1)
- membrane-lipid therapy (1)
- menschliche Ernährung (1)
- mercuric mercury (1)
- metablism (1)
- metabolic cage (1)
- metabolic response (1)
- metabolischer Stress (1)
- metabolisches Syndrom (1)
- methionine restriction (1)
- method development (1)
- method validation (1)
- methyl jasmonate (1)
- methylmercury (1)
- miRNAs (1)
- microRNAs (1)
- microbial mining (1)
- microbiology (1)
- microbiomics (1)
- microbiota (1)
- microgreen (1)
- micronutrient (1)
- micronutrient deficiencies (1)
- microorganisms (1)
- microparticle (1)
- microplastics (1)
- microscope (1)
- migration (1)
- mikrovaskuläre Komplikationen (1)
- mitochondria, (1)
- mixtures (1)
- molecular dynamics (1)
- molecular modeling (1)
- molecular pathways (1)
- monochlorobenzene (1)
- morpholino analogues of fingolimod (1)
- motor neurons (1)
- mouse models (1)
- moxidectin (1)
- mtDNA (1)
- mucus (1)
- multiple sclerosis (1)
- muscle (1)
- muscle atrophy (1)
- muscle fibre composition (1)
- muscle fibre type (1)
- muscle metabolism (1)
- muscle protein turnover (1)
- muscle wasting (1)
- myoglobin (1)
- myokine (1)
- myrrh (1)
- n-3 fatty acid (1)
- n-6 fatty acid (1)
- n-oxPTH (1)
- narrow-banded UVB (1)
- natural compounds (1)
- nephrin (1)
- nephropathy (1)
- network (1)
- networks (1)
- neurofibromatosis (1)
- neuron (1)
- neurons (1)
- neuropathy (1)
- neuropeptides (1)
- neutral endopeptidase (1)
- neutrophil chemotaxis (1)
- neutrophil gelatinase-associated lipocalin (1)
- new analysis method (1)
- nomadic pastoralist (1)
- non-alcoholic steatohepatitis (1)
- nonlinear microscopy (1)
- nuclear receptor (1)
- nucleosidadduct (1)
- nucleus of the solitary tract (1)
- nukleärer Rezeptor (1)
- nutrition security (1)
- nutritional factors (1)
- nutritional supplements (1)
- old adults (1)
- oligomers (1)
- omega-3 fatty acid (1)
- one dot two development signals (ODTDS) dot blot (1)
- ontogeny (1)
- operant behavior (1)
- optogenetic (1)
- oral immunotherapy (1)
- orale Immuntherapie (1)
- orangutan (1)
- organ failure (1)
- organic mercury (1)
- orphan crops (1)
- osteoblast (1)
- osteopontin (1)
- osteoporosis (1)
- osterix (1)
- outcome (1)
- ovarian cancer (1)
- oxidation (1)
- oxidativer Stress (1)
- p-AKT (1)
- p-mTOR (1)
- pH-sensitive nanoparticle (1)
- pH-sensitive nanoparticles (1)
- palm oil (1)
- paternal programming (1)
- pathogen (1)
- peanut allergy (1)
- pentadecanoic acid (C15:0) (1)
- peptide (1)
- performance (1)
- peripheral nervous system (1)
- peripheres Nervensystem (1)
- perturbation (1)
- pflanzliche Sekundär Metabolite (1)
- phase II enzymes (1)
- phenol nitration (1)
- phenol oxidation (1)
- phenols (1)
- phosphorus (1)
- photochemistry (1)
- photosynthesis (1)
- photothermal therapy (1)
- phthalates (1)
- physiology (1)
- phytochemicals (1)
- pilot study (1)
- placenta (1)
- plant growth-promoting bacteria (1)
- plant phenolic compounds (1)
- plant protease (1)
- plant secondary metabolites (1)
- plant-based diets (1)
- plasma process indicators (1)
- plastic additives (1)
- point mutation (1)
- pollution (1)
- poly ungesättigte Fettsäuren (1)
- polyamines (1)
- polycystic kidney disease (1)
- polycystic ovary syndrome (1)
- polytunnel (1)
- polyunsaturated fatty acids (1)
- ponderostat (1)
- positional cloning (1)
- post-hospital syndrome (1)
- post-menopausal Thai women (1)
- postmenopausal (1)
- postprandial response (1)
- postprandial study (1)
- potassium iodate (1)
- potency assessment (1)
- preadipocyte (1)
- prebiotics (1)
- pregnancy induced diabetes (1)
- pregnane X-receptor (1)
- prepared foods (1)
- presystemic metabolism (1)
- preterm delivery (1)
- preterm infant (1)
- preventive measures (1)
- primary immunodeficiencies (1)
- priming effect (1)
- principal component analysis (1)
- proinsulin (1)
- proline rich proteins (1)
- prolinreiche Proteine (1)
- propionate (1)
- prostaglandin receptor (1)
- prostaglandine (1)
- prostate cancer (1)
- protected cultivation (1)
- protein derivatization (1)
- protein digestibility (1)
- protein interactions (1)
- protein microheterogeneity (1)
- protein pattern (1)
- protein quantification (1)
- protein-phenol binding (1)
- protein-phenol interactions (1)
- proteomics (1)
- proteomix analysis (1)
- pulmonalarterielle glatte Muskelzellen (1)
- pulmonary artery smooth muscle cells (1)
- qPCR-based gene expression screening (1)
- quality control (1)
- quantitativ (1)
- quantitative (1)
- ramipril (1)
- randomisierte Studie (1)
- randomized controlled intervention study (1)
- randomized controlled trial (1)
- rapeseed protein (1)
- rapid detection method (1)
- reactive oxygen and nitrogen species (1)
- reactive oxygen species (1)
- real life context (1)
- receptor (1)
- red wine (1)
- redox (1)
- redox homeostasis (1)
- reductase (1)
- reflection spectroscopy (1)
- regional diets (1)
- regulatory T cells (1)
- regulatory monitoring (1)
- relative dose response test (1)
- reliability; (1)
- renal dysfunction (1)
- renal function (1)
- renal haemodynamics (1)
- repeated measures design (1)
- replication (1)
- reporter gene assay (1)
- reproducibility (1)
- resistência à insulina (1)
- respiratory diseases (1)
- resveratrol (1)
- resveratrol oligomers (1)
- retinoic acid (1)
- retinol (ROH) (1)
- retinol binding protein 4 (1)
- retinol-binding protein (1)
- retinopathy (1)
- retinyl esters (1)
- retinyl palmitate (1)
- risk assessment (1)
- risk factors (1)
- risk score (1)
- risk scores (1)
- roe deer (1)
- ruminant (1)
- ruminants (1)
- sFlt-1 (1)
- safety efficacy (1)
- salinomycin (1)
- saliva proteins (1)
- salivary proteins (1)
- salmon fish (1)
- salt composition (1)
- salt taste perception (1)
- scores (1)
- screening (1)
- scrub typhus (1)
- seawater (1)
- sekundäre Pflanzenstoffe (1)
- selenium transport (1)
- selenoprotein (1)
- sensory analysis (1)
- sepsis (1)
- serine protease (1)
- serum amyloid A (SAA) (1)
- serum retinol binding protein (RBP4) (1)
- set-point (1)
- short chain fatty acids (1)
- shortening rate (1)
- single nucleotide polymorphism (1)
- single-cell analysis (1)
- situation (1)
- skeletal muscle aging (1)
- skeletal-muscle (1)
- skin (1)
- skin equivalents (1)
- slow and fast fiber types (1)
- smartphone (1)
- smoking (1)
- sodium (1)
- soy (1)
- soy isoflavones (1)
- spectrophotometry (1)
- sperm motility (1)
- spermatogenesis (1)
- sphingomyelin phosphodiesterase 1 (1)
- sphingosine kinase-1 (1)
- sphingosine kinases (1)
- sphingosine-1-phosphate (S1P) (1)
- spider mites (1)
- starter formula (1)
- stem cell (1)
- stereotypy (1)
- stomach model (1)
- storage (1)
- styrene (1)
- suPAR (1)
- substrate utilisation (1)
- succession (1)
- sudden death (1)
- sulfide (1)
- sulforaphan (1)
- sulforaphane (1)
- superoxide dismutase (1)
- suppressor of cytokine signaling (SOCS) (1)
- sweet taste (1)
- sweet taste receptor (1)
- sweetener (1)
- synbiotics (1)
- synovial fluid (1)
- systematischer Review (1)
- systemic response (1)
- systolic function (1)
- síndrome metabólica (1)
- tannin binding salivary proteins (1)
- tannin-protein interaction (1)
- tanninbindende Speichelproteine (1)
- targeted metabolomics (1)
- taste receptor (1)
- taste receptor screening (1)
- tea catechin (1)
- tea processing (1)
- telbivudine (1)
- telmisartan (1)
- terpenoids (1)
- therapy (1)
- thermal processing (1)
- thermal processing of food (1)
- thermogenesis (1)
- thermoresponsive-nanogel (1)
- thiol modification (1)
- thiomersal (1)
- thioredoxin-interacting protein (1)
- thymosin beta 4 (1)
- tight junction (1)
- tight junctions (1)
- tissue inhibitior of metalloproteinases 1 (1)
- tocopherol (1)
- topical (1)
- total body fat (1)
- total glycated hemoglobin (1)
- total glycosylated hemoglobin (1)
- total phenol content (1)
- toxicology (1)
- trace element (1)
- training intervention (1)
- trans fatty acids (1)
- trans-Golgi (1)
- trans-migration (1)
- transcription factor (1)
- transformation product (1)
- transfusion-related acute lung injury (1)
- transgenerational effects (1)
- transgenes Mausmodell (1)
- transgenic mousemodel (1)
- transient receptor potential (1)
- transmission of hepatitis B virus (HBV) (1)
- transport proteins (1)
- transthyretin (TTR) (1)
- triazole fungicides (1)
- tryptophan quenching (1)
- tumor (1)
- tumor-metastasis (1)
- twin study (1)
- type 2 diabetes (T2DM) (1)
- type II diabetes (T2DM) (1)
- type-2-diabetes (1)
- ubiquitin proteasomal system (1)
- ultra heat treatment (1)
- ultrasound (1)
- umami (1)
- underutilized species (1)
- universal coating (1)
- urban (1)
- urinary biomarker (1)
- urine (1)
- valine (1)
- vascular disease; (1)
- vascular smooth muscle cells (1)
- vegan diet (1)
- vending machine (1)
- verzweigtkettige Aminosäuren (1)
- vesicular trafficking (1)
- vesicular transport (1)
- vesikulärer Transport (1)
- veterinary drug (1)
- vitamin (1)
- vitamin A deficiency (1)
- vitamin D binding protein (1)
- vitamin D-binding protein (1)
- vitamin E (1)
- vitamins (1)
- volatile compounds (1)
- weight loss intervention (1)
- weight maintenance (1)
- weight reduction (1)
- weight regulation (1)
- western blot (1)
- whey proteins (1)
- white adipose tissue (1)
- whole grains (1)
- whole-grain (1)
- yield enhancement (1)
- yolk (1)
- zeaxanthin (1)
- zentrales Nervensystem (1)
- zinc/iron supplementation (1)
- Östrogene (1)
- Übertragung (1)
- ß-Glucan (1)
- ätherische Öle (1)
- α-Tocopheroltransferprotein (Ttpa) (1)
- α-tocophero (1)
Institute
- Institut für Ernährungswissenschaft (1244) (remove)
Epigenetic DNA methylation of EBI3 modulates human interleukin-35 formation via NFkB signaling
(2021)
Ulcerative colitis (UC), a severe chronic disease with unclear etiology that is associated with increased risk for colorectal cancer, is accompanied by dysregulation of cytokines. Epstein-Barr virus-induced gene 3 (EBI3) encodes a subunit in the unique heterodimeric IL-12 cytokine family of either pro- or anti-inflammatory function. After having recently demonstrated that upregulation of EBI3 by histone acetylation alleviates disease symptoms in a dextran sulfate sodium (DSS)-treated mouse model of chronic colitis, we now aimed to examine a possible further epigenetic regulation of EBI3 by DNA methylation under inflammatory conditions. Treatment with the DNA methyltransferase inhibitor (DNMTi) decitabine (DAC) and TNF alpha led to synergistic upregulation of EBI3 in human colon epithelial cells (HCEC). Use of different signaling pathway inhibitors indicated NF kappa B signaling was necessary and proportional to the synergistic EBI3 induction. MALDI-TOF/MS and HPLC-ESIMS/MS analysis of DAC/TNF alpha-treated HCEC identified IL-12p35 as the most probable binding partner to form a functional protein. EBI3/IL-12p35 heterodimers (IL-35) induce their own gene upregulation, something that was indeed observed in HCEC cultured with media from previously DAC/TNF alpha-treated HCEC. These results suggest that under inflammatory and demethylating conditions the upregulation of EBI3 results in the formation of anti-inflammatory IL-35, which might be considered as a therapeutic target in colitis.
Real time monitoring of oxygen uptake of hepatocytes in a microreactor using optical microsensors
(2020)
Most in vitro test systems for the assessment of toxicity are based on endpoint measurements and cannot contribute much to the establishment of mechanistic models, which are crucially important for further progress in this field. Hence, in recent years, much effort has been put into the development of methods that generate kinetic data. Real time measurements of the metabolic activity of cells based on the use of oxygen sensitive microsensor beads have been shown to provide access to the mode of action of compounds in hepatocytes. However, for fully exploiting this approach a detailed knowledge of the microenvironment of the cells is required. In this work, we investigate the cellular behaviour of three types of hepatocytes, HepG2 cells, HepG2-3A4 cells and primary mouse hepatocytes, towards their exposure to acetaminophen when the availability of oxygen for the cell is systematically varied. We show that the relative emergence of two modes of action, one NAPQI dependent and the other one transient and NAPQI independent, scale with expression level of CYP3A4. The transient cellular response associated to mitochondrial respiration is used to characterise the influence of the initial oxygen concentration in the wells before exposure to acetaminophen on the cell behaviour. A simple model is presented to describe the behaviour of the cells in this scenario. It demonstrates the level of control over the role of oxygen supply in these experiments. This is crucial for establishing this approach into a reliable and powerful method for the assessment of toxicity.
Diabetesrisikoscores
(2020)
Risikoscores werden zur Identifizierung von Hochrisikopersonen für Typ-2-Diabetes (T2DM) eingesetzt, die von Präventionsmaßnahmen profitieren. Der DIfE – DEUTSCHER DIABETES-RISIKO-TEST® (DRT [DIfE: Deutsches Institut für Ernährungsforschung Potsdam‐Rehbrücke]) wird genutzt, um das absolute 5‑Jahres-Risiko für T2DM zu bestimmen. Da die Berechnung auf nichtklinischen Informationen basiert, kann der Test unabhängig von einem Arztbesuch genutzt werden. Als Grundlage für die Entwicklung von Risikoscores dienen Daten aus prospektiven populationsbezogenen Langzeitstudien. Die sehr gute Vorhersagegüte eines Scores sollte, wie im Fall des DRT, in unabhängigen Populationen bestätigt werden. Neben dem Einsatz durch Ärzte/‑innen und zur individuellen Selbstanamnese können nichtklinische Risikoscores im Kontext breiterer, bevölkerungsbezogener Präventionskonzepte und Informationsangebote zur Senkung des Erkrankungsrisikos Anwendung finden. Durch Krankenkassen abrechenbare Präventionsleistungen sollen im Sinne des deutschen Präventionsgesetzes die Integration von gesundheitsförderndem Verhalten in den Alltag unterstützen. Obwohl Übergewicht und Ernährung relevante Lebensstilrisikofaktoren für T2DM sind, beträgt der Anteil der in Anspruch genommenen Präventionskurse in diesem Bereich nur 3 % der abgerechneten Kurse. Entsprechende Empfehlungen in ärztlichen Untersuchungen könnten eine umfangreichere Inanspruchnahme fördern. Die Verwendung von Risikoscores als Grundlage für systematische und gezielte Handlungsempfehlungen hinsichtlich einer Verhaltensprävention könnte dies, wie es bereits in Richtlinien der kardiovaskulären Prävention etabliert ist, darüber hinaus unterstützen. Auch die Weiterentwicklung der Implementationsforschung ist für den effizienten Einsatz von Risikoscores von Bedeutung.
Scope:
Nutrition is a critical determinant of a functional immune system. The aim of this study is to investigate the molecular mechanisms by which immune cells are influenced by zinc and sodium.
Methods and Results:
Mixed lymphocyte cultures and Jurkat cells are generated and incubated with zinc, sodium, or a combination of both for further tests. Zinc induces the number of regulatory T cells (Treg) and decreases T helper 17 cells (Th17), and sodium has the opposite effect. The transforming growth factor beta receptor signaling pathway is also enhanced by zinc and reduced by sodium as indicated by contrary phosphoSmad 2/3 induction. Antagonistic effects can also be seen on zinc transporter and metallothionein-1 (MT-1) mRNA expression: zinc declines Zip10 mRNA expression while sodium induces it, whereas MT-1 mRNA expression is induced by zinc while it is reduced by sodium.
Conclusion:
This data indicate that zinc and sodium display opposite effects regarding Treg and Th17 induction in MLC, respectively, resulting in a contrary effect on the immune system. Additionally, it reveals a direct interaction of zinc and sodium in the priming of T cell subpopulations and shows that Zip10 and MT-1 play a significant role in those differentiation pathways.
Moxidectin (MOX) is a widely used anthelmintic drug for the treatment of internal and external parasites in food-producing and companion animals. Transformation products (TPs) of MOX, formed through metabolic degradation or acid hydrolysis, may pose a potential environmental risk, but only few were identified so far. In this study, we therefore systematically characterized electro- and photochemically generated MOX TPs using high-resolution mass spectrometry (HRMS). Oxidative electrochemical (EC) TPs were generated in an electrochemical reactor and photochemical (PC) TPs by irradiation with UV-C light. Subsequent HRMS measurements were performed to identify accurate masses and deduce occurring modification reactions of derived TPs in a suspected target analysis. In total, 26 EC TPs and 59 PC TPs were found. The main modification reactions were hydroxylation, (de-)hydration, and derivative formation with methanol for EC experiments and isomeric changes, (de-)hydration, and changes at the methoxime moiety for PC experiments. In addition, several combinations of different modification reactions were identified. For 17 TPs, we could predict chemical structures through interpretation of acquired MS/MS data. Most modifications could be linked to two specific regions of MOX. Some previously described metabolic reactions like hydroxylation or O-demethylation were confirmed in our EC and PC experiments as reaction type, but the corresponding TPs were not identical to known metabolites or degradation products. The obtained knowledge regarding novel TPs and reactions will aid to elucidate the degradation pathway of MOX which is currently unknown.
Obesity is a worldwide epidemic and contributes to global morbidity and mortality mediated via the development of nonalcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), cardiovascular (CVD) and other diseases. It is a consequence of an elevated caloric intake, a sedentary lifestyle and a genetic as well as an epigenetic predisposition. This review summarizes changes in DNA methylation and microRNAs identified in blood cells and different tissues in obese human and rodent models. It includes information on epigenetic alterations which occur in response to fat-enriched diets, exercise and metabolic surgery and discusses the potential of interventions to reverse epigenetic modifications.
Aging has been viewed both as a random process due to accumulation of molecular and cellular damage over time and as a programmed process linked to cellular pathway important for growth and maturation. These views converge on mitochondria as both the major producer of damaging reactive oxidant species (ROS) and as signaling organelles. A finite proton leak across the inner mitochondrial membrane leading to a slight uncoupling of oxidative phosphorylation and respiration is an intrinsic property of all mitochondria and according to the "uncoupling to survive" hypothesis it has evolved to protect against ROS production to minimize oxidative damage. This hypothesis is supported by evidence linking an increased endogenous, uncoupling protein (UCP1) mediated, as well as experimentally induced mitochondrial uncoupling to an increased lifespan in rodents. This is possibly due to the synergistic activation of molecular pathways linked to life extending effects of caloric restriction as well as a mitohormetic response. Mitohormesis is an adaptive stress response through mitonuclear signaling which increases stress resistance resulting in health promoting effects. Part of this response is the induction of fibroblast growth factor 21 (FGF21) and growth and differentiation factor 15 (GDF15), two stress-induced mitokines which elicit beneficial systemic metabolic effects via endocrine action.
Analysis of electrochemical and liver microsomal transformation products of lasalocid by LC/HRMS
(2022)
Rationale:
Lasalocid (LAS), an ionophore, is used in cattle and poultry farming as feed additive for its antibiotic and growth-promoting properties. Literature on transformation products (TP) resulting from LAS degradation is limited. So far, only hydroxylation is found to occur as the metabolic reaction during the LAS degradation. To investigate potential TPs of LAS, we used electrochemistry (EC) and liver microsome (LM) assays to synthesize TPs, which were identified using liquid chromatography high-resolution mass spectrometry (LC/HRMS).
Methods:
Electrochemically produced TPs were analyzed online by direct coupling of the electrochemical cell to the electrospray ionization (ESI) source of a Sciex Triple-TOF high resolution mass spectrometer. Then, EC-treated LAS solution was collected and analyzed offline using LC/HRMS to confirm stable TPs and improve their annotation with a chemical structure due to informative MS/MS spectra. In a complementary approach, TPs formed by rat and human microsomal incubation were investigated using LC/HRMS. The resulting data were used to investigate LAS modification reactions and elucidate the chemical structure of obtained TPs.
Results:
The online measurements identified a broad variety of TPs, resulting from modification reactions like (de-)hydrogenation, hydration, methylation, oxidation as well as adduct formation with methanol. We consistently observed different ion complexations of LAS and LAS-TPs (Na+; 2Na(+) K+; NaNH4+; KNH4+). Two stable methylated EC-TPs were found, structurally annotated, and assigned to a likely modification reaction. Using LM incubation, seven TPs were formed, mostly by oxidation/hydroxylation. After the identification of LM-TPs as Na+-complexes, we identified LM-TPs as K+-complexes.
Conclusion:
We identified and characterized TPs of LAS using EC- and LM-based methods. Moreover, we found different ion complexes of LAS-based TPs. This knowledge, especially the different ion complexes, may help elucidate the metabolic and environmental degradation pathways of LAS.
The bioactive sphingolipid sphingosine 1-phosphate (S1P) has emerged in the last three decades as main regulator of key cellular processes including cell proliferation, survival, migration and differentiation. A crucial role for this sphingolipid has been recognized in skeletal muscle cell biology both in vitro and in vivo. S1P lyase (SPL) is responsible for the irreversible degradation of S1P and together with sphingosine kinases, the S1P producing enzymes, regulates cellular S1P levels. In this study is clearly showed that the blockade of SPL by pharmacological or RNA interference approaches induces myogenic differentiation of C2C12 myoblasts. Moreover, down-regulation of the specific S1P transporter spinster homolog 2 (Spns2) abrogates myogenic differentiation brought about by SPL inhibition or down-regulation, pointing at a role of extracellular S1P in the pro-myogenic action induced by SPL blockade. Furthermore, also S1P(2) receptor down-regulation was found to abrogate the pro-myogenic effect of SPL blockade. These results provide further proof that inside-out S1P signaling is critically implicated in skeletal muscle biology and provide support to the concept that the specific targeting of SPL could represent an exploitable strategy to treat skeletal muscle disorders.
Dairy intake, as a source of branched-chain amino acids (BCAA), has been linked to a lower incidence of type-2-diabetes and increased circulating odd-chain fatty acids (OCFA). To understand this connection, we aimed to investigate differences in BCAA metabolism of leucine and valine, a possible source of OCFA, and their role in hepatic metabolism. Male mice were fed a high-fat diet supplemented with leucine and valine for 1 week and phenotypically characterized with a focus on lipid metabolism. Mouse primary hepatocytes were treated with the BCAA or a Ppar alpha activator WY-14643 to systematically examine direct hepatic effects and their mechanisms. Here, we show that only valine supplementation was able to increase hepatic and circulating OCFA levels via two pathways; a PPAR alpha-dependent induction of alpha-oxidation and an increased supply of propionyl-CoA for de novo lipogenesis. Meanwhile, we were able to confirm leucine-mediated effects on the inhibition of food intake and transport of fatty acids, as well as induction of S6 ribosomal protein phosphorylation. Taken together, these data illustrate differential roles of the BCAA in lipid metabolism and provide preliminary evidence that exclusively valine contributes to the endogenous formation of OCFA which is important for a better understanding of these metabolites in metabolic health.
Vitamin A, vitamin E and retinol-binding protein 4 (RBP4) are a focus of current obesity research in humans. The impact of body weight (BW) gain on fat-soluble vitamins and its associated parameters in equines has not been previously reported. Ten Shetland ponies and 9 Warmblood horses, all adult geldings, non-obese and healthy, were fed an excessive energy diet for 20 months to induce BW gain. Serum alpha-tocopherol (vitamin E), retinol (vitamin A), retinol-binding protein 4 (RBP4) and retinol/RBP4 ratio were analysed before BW gain induction and at six timepoints during the BW gaining period. The mean (+/- SD) % BW gain achieved during two years of excess energy intake was 29.9 +/- 19.4% for ponies and 17 +/- 6.74% for horses. Serum alpha-tocopherol increased significantly in ponies and horses during excess energy intake and circulating alpha-tocopherol levels correlated positively with alpha-tocopherol intake (r = .6; p < .001). Serum retinol concentrations showed variations during the study but without relation to intake. Serum RBP4 decreased at the end of the study. The retinol/RBP4 ratio increased with BW gain without differences between ponies and horses. In comparison with human research, the increase in the retinol/RBP4 ratio was unexpected and needs further elucidation.
Sarcopenia
(2020)
Sarcopenia represents a muscle-wasting syndrome characterized by progressive and generalized degenerative loss of skeletal muscle mass, quality, and strength occurring during normal aging. Sarcopenia patients are mainly suffering from the loss in muscle strength and are faced with mobility disorders reducing their quality of life and are, therefore, at higher risk for morbidity (falls, bone fracture, metabolic diseases) and mortality. <br /> Several molecular mechanisms have been described as causes for sarcopenia that refer to very different levels of muscle physiology. These mechanisms cover e. g. function of hormones (e. g. IGF-1 and Insulin), muscle fiber composition and neuromuscular drive, myo-satellite cell potential to differentiate and proliferate, inflammatory pathways as well as intracellular mechanisms in the processes of proteostasis and mitochondrial function. <br /> In this review, we describe sarcopenia as a muscle-wasting syndrome distinct from other atrophic diseases and summarize the current view on molecular causes of sarcopenia development as well as open questions provoking further research efforts for establishing efficient lifestyle and therapeutic interventions.
Metabolic signatures of healthy lifestyle patterns and colorectal cancer risk in a European cohort
(2020)
BACKGROUND & AIMS: Colorectal cancer risk can be lowered by adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines. We derived metabolic signatures of adherence to these guidelines and tested their associations with colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.
METHODS: Scores reflecting adherence to the WCRF/AICR recommendations (scale, 1-5) were calculated from participant data on weight maintenance, physical activity, diet, and alcohol among a discovery set of 5738 cancer-free European Prospective Investigation into Cancer and Nutrition participants with metabolomics data. Partial least-squares regression was used to derive fatty acid and endogenous metabolite signatures of the WCRF/AICR score in this group. In an independent set of 1608 colorectal cancer cases and matched controls, odds ratios (ORs) and 95% CIs were calculated for colorectal cancer risk per unit increase in WCRF/AICR score and per the corresponding change in metabolic signatures using multivariable conditional logistic regression.
RESULTS: Higher WCRF/AICR scores were characterized by metabolic signatures of increased odd-chain fatty acids, serine, glycine, and specific phosphatidylcholines. Signatures were inversely associated more strongly with colorectal cancer risk (fatty acids: OR, 0.51 per unit increase; 95% CI, 0.29-0.90; endogenous metabolites: OR, 0.62 per unit change; 95% CI, 0.50-0.78) than the WCRF/AICR score (OR, 0.93 per unit change; 95% CI, 0.86-1.00) overall. Signature associations were stronger in male compared with female participants.
CONCLUSIONS: Metabolite profiles reflecting adherence to WCRF/AICR guidelines and additional lifestyle or biological risk factors were associated with colorectal cancer. Measuring a specific panel of metabolites representative of a healthy or unhealthy lifestyle may identify strata of the population at higher risk of colorectal cancer.
Cold plasma is considered to be a novel, non-thermal, chemical-free and eco-friendly disinfection and surface modification technology. Plasma treatment of air to generate the so called plasma processed air (PPA) induces the formation of reactive oxygen (ROS) and nitrogen species (RNS). As a result, PPA has a different chemical composition compared to untreated air and suits therefore as an alternative method for microbial disinfection. However, depending on the product properties of the food matrix and its composition, a number of plasmainduced reactions also need to be taken into consideration.
This necessitates also the elucidation and understanding of the basic interactions of plasma species with bioactive compounds. The intention here is to avoid the degradation of these valuable substances and to prevent other undesirable effects in future food related applications.
In the present study, the effects of PPA treatment on selected antioxidants such as pyrocatechol and derivatives of hydroxycinnimic acid were investigated in model systems to specify possible reactions induced. Antioxidant capacity, pH value, UV-Vis spectroscopy, RP-HPLC and LC-MS analysis were applied to identify reaction products providing information on possible changes induced in food matrices by PPA treatment.
Exposure to PPA caused a perceptible color change towards yellow-brown accompanied by a strong reduction of the pH and the formation of insoluble sediments in the model solutions. The accumulation of nitrate, nitrite, but not of hydrogen peroxide was shown. LC-MS analysis demonstrated the formation of plasma-modified derivatives in all tested systems. The main reactions in liquid model solutions exposed to PPA were attributed to oxidation, nitration and polymerization of the phenolic compounds.
Nanomaterials play an important role in mimicking the biochemical and biophysical cues of the extracellular matrix in human mesenchymal stem cells (MSCs). Increasing studies have demonstrated the crucial impact of functional groups on MSCs, while limited research is available on how the functional group's density on nanoparticles regulates MSC behavior. Herein, the effects of dendritic polyglycerol (dPG)-conjugated gold nanostars (GNSs) with different densities of functional groups on the osteogenesis of MSCs are systematically investigated. dPG@GNS nanocomposites have good biocompatibility and the uptake by MSCs is in a functional group density-dependent manner. The osteogenic differentiation of MSCs is promoted by all dPG@GNS nanocomposites, in terms of alkaline phosphatase activity, calcium deposition, and expression of osteogenic protein and genes. Interestingly, the dPGOH@GNSs exhibit a slight upregulation in the expression of osteogenic markers, while the different charged densities of sulfate and amino groups show more efficacy in the promotion of osteogenesis. Meanwhile, the sulfated nanostars dPGS20@GNSs show the highest enhancement. Furthermore, various dPG@GNS nanocomposites exerted their effects by regulating the activation of Yes-associated protein (YAP) to affect osteogenic differentiation. These results indicate that dPG@GNS nanocomposites have functional group density-dependent influence on the osteogenesis of MSCs, which may provide a new insight into regulating stem cell fate.
Background: The role of fatty acid (FA) intake and metabolism in type 2 diabetes (T2D) incidence is controversial. Some FAs are not synthesised endogenously and, therefore, these circulating FAs reflect dietary intake, for example, the trans fatty acids (TFAs), saturated odd chain fatty acids (OCFAs), and linoleic acid, an n-6 polyunsaturated fatty acids (PUFA). It remains unclear if intake of TFA influence T2D risk and whether industrial TFAs (iTFAs) and ruminant TFAs (rTFAs) exert the same effect. Unlike even chain saturated FAs, the OCFAs have been inversely associated with T2D risk, but this association is poorly understood. Furthermore, the associations of n-6 PUFAs intake with T2D risk are still debated, while delta-5 desaturase (D5D), a key enzyme in the metabolism of PUFAs, has been consistently related to T2D risk. To better understand these relationships, the FA composition in circulating lipid fractions can be used as biomarkers of dietary intake and metabolism. The exploration of TFAs subtypes in plasma phospholipids and OCFAs and n-6 PUFAs within a wide range of lipid classes may give insights into the pathophysiology of T2D.
Aim: This thesis aimed mainly to analyse the association of TFAs, OCFAs and n-6 PUFAs with self-reported dietary intake and prospective T2D risk, using seven types of TFAs in plasma phospholipids and deep lipidomics profiling data from fifteen lipid classes.
Methods: A prospective case-cohort study was designed within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study, including all the participants who developed T2D (median follow-up 6.5 years) and a random subsample of the full cohort (subcohort: n=1248; T2D cases: n=820). The main analyses included two lipid profiles. The first was an assessment of seven TFA in plasma phospholipids, with a modified method for analysis of FA with very low abundances. The second lipid profile was derived from a high-throughout lipid profiling technology, which identified 940 distinct molecular species and allowed to quantify OCFAs and PUFAs composition across 15 lipid classes. Delta-5 desaturase (D5D) activity was estimated as 20:4/20:3-ratio. Using multivariable Cox regression models, we examined the associations of TFA subtypes with incident T2D and class-specific associations of OCFA and n-6 PUFAs with T2D risk.
Results: 16:1n-7t, 18:1n-7t, and c9t11-CLA were positively correlated with the intake of fat-rich dairy foods. iTFA 18:1 isomers were positively correlated with margarine. After adjustment for confounders and other TFAs, higher plasma phospholipid concentrations of two rTFAs were associated with a lower incidence of T2D: 18:1n-7t and t10c12-CLA. In contrast, the rTFA c9t11-CLA was associated with a higher incidence of T2D. rTFA 16:1n-7t and iTFAs (18:1n-6t, 18:1n-9t, 18:2n-6,9t) were not statistically significantly associated with T2D risk.
We observed heterogeneous integration of OCFA in different lipid classes, and the contribution of 15:0 versus 17:0 to the total OCFA abundance differed across lipid classes. Consumption of fat-rich dairy and fiber-rich foods were positively and red meat inversely correlated to OCFA abundance in plasma phospholipid classes. In women only, higher abundances of 15:0 in phosphatidylcholines (PC) and diacylglycerols (DG), and 17:0 in PC, lysophosphatidylcholines (LPC), and cholesterol esters (CE) were inversely associated with T2D risk. In men and women, a higher abundance of 15:0 in monoacylglycerols (MG) was also inversely associated with T2D. Conversely, a higher 15:0 concentration in LPC and triacylglycerols (TG) was associated with higher T2D risk in men. Women with a higher concentration of 17:0 as free fatty acids (FFA) also had higher T2D incidence.
The integration of n-6 PUFAs in lipid classes was also heterogeneous. 18:2 was highly abundant in phospholipids (particularly PC), CE, and TG; 20:3 represented a small fraction of FA in most lipid classes, and 20:4 accounted for a large proportion of circulating phosphatidylinositol (PI) and phosphatidylethanolamines (PE). Higher concentrations of 18:2 were inversely associated with T2D risk, especially within DG, TG, and LPC. However, 18:2 as part of MG was positively associated with T2D risk. Higher concentrations of 20:3 in phospholipids (PC, PE, PI), FFA, CE, and MG were linked to higher T2D incidence. 20:4 was unrelated to risk in most lipid classes, except positive associations were observed for 20:4 enriched in FFA and PE. The estimated D5D activities in PC, PE, PI, LPC, and CE were inversely associated with T2D and explained variance of estimated D5D activity by genomic variation in the FADS locus was only substantial in those lipid classes.
Conclusion: The TFAs' conformation is essential in their relationship to diabetes risk, as indicated by plasma rTFA subtypes concentrations having opposite directions of associations with diabetes risk. Plasma OCFA concentration is linked to T2D risk in a lipid class and sex-specific manner. Plasma n-6 PUFA concentrations are associated differently with T2D incidence depending on the specific FA and the lipid class. Overall, these results highlight the complexity of circulating FAs and their heterogeneous association with T2D risk depending on the specific FA structure, lipid class, and sex. My results extend the evidence of the relationship between diet, lipid metabolism, and subsequent T2D risk. In addition, my work generated several potential new biomarkers of dietary intake and prospective T2D risk.
Background: Hepatic steatosis is a common chronic liver disease that can progress into more severe stages of NAFLD or promote the development of life-threatening secondary diseases for some of those affected. These include the liver itself (nonalcoholic steatohepatitis or NASH; fibrosis and cirrhosis, and hepatocellular carcinoma) or other organs such as the vessels and the heart (cardiovascular disease) or the islets of Langerhans (type 2 diabetes). In addition to elevated caloric intake and a sedentary lifestyle, genetic and epigenetic predisposition contribute to the development of NAFLD and the secondary diseases. Scope of review: We present data from genome-wide association studies (GWAS) and functional studies in rodents which describe polymorphisms identified in genes relevant for the disease as well as changes caused by altered DNA methylation and gene regulation via specific miRNAs. The review also provides information on the current status of the use of genetic and epigenetic factors as risk markers. Major conclusion: With our overview we provide an insight into the genetic and epigenetic landscape of NAFLD and argue about the applicability of currently defined risk scores for risk stratification and conclude that further efforts are needed to make the scores more usable and meaningful.
Over the last decades, interest in the impact of the intestinal microbiota on host health has steadily increased. Diet is a major factor that influences the gut microbiota and thereby indirectly affects human health. For example, a high fat diet rich in saturated fatty acids led to an intestinal proliferation of the colitogenic bacterium Bilophila (B.) wadsworthia by stimulating the release of the bile acid taurocholate (TC). TC contains the sulfonated head group taurine, which undergoes conversion to sulfide (H2S) by B. wadsworthia. In a colitis prone murine animal model (IL10 / mice), the bloom of B. wadsworthia was accompanied by an exacerbation of intestinal inflammation. B. wadsworthia is able to convert taurine and also other sulfonates to H2S, indicating the potential association of sulfonate utilization and the stimulation of colitogenic bacteria.
This potential link raised the question, whether dietary sulfonates or their sulfonated metabolites stimulate the growth of colitogenic bacteria such as B. wadsworthia and whether these bacteria convert sulfonates to H2S. Besides taurine, which is present in meat, fish and life-style beverages, other dietary sulfonates are part of daily human nutrition. Sulfolipids such as sulfoquinovosyldiacylglycerols (SQDG) are highly abundant in salad, parsley and the cyanobacterium Arthrospira platensis (Spirulina). Based on previous findings, Escherichia (E.) coli releases the polar headgroup sulfoquinovose (SQ) from SQDG. Moreover, E. coli is able to convert SQ to 2,3 dihydroxypropane 1 sulfonate (DHPS) under anoxic conditions. DHPS is also converted to H2S by B. wadsworthia or by other potentially harmful gut bacteria such as members of the genus Desulfovibrio. However, only few studies report the conversion of sulfonates to H2S by bacteria directly isolated from the human intestinal tract. Most sulfonate utilizing bacteria were obtained from environmental sources such as soil or lake sediment or from potentially intestinal sources such as sewage.
In the present study, fecal slurries from healthy human subjects were incubated with sulfonates under strictly anoxic conditions, using formate and lactate as electron donors. Fecal slurries that converted sulfonates to H2S, were used as a source for the isolation of H2S forming bacteria. Isolates were identified based on their 16S ribosomal RNA (16S rRNA) gene sequence. In addition, conventional C57BL/6 mice were fed a semisynthetic diet supplemented with the SQDG rich Spirulina (SD) or a Spirulina free control diet (CD). During the intervention, body weight, water and food intake were monitored and fecal samples were collected. After three weeks, mice were killed and organ weight and size were measured, intestinal sulfonate concentrations were quantified, gut microbiota composition was determined and parameters of intestinal and hepatic fat metabolism were analyzed.
Human fecal slurries converted taurine, isethionate, cysteate, 3 sulfolacate, SQ and DHPS to H2S. However, inter individual differences in the degradation of these sulfonates were observed. Taurine, isethionate, and 3 sulfolactate were utilized by fecal microbiota of all donors, while SQ, DHPS and cysteate were converted to H2S only by microbiota from certain individuals. Bacterial isolates from human feces able to convert sulfonates to H2S were identified as taurine-utilizing Desulfovibrio strains, taurine- and isethionate-utilizing B. wadsworthia, or as SQ- and 3-sulfolactate- utilizing E. coli. In addition, a co culture of E. coli and B. wadsworthia led to complete degradation of SQ to H2S, with DHPS as an intermediate. Of the human fecal isolates, B. wadsworthia and Desulfovibrio are potentially harmful. E. coli strains might be also pathogenic, but isolated E. coli strains from human feces were identified as commensal gut bacteria.
Feeding SD to mice increased the cecal and fecal SQ concentration and altered the microbiota composition, but the relative abundance of SQDG or SQ converting bacteria and colitogenic bacteria was not enriched in mice fed SD for 21 days. SD did not affect the relative abundance of Enterobacteriaceae, to which the SQDG- and SQ-utilizing E. coli strain belong to. Furthermore, the abundance of B. wadsworthia decreased from day 2 to day 9 in feces, but recovered afterwards in the same mice. In cecum, the family Desulfovibrionaceae, to which B. wadsworthia and Desulfovibrio belong to, were reduced. No changes in the number of B. wadsworthia in cecal contents or of Desulfovibrionaceae in feces were observed. SD led to a mild activation of the immune system, which was not observed in control mice fed CD. Mice fed SD had an increased body weight, a higher adipose tissue weight, and a decreased liver weight compared to the control mice, suggesting an impact of Spirulina supplementation on fat metabolism. However, expression levels of genes involved in intestinal and hepatic intracellular lipid uptake and availability were reduced. Further investigations on the lipid metabolism at protein level could help to clarify these discrepancies.
In summary, humans differ in the ability of their fecal microbiota to utilize dietary sulfonates. While sulfonates stimulated the proliferation of potentially colitogenic isolates from human fecal slurries, the increased availability of SQ in Spirulina fed conventional mice did not lead to an enrichment of such bacteria. Presence or absence of these bacteria may explain the inter individual differences in sulfonate conversion observed for fecal slurries. This work provides new insights in the ability of intestinal bacteria to utilize sulfonates and thus, contributes to a better understanding of microbiota-mediated effects on dietary sulfonate utilization. Interestingly, feeding of the Spirulina-supplemented diet led to body-weight gain in mice in the first two days of intervention, the reasons for which are unknown.
To better understand the role of individual and lifestyle factors in human disease, an exposome-wide association study was performed to investigate within a single-study anthropometry measures and lifestyle factors previously associated with B-cell lymphoma (BCL). Within the European Prospective Investigation into Cancer and nutrition study, 2402 incident BCL cases were diagnosed from 475 426 participants that were followed-up on average 14 years. Standard and penalized Cox regression models as well as principal component analysis (PCA) were used to evaluate 84 exposures in relation to BCL risk. Standard and penalized Cox regression models showed a positive association between anthropometric measures and BCL and multiple myeloma/plasma cell neoplasm (MM). The penalized Cox models additionally showed the association between several exposures from categories of physical activity, smoking status, medical history, socioeconomic position, diet and BCL and/or the subtypes. PCAs confirmed the individual associations but also showed additional observations. The PC5 including anthropometry, was positively associated with BCL, diffuse large B-cell lymphoma (DLBCL) and MM. There was a significant positive association between consumption of sugar and confectionary (PC11) and follicular lymphoma risk, and an inverse association between fish and shellfish and Vitamin D (PC15) and DLBCL risk. The PC1 including features of the Mediterranean diet and diet with lower inflammatory score showed an inverse association with BCL risk, while the PC7, including dairy, was positively associated with BCL and DLBCL risk. Physical activity (PC10) was positively associated with DLBCL risk among women. This study provided informative insights on the etiology of BCL.
Selenium (Se) is an essential trace element that is ubiquitously present in the environment in small concentrations. Essential functions of Se in the human body are manifested through the wide range of proteins, containing selenocysteine as their active center. Such proteins are called selenoproteins which are found in multiple physiological processes like antioxidative defense and the regulation of thyroid hormone functions. Therefore, Se deficiency is known to cause a broad spectrum of physiological impairments, especially in endemic regions with low Se content. Nevertheless, being an essential trace element, Se could exhibit toxic effects, if its intake exceeds tolerable levels. Accordingly, this range between deficiency and overexposure represents optimal Se supply. However, this range was found to be narrower than for any other essential trace element. Together with significantly varying Se concentrations in soil and the presence of specific bioaccumulation factors, this represents a noticeable difficulty in the assessment of Se
epidemiological status. While Se is acting in the body through multiple selenoproteins, its intake occurs mainly in form of small organic or inorganic molecular mass species. Thus, Se exposure not only depends on daily intake but also on the respective chemical form, in which it is present.
The essential functions of selenium have been known for a long time and its primary forms in different food sources have been described. Nevertheless, analytical capabilities for a comprehensive investigation of Se species and their derivatives have been introduced only in the last decades. A new Se compound was identified in 2010 in the blood and tissues of bluefin tuna. It was called selenoneine (SeN) since it is an isologue of naturally occurring antioxidant ergothioneine (ET), where Se replaces sulfur. In the following years, SeN was identified in a number of edible fish species and attracted attention as a new dietary Se source and potentially strong antioxidant. Studies in populations whose diet largely relies on fish revealed that SeN
represents the main non-protein bound Se pool in their blood. First studies, conducted with enriched fish extracts, already demonstrated the high antioxidative potential of SeN and its possible function in the detoxification of methylmercury in fish. Cell culture studies demonstrated, that SeN can utilize the same transporter as ergothioneine, and SeN metabolite was found in human urine.
Until recently, studies on SeN properties were severely limited due to the lack of ways to obtain the pure compound. As a predisposition to this work was firstly a successful approach to SeN synthesis in the University of Graz, utilizing genetically modified yeasts. In the current study, by use of HepG2 liver carcinoma cells, it was demonstrated, that SeN does not cause toxic effectsup to 100 μM concentration in hepatocytes. Uptake experiments showed that SeN is not bioavailable to the used liver cells.
In the next part a blood-brain barrier (BBB) model, based on capillary endothelial cells from the porcine brain, was used to describe the possible transfer of SeN into the central nervous system (CNS). The assessment of toxicity markers in these endothelial cells and monitoring of barrier conditions during transfer experiments demonstrated the absence of toxic effects from SeN on the BBB endothelium up to 100 μM concentration. Transfer data for SeN showed slow but substantial transfer. A statistically significant increase was observed after 48 hours following SeN incubation from the blood-facing side of the barrier. However, an increase in Se content was clearly visible already after 6 hours of incubation with 1 μM of SeN. While the transfer rate of SeN after application of 0.1 μM dose was very close to that for 1 μM, incubation with 10 μM of SeN resulted in a significantly decreased transfer rate. Double-sided application of SeN caused no side-specific transfer of SeN, thus suggesting a passive diffusion mechanism of SeN across the BBB. This data is in accordance with animal studies, where ET accumulation was observed in the rat brain, even though rat BBB does not have the primary ET transporter – OCTN1. Investigation of capillary endothelial cell monolayers after incubation with SeN and reference selenium compounds showed no significant increase of intracellular selenium concentration. Speciesspecific Se measurements in medium samples from apical and basolateral compartments, as good as in cell lysates, showed no SeN metabolization. Therefore, it can be concluded that SeN may reach the brain without significant transformation.
As the third part of this work, the assessment of SeN antioxidant properties was performed in Caco-2 human colorectal adenocarcinoma cells. Previous studies demonstrated that the intestinal epithelium is able to actively transport SeN from the intestinal lumen to the blood side and accumulate SeN. Further investigation within current work showed a much higher antioxidant potential of SeN compared to ET. The radical scavenging activity after incubation with SeN was close to the one observed for selenite and selenomethionine. However, the SeN effect on the viability of intestinal cells under oxidative conditions was close to the one caused by ET. To answer the question if SeN is able to be used as a dietary Se source and induce the activity of selenoproteins, the activity of glutathione peroxidase (GPx) and the secretion of selenoprotein P (SelenoP) were measured in Caco-2 cells, additionally. As expected, reference selenium compounds selenite and selenomethionine caused efficient induction of GPx activity. In contrast to those SeN had no effect on GPx activity. To examine the possibility of SeN being embedded into the selenoproteome, SelenoP was measured in a culture medium. Even though Caco-2 cells effectively take up SeN in quantities much higher than selenite or selenomethionine, no secretion of SelenoP was observed after SeN incubation.
Summarizing, we can conclude that SeN can hardly serve as a Se source for selenoprotein synthesis. However, SeN exhibit strong antioxidative properties, which appear when sulfur in ET is exchanged by Se. Therefore, SeN is of particular interest for research not as part of Se metabolism, but important endemic dietary antioxidant.
Liposomal FRET assay identifies potent drug-like inhibitors of the Ceramide Transport Protein (CERT)
(2020)
Ceramide transfer protein (CERT) mediates non-vesicular transfer of ceramide from endoplasmic reticulum to Golgi apparatus and thus catalyzes the rate-limiting step of sphingomyelin biosynthesis. Usually, CERT ligands are evaluated in tedious binding assays or non-homogenous transfer assays using radiolabeled ceramides. Herein, a facile and sensitive assay for CERT, based on Forster resonance energy transfer (FRET), is presented. To this end, we mixed donor and acceptor vesicles, each containing a different fluorescent ceramide species. By CERT-mediated transfer of fluorescent ceramide, a FRET system was established, which allows readout in 96-well plate format, despite the high hydrophobicity of the components. Screening of a 2 000 compound library resulted in two new potent CERT inhibitors. One is approved for use in humans and one is approved for use in animals. Evaluation of cellular activity by quantitative mass spectrometry and confocal microscopy showed inhibition of ceramide trafficking and sphingomyelin biosynthesis.
Diabetes is hallmarked by high blood glucose levels, which cause progressive generalised vascular damage, leading to microvascular and macrovascular complications. Diabetes-related complications cause severe and prolonged morbidity and are a major cause of mortality among people with diabetes. Despite increasing attention to risk factors of type 2 diabetes, existing evidence is scarce or inconclusive regarding vascular complications and research investigating both micro- and macrovascular complications is lacking. This thesis aims to contribute to current knowledge by identifying risk factors – mainly related to lifestyle – of vascular complications, addressing methodological limitations of previous literature and providing comparative data between micro- and macrovascular complications.
To address this overall aim, three specific objectives were set. The first was to investigate the effects of diabetes complication burden and lifestyle-related risk factors on the incidence of (further) complications. Studies suggest that diabetes complications are interrelated. However, they have been studied mainly independently of individuals’ complication burden. A five-state time-to-event model was constructed to examine the longitudinal patterns of micro- (kidney disease, neuropathy and retinopathy) and macrovascular complications (myocardial infarction and stroke) and their association with the occurrence of subsequent complications. Applying the same model, the effect of modifiable lifestyle factors, assessed alone and in combination with complication load, on the incidence of diabetes complications was studied. The selected lifestyle factors were body mass index (BMI), waist circumference, smoking status, physical activity, and intake of coffee, red meat, whole grains, and alcohol. Analyses were conducted in a cohort of 1199 participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam, who were free of vascular complications at diabetes diagnosis. During a median follow-up time of 11.6 years, 96 cases of macrovascular complications (myocardial infarction and stroke) and 383 microvascular complications (kidney disease, neuropathy and retinopathy) were identified. In multivariable-adjusted models, the occurrence of a microvascular complication was associated with a higher incidence of further micro- (Hazard ratio [HR] 1.90; 95% Confidence interval [CI] 0.90, 3.98) and macrovascular complications (HR 4.72; 95% CI 1.25, 17.68), compared with persons without a complication burden. In addition, participants who developed a macrovascular event had a twofold higher risk of future microvascular complications (HR 2.26; 95% CI 1.05, 4.86). The models were adjusted for age, sex, state duration, education, lifestyle, glucose-lowering medication, and pre-existing conditions of hypertension and dyslipidaemia. Smoking was positively associated with macrovascular disease, while an inverse association was observed with higher coffee intake. Whole grain and alcohol intake were inversely associated with microvascular complications, and a U-shaped association was observed for red meat intake. BMI and waist circumference were positively associated with microvascular events. The associations between lifestyle factors and incidence of complications were not modified by concurrent complication burden, except for red meat intake and smoking status, where the associations were attenuated among individuals with a previous complication.
The second objective was to perform an in-depth investigation of the association between BMI and BMI change and risk of micro- and macrovascular complications. There is an ongoing debate on the association between obesity and risk of macrovascular and microvascular outcomes in type 2 diabetes, with studies suggesting a protective effect among people with overweight or obesity. These findings, however, might be limited due to suboptimal control for smoking, pre-existing chronic disease, or short-follow-up. After additional exclusion of persons with cancer history at diabetes onset, the associations between pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI and incidence of complications were evaluated in multivariable-adjusted Cox models. The analyses were adjusted for age, sex, education, smoking status and duration, physical activity, alcohol consumption, adherence to the Mediterranean diet, and family history of diabetes and cardiovascular disease (CVD). Among 1083 EPIC-Potsdam participants, 85 macrovascular and 347 microvascular complications were identified during a median follow-up period of 10.8 years. Higher pre-diagnosis BMI was associated with an increased risk of total microvascular complications (HR per 5 kg/m2 1.21; 95% CI 1.07, 1.36), kidney disease (HR 1.39; 95% CI 1.21, 1.60) and neuropathy (HR 1.12; 95% CI 0.96, 1.31); but no association was observed for macrovascular complications (HR 1.05; 95% CI 0.81, 1.36). Effect modification was not evident by sex, smoking status, or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62; 95% CI 0.47, 0.80), kidney disease (HR 0.57; 95% CI 0.40, 0.81) and neuropathy (HR 0.73; 95% CI 0.52, 1.03), compared with participants with a stable BMI. No clear association was observed for macrovascular complications (HR 1.04; 95% CI 0.62, 1.74). The impact of BMI gain on diabetes-related vascular disease was less evident. Associations were consistent across strata of age, sex, pre-diagnosis BMI, or medication but appeared stronger among never-smokers than current or former smokers.
The last objective was to evaluate whether individuals with a high-risk profile for diabetes and cardiovascular disease (CVD) also have a greater risk of complications. Within the EPIC-Potsdam study, two accurate prognostic tools were developed, the German Diabetes Risk Score (GDRS) and the CVD Risk Score (CVDRS), which predict the 5-year type 2 diabetes risk and 10-year CVD risk, respectively. Both scores provide a non-clinical and clinical version. Components of the risk scores include age, sex, waist circumference, prevalence of hypertension, family history of diabetes or CVD, lifestyle factors, and clinical factors (only in clinical versions). The association of the risk scores with diabetes complications and their discriminatory performance for complications were assessed. In crude Cox models, both versions of GDRS and CVDRS were positively associated with macrovascular complications and total microvascular complications, kidney disease and neuropathy. Higher GDRS was also associated with an elevated risk of retinopathy. The discrimination of the scores (clinical and non-clinical) was poor for all complications, with the C-index ranging from 0.58 to 0.66 for macrovascular complications and from 0.60 to 0.62 for microvascular complications.
In conclusion, this work illustrates that the risk of complication development among individuals with type 2 diabetes is related to the existing complication load, and attention should be given to regular monitoring for future complications. It underlines the importance of weight management and adherence to healthy lifestyle behaviours, including high intake of whole grains, moderation in red meat and alcohol consumption and avoidance of smoking to prevent major diabetes-associated complications, regardless of complication burden. Risk scores predictive for type 2 diabetes and CVD were related to elevated risks of complications. By optimising several lifestyle and clinical factors, the risk score can be improved and may assist in lowering complication risk.
Mammalian arachidonic acid lipoxygenases (ALOXs) have been implicated in cell differentiation and in the pathogenesis of inflammation. The mouse genome involves seven functional Alox genes and the encoded enzymes share a high degree of amino acid conservation with their human orthologs. There are, however, functional differences between mouse and human ALOX orthologs. Human ALOX15B oxygenates arachidonic acid exclusively to its 15-hydroperoxy derivative (15S-HpETE), whereas 8S-HpETE is dominantly formed by mouse Alox15b. The structural basis for this functional difference has been explored and in vitro mutagenesis humanized the reaction specificity of the mouse enzyme. To explore whether this mutagenesis strategy may also humanize the reaction specificity of mouse Alox15b in vivo, we created Alox15b knock-in mice expressing the arachidonic acid 15-lipoxygenating Tyr603Asp+His604Val double mutant instead of the 8-lipoxygenating wildtype enzyme. These mice are fertile, display slightly modified plasma oxylipidomes and develop normally up to an age of 24 weeks. At later developmental stages, male Alox15b-KI mice gain significantly less body weight than outbred wildtype controls, but this effect was not observed for female individuals. To explore the possible reasons for the observed gender-specific growth arrest, we determined the basic hematological parameters and found that aged male Alox15b-KI mice exhibited significantly attenuated red blood cell parameters (erythrocyte counts, hematocrit, hemoglobin). Here again, these differences were not observed in female individuals. These data suggest that humanization of the reaction specificity of mouse Alox15b impairs the functionality of the hematopoietic system in males, which is paralleled by a premature growth arrest.
Mammalian arachidonic acid lipoxygenases (ALOXs) have been implicated in cell differentiation and in the pathogenesis of inflammation. The mouse genome involves seven functional Alox genes and the encoded enzymes share a high degree of amino acid conservation with their human orthologs. There are, however, functional differences between mouse and human ALOX orthologs. Human ALOX15B oxygenates arachidonic acid exclusively to its 15-hydroperoxy derivative (15S-HpETE), whereas 8S-HpETE is dominantly formed by mouse Alox15b. The structural basis for this functional difference has been explored and in vitro mutagenesis humanized the reaction specificity of the mouse enzyme. To explore whether this mutagenesis strategy may also humanize the reaction specificity of mouse Alox15b in vivo, we created Alox15b knock-in mice expressing the arachidonic acid 15-lipoxygenating Tyr603Asp+His604Val double mutant instead of the 8-lipoxygenating wildtype enzyme. These mice are fertile, display slightly modified plasma oxylipidomes and develop normally up to an age of 24 weeks. At later developmental stages, male Alox15b-KI mice gain significantly less body weight than outbred wildtype controls, but this effect was not observed for female individuals. To explore the possible reasons for the observed gender-specific growth arrest, we determined the basic hematological parameters and found that aged male Alox15b-KI mice exhibited significantly attenuated red blood cell parameters (erythrocyte counts, hematocrit, hemoglobin). Here again, these differences were not observed in female individuals. These data suggest that humanization of the reaction specificity of mouse Alox15b impairs the functionality of the hematopoietic system in males, which is paralleled by a premature growth arrest.
Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (+/- 0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood.
Over the last few decades, the prevalence of obesity has risen to epidemic proportions worldwide. Consequently, the number of obesity in pregnancy has risen drastically. Gestational overweight and obesity are associated with impaired outcomes for mother and child. Furthermore, studies show that maternal obesity can lead to long-term consequences in the offspring, increasing the risk for obesity and cardiometabolic disease in later life. In addition to genetic mechanisms, mounting evidence demonstrates the induction of epigenetic alterations by maternal obesity, which can affect the offspring's phenotype, thereby influencing the later risk of obesity and cardiometabolic disease. Clear evidence in this regard comes from various animal models of maternal obesity. Evidence derived from clinical studies remains limited. The current article gives an overview of pathophysiological changes associated with maternal obesity and their consequences on placental structure and function. Furthermore, a short excurse is given on epigenetic mechanisms and emerging data regarding a putative interaction between metabolism and epigenetics. Finally, a summary of important findings of animal and clinical studies investigating maternal obesity-related epigenetic effects is presented also addressing current limitations of clinical studies.
Extra-cellular matrix (ECM) components are important and their stabilization is significant in maintaining normal healthy joint environment. In osteoarthritis (OA), ECM components are altered and indicate disease progression. The joint ECM is composed of proteoglycans (aggrecan, perlecan,inter α-trypsin inhibitor), glycoproteins (fibronectin, lubricin, COMP) and collagen types (most abundantly collagen type II) which represent structural and functional transformation during disease advancement. ECM investigation revealed significant biomarkers of OA that could be used as a diagnostic and therapeutic tool in different canine orthopedic diseases. This review deliberates our current findings of how the components of ECM change at the molecular level during disease progression in canine OA.
Metabolic derangement with poor glycemic control accompanying overweight and obesity is associated with chronic low-grade inflammation and hyperinsulinemia. Macrophages, which present a very heterogeneous population of cells, play a key role in the maintenance of normal tissue homeostasis, but functional alterations in the resident macrophage pool as well as newly recruited monocyte-derived macrophages are important drivers in the development of low-grade inflammation. While metabolic dysfunction, insulin resistance and tissue damage may trigger or advance pro-inflammatory responses in macrophages, the inflammation itself contributes to the development of insulin resistance and the resulting hyperinsulinemia. Macrophages express insulin receptors whose downstream signaling networks share a number of knots with the signaling pathways of pattern recognition and cytokine receptors, which shape macrophage polarity. The shared knots allow insulin to enhance or attenuate both pro-inflammatory and anti-inflammatory macrophage responses. This supposedly physiological function may be impaired by hyperinsulinemia or insulin resistance in macrophages. This review discusses the mutual ambiguous relationship of low-grade inflammation, insulin resistance, hyperinsulinemia and the insulin-dependent modulation of macrophage activity with a focus on adipose tissue and liver.
Metabolic derangement with poor glycemic control accompanying overweight and obesity is associated with chronic low-grade inflammation and hyperinsulinemia. Macrophages, which present a very heterogeneous population of cells, play a key role in the maintenance of normal tissue homeostasis, but functional alterations in the resident macrophage pool as well as newly recruited monocyte-derived macrophages are important drivers in the development of low-grade inflammation. While metabolic dysfunction, insulin resistance and tissue damage may trigger or advance pro-inflammatory responses in macrophages, the inflammation itself contributes to the development of insulin resistance and the resulting hyperinsulinemia. Macrophages express insulin receptors whose downstream signaling networks share a number of knots with the signaling pathways of pattern recognition and cytokine receptors, which shape macrophage polarity. The shared knots allow insulin to enhance or attenuate both pro-inflammatory and anti-inflammatory macrophage responses. This supposedly physiological function may be impaired by hyperinsulinemia or insulin resistance in macrophages. This review discusses the mutual ambiguous relationship of low-grade inflammation, insulin resistance, hyperinsulinemia and the insulin-dependent modulation of macrophage activity with a focus on adipose tissue and liver.
Respiratorische Erkrankungen stellen zunehmend eine relevante globale Problematik dar. Die Erweiterung bzw. Modifizierung von Applikationswegen möglicher Arzneimittel für gezielte topische Anwendungen ist dabei von größter Bedeutung. Die Variation eines bekannten Applikationsweges durch unterschiedliche technologische Umsetzungen kann die Vielfalt der Anwendungsmöglichkeiten, aber auch die Patienten-Compliance erhöhen. Die einfache und flexible Verfahrensweise durch schnelle Verfügbarkeit und eine handliche Technologie sind heutzutage wichtige Eigenschaften im Entwicklungsprozess eines Produktes. Eine direkte topische Behandlung von Atemwegserkrankungen am Wirkort in Form einer inhalativen Applikation bietet dabei viele Vorteile gegenüber einer systemischen Therapie. Die medizinische Inhalation von Wirkstoffen über die Lunge ist jedoch eine komplexe Herausforderung. Inhalatoren gehören zu den erklärungsbedürftigen Applikationsformen, die zur Erhöhung der konsequenten Einhaltung der Verordnung so einfach, wie möglich gestaltet werden müssen. Parallel besitzen und nutzen weltweit annähernd 68 Millionen Menschen die Technologie eines inhalativen Applikators zur bewussten Schädigung ihrer Gesundheit in Form einer elektronischen Zigarette. Diese bekannte Anwendung bietet die potentielle Möglichkeit einer verfügbaren, kostengünstigen und qualitätsgeprüften Gesundheitsmaßnahme zur Kontrolle, Prävention und Heilung von Atemwegserkrankungen. Sie erzeugt ein Aerosol durch elektrothermische Erwärmung eines sogenannten Liquids, das durch Kapillarkräfte eines Trägermaterials an ein Heizelement gelangt und verdampft. Ihr Bekanntheitsgrad zeigt, dass eine beabsichtigte Wirkung in den Atemwegen eintritt. Diese Wirkung könnte jedoch auch auf potentielle pharmazeutische Einsatzgebiete übertragbar sein. Die Vorteile der pulmonalen Verabreichung sind dabei vielfältig. Im Vergleich zur peroralen Applikation gelangt der Wirkstoff gezielt zum Wirkort. Wenn eine systemische Applikation zu Arzneimittelkonzentrationen unterhalb der therapeutischen Wirksamkeit in der Lunge führt, könnte eine inhalative Darreichung bereits bei niedriger Dosierung die gewünschten höheren Konzentrationen am Wirkort hervorrufen. Aufgrund der großen Resorptionsfläche der Lunge sind eine höhere Bioverfügbarkeit und ein schnellerer Wirkungseintritt infolge des fehlenden First-Pass-Effektes möglich. Es kommt ebenfalls zu minimalen systemischen Nebenwirkungen. Die elektronische Zigarette erzeugt wie die medizinischen Inhalatoren lungengängige Partikel. Die atemzuggesteuerte Technik ermöglicht eine unkomplizierte und intuitive Anwendung. Der prinzipielle Aufbau besteht aus einer elektrisch beheizten Wendel und einem Akku. Die Heizwendel ist von einem sogenannten Liquid in einem Tank umgeben und erzeugt das Aerosol. Das Liquid beinhaltet eine Basismischung bestehend aus Propylenglycol, Glycerin und reinem Wasser in unterschiedlichen prozentualen Anteilen. Es besteht die Annahme, dass das Basisliquid auch mit pharmazeutischen Wirkstoffen für die pulmonale Applikation beladen werden kann. Aufgrund der thermischen Belastung durch die e-Zigarette müssen potentielle Wirkstoffe sowie das Vehikel eine thermische Stabilität aufweisen.
Die potentielle medizinische Anwendung der Technologie einer handelsüblichen e-Zigarette wurde anhand von drei Schwerpunkten an vier Wirkstoffen untersucht. Die drei ätherischen Öle Eucalyptusöl, Minzöl und Nelkenöl wurden aufgrund ihrer leichten Flüchtigkeit und der historischen pharmazeutischen Anwendung anhand von Inhalationen bei Erkältungssymptomen bzw. im zahnmedizinischen Bereich gewählt. Das eingesetzte Cannabinoid Cannabidiol (CBD) hat einen aktuellen Bezug zu dem pharmazeutischen Markt Deutschlands zur Legalisierung von cannabishaltigen Produkten und der medizinischen Forschung zum inhalativen Konsum. Es wurden relevante wirkstoffhaltige Flüssigformulierungen entwickelt und hinsichtlich ihrer Verdampfbarkeit zu Aerosolen bewertet. In den quantitativen und qualitativen chromatographischen Untersuchungen konnten spezifische Verdampfungsprofile der Wirkstoffe erfasst und bewertet werden. Dabei stieg die verdampfte Masse der Leitsubstanzen 1,8-Cineol (Eucalyptusöl), Menthol (Minzöl) und Eugenol (Nelkenöl) zwischen 33,6 µg und 156,2 µg pro Zug proportional zur Konzentration im Liquid im Bereich zwischen 0,5% und 1,5% bei einer Leistung von 20 Watt. Die Freisetzungsrate von Cannabidiol hingegen schien unabhängig von der Konzentration im Liquid im Mittelwert bei 13,3 µg pro Zug zu liegen. Dieses konnte an fünf CBD-haltigen Liquids im Konzentrationsbereich zwischen 31 µg/g und 5120 µg/g Liquid gezeigt werden. Außerdem konnte eine Steigerung der verdampften Massen mit Zunahme der Leistung der e-Zigarette festgestellt werden. Die Interaktion der Liquids bzw. Aerosole mit den Bestandteilen des Speichels sowie weiterer gastrointestinaler Flüssigkeiten wurde über die Anwendung von zugehörigen in vitro Modellen und Einsatz von Enzymaktivitäts-Assays geprüft. In den Untersuchungen wurden Änderungen von Enzymaktivitäten anhand des oralen Schlüsselenzyms α-Amylase sowie von Proteasen ermittelt. Damit sollte exemplarisch ein möglicher Einfluss auf physiologische bzw. metabolische Prozesse im humanen Organismus geprüft werden. Das Bedampfen von biologischen Suspensionen führte bei niedriger Leistung der e-Zigarette (20 Watt) zu keiner bzw. einer leichten Änderung der Enzymaktivität. Die Anwendung einer hohen Leistung (80 Watt) bewirkte tendenziell das Herabsetzen der Enzymaktivitäten. Die Erhöhung der Enzymaktivitäten könnte zu einem enzymatischen Abbau von Schleimstoffen wie Mucinen führen, was wiederum die effektive, mechanische Abwehr gegenüber bakteriellen Infektionen zur Folge hätte. Da eine Anwendung der Applikation insbesondere bei bakteriellen Atemwegserkrankungen denkbar wäre, folgten abschließend Untersuchungen der antibakteriellen Eigenschaften der Liquids bzw. Aerosole in vitro. Es wurden sechs klinisch relevante bakterielle Krankheitserreger ausgewählt, die nach zwei Charakteristika gruppiert werden können. Die drei multiresistenten Bakterien Pseudomonas aeruginosa, Klebsiella pneumoniae und Methicillin-resistenter Staphylococcus aureus können mithilfe von üblichen Therapien mit Antibiotika nicht abgetötet werden und haben vor allem eine nosokomiale Relevanz. Die zweite Gruppe weist Eigenschaften auf, die vordergründig assoziiert sind mit respiratorischen Erkrankungen. Die Bakterien Streptococcus pneumoniae, Moraxella catarrhalis und Haemophilus influenzae sind repräsentativ beteiligt an Atemwegserkrankungen mit diverser Symptomatik. Die Bakterienarten wurden mit den jeweiligen Liquids behandelt bzw. bedampft und deren grundlegende Dosis-Wirkungsbeziehung charakterisiert. Dabei konnte eine antibakterielle Aktivität der Formulierungen ermittelt werden, die durch Zugabe eines Wirkstoffes die bereits antibakterielle Wirkung der Bestandteile Glycerin und Propylenglycol verstärkte. Die hygroskopischen Eigenschaften dieser Substanzen sind vermutlich für eine Wirkung in aerosolierter Form verantwortlich. Sie entziehen die Feuchtigkeit aus der Luft und haben einen austrocknenden Effekt auf die Bakterien. Das Bedampfen der Bakterienarten Streptococcus pneumoniae, Moraxella catarrhalis und Haemophilus influenzae hatte einen antibakteriellen Effekt, der zeitlich abhängig von der Leistung der e-Zigarette war.
Die Ergebnisse der Untersuchungen führen zu dem Schluss, dass jeder Wirkstoff bzw. jede Substanzklasse individuell zu bewerten ist und somit Inhalator und Formulierung aufeinander abgestimmt werden müssen. Der Einsatz der e-Zigarette als Medizinprodukt zur Applikation von Arzneimitteln setzt stets Prüfungen nach Europäischem Arzneibuch voraus. Durch Modifizierungen könnte eine Dosierung gut kontrollierbar gemacht werden, aber auch die Partikelgrößenverteilung kann insoweit reguliert werden, dass die Wirkstoffe je nach Partikelgröße zu einem geeigneten Applikationsort wie Mund, Rachen oder Bronchien transportiert werden. Der Vergleich mit den Eigenschaften anderer medizinischer Inhalatoren führt zu dem Schluss, dass die Technologie der e-Zigarette durchaus eine gleichartige oder bessere Performance für thermisch stabile Wirkstoffe bieten könnte. Dieses fiktive Medizinprodukt könnte aus einer hersteller-unspezifisch produzierten, wieder aufladbaren Energiequelle mit Universalgewinde zum mehrfachen Gebrauch und einer hersteller- und wirkstoffspezifisch produzierten Einheit aus Verdampfer und Arzneimittel bestehen. Das Arzneimittel, ein medizinisches Liquid (Vehikel und Wirkstoff) kann in dem Tank des Verdampfers mit konstanten, nicht variablen Parametern patientenindividuell produziert werden. Inhalative Anwendungen werden perspektivisch wohl nicht zuletzt aufgrund der aktuellen COVID-19-Pandemie eine zunehmende Rolle spielen. Der Bedarf nach alternativen Therapieoptionen wird weiter ansteigen. Diese Arbeit liefert einen Beitrag zum Einsatz der Technologie der elektronischen Zigarette als electronic nicotin delivery system (ENDS) nach Modifizierung zu einem potentiellen pulmonalen Applikationssystem als electronic drug delivery system (EDDS) von inhalativen, thermisch stabilen Arzneimitteln in Form eines Medizinproduktes.
Die allergische Kontaktdermatitis ist eine immunologisch bedingte Hauterkrankung mit insbesondere in den westlichen Industrienationen hoher und weiter ansteigender Prävalenz. Es handelt sich hierbei um eine Hypersensitivitätsreaktion vom Typ IV, die sich nach Allergenkontakt durch Juckreiz, Rötung, Bläschenbildung und Abschälung der Haut äußert. Zahlreiche Xenobiotika besitzen das Potenzial, Kontaktallergien auszulösen, darunter Konservierungsstoffe, Medikamente, Duftstoffe und Chemikalien. Die wirksamste Maßnahme zur Eindämmung der Erkrankung ist die Expositionsprophylaxe, also die Vermeidung des Kontakts mit den entsprechenden Substanzen. Dies wiederum setzt die Kenntnis des jeweiligen sensibilisierenden Potenzials einer Substanz voraus, dessen Bestimmung aus diesem Grund eine hohe toxikologische Relevanz besitzt. Zu diesem Zweck existieren von der OECD veröffentlichte Testleitlinien, welche auf entsprechend validierten Testmethoden basieren. Goldstandard bei der Prüfung auf hautsensibilisierendes Potenzial war über lange Zeit der murine Lokale Lymphknotentest. Seit der 7. Änderung der EU-Kosmetikrichtlinie, welche Tierversuche für Kosmetika und deren Inhaltsstoffe untersagt, wurden vermehrt Alternativmethoden in die OECD-Testleitlinien implementiert.. Die bestehenden in vitro Methoden sind jedoch alleinstehend nur begrenzt aussagekräftig, da sie lediglich singuläre Mechanismen bei der Entstehung einer Kontaktallergie abbilden. Die Entwicklung von Testmethoden, welche mehrere dieser Schlüsselereignisse berücksichtigen, erscheint daher richtungsweisend. Einen vielversprechenden Ansatz liefert hierbei der Loose-fit coculture-based sensitisation assay (LCSA), welcher eine Kokultur aus primären Keratinozyten und PBMC darstellt. Bei der Kokultivierung von Immunzellen mit anderen Zelltypen stellt sich allerdings die Frage, inwiefern die Nutzung von Zellen derselben Spender*innen (autologe Kokultur) bzw. verschiedener Spender*innen (allogene Kokultur) einen Einfluss nimmt. Zu diesem Zweck wurden im Rahmen dieser Arbeit Hautzellen spenderspezifisch aus gezupften Haarfollikeln isoliert und der LCSA mit den generierten HFDK in autologen und allogenen Ansätzen verglichen. Zusätzlich wurde auch ein Vergleich zwischen der Nutzung von HFDK und NHK, welche aus humaner Vorhaut isoliert wurden, im LCSA durchgeführt. Dabei ergaben sich keine signifikanten Unterschiede zwischen autologen und allogenen Kokulturen bzw. zwischen der Verwendung von HFDK und NHK. Die Verwendung allogener Zellen aus anonymem Spendermaterial sowie die Nutzung von Keratinozyten aus unterschiedlichen Quellen scheint im Rahmen des LCSA problemlos möglich. Einige der getesteten Kontaktallergene, darunter DNCB und NiCl2, erwiesen sich im LCSA jedoch als problematisch und konnten nicht zufriedenstellend als sensibilisierend detektiert werden. Daher wurde eine Optimierung der Kokultur durch Verwendung ex vivo differenzierter Langerhans Zellen (MoLC) angestrebt, welche ein besseres Modell primärer epidermaler Langerhans Zellen darstellen als die dendritischen Zellen aus dem LCSA. Zusätzlich wurden weitere, den Erfolg der Kokultur beeinflussende Faktoren, wie die Art und Zusammensetzung des Mediums und die Kokultivierungsdauer, untersucht und angepasst. Das schlussendlich etablierte Kokultivierungsprotokoll führte zu einer maßgeblich verstärkten Expression von CD207 (Langerin) auf den MoLC, was auf eine wirkungsvolle Interaktion zwischen Haut- und Immunzellen in der Kokultur hindeutete. Des Weiteren konnten DNCB und NiCl2 im Gegensatz zum LCSA durch Verwendung des kostimulatorischen Moleküls CD86 sowie des Reifungsmarkers CD83 als Ausleseparameter eindeutig als Kontaktallergene identifiziert werden. Die Untersuchungen zur Kokultur von MoLC und HFDK wurden jeweils vergleichend in autologen und allogenen Ansätzen durchgeführt. Ähnlich wie beim LCSA kam es aber auch hier zu keinen signifikanten Unterschieden, weder hinsichtlich der Expression von Charakterisierungs- und Aktivierungsmarkern auf MoLC noch hinsichtlich der Zytokinsekretion in den Zellkulturüberstand. Die Hinweise aus zahlreichen Studien im Mausmodell, dass Zellen des angeborenen Immunsystems zur Erkennung von und Aktivierung durch allogene Zellen bzw. Gewebe in der Lage sind, bestätigten sich im Rahmen dieser Arbeit dementsprechend nicht. Aus diesem Grund wurden abschließend CD4+ T-Lymphozyten, die Effektorzellen des adaptiven Immunsystems, in die Kokultur aus MoLC und autologen bzw. allogenen HFDK integriert. Überraschenderweise traten auch hier keine verstärkten Aktivierungen in allogener Kokultur im Vergleich zur autologen Kokultur auf. Die Nutzung autologer Primärzellen scheint im Rahmen der hier getesteten Methoden nicht notwendig zu sein, was die Validierung von Kokulturen und deren Implementierung in die OECD-Testleitlinien erleichtern dürfte. Zuletzt wurde eine Kokultivierung primärer Haut- und Immunzellen auch im 3D-Vollhautmodell durchgeführt, wobei autologe MoLC in die Epidermisäquivalente entsprechender Modelle integriert werden sollten. Obwohl die erstellten Hautmodelle unter Verwendung autologer Haarfollikel-generierter Keratinozyten und Fibroblasten eine zufriedenstellende Differenzierung und Stratifizierung aufwiesen, gestaltete sich die Inkorporation der MoLC als problematisch und konnte im Rahmen dieser Arbeit nicht erreicht werden.
Objective: Hormone secretion from metabolically active tissues, such as pancreatic islets, is governed by specific and highly regulated signaling pathways. Defects in insulin secretion are among the major causes of diabetes. The molecular mechanisms underlying regulated insulin secretion are, however, not yet completely understood. In this work, we studied the role of the GTPase ARFRP1 on insulin secretion from pancreatic 13-cells. <br /> Methods: A 13-cell-specific Arfrp1 knockout mouse was phenotypically characterized. Pulldown experiments and mass spectrometry analysis were employed to screen for new ARFRP1-interacting proteins. Co-immunoprecipitation assays as well as super-resolution microscopy were applied for validation. <br /> Results: The GTPase ARFRP1 interacts with the Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC). Both proteins are co localized at the trans-Golgi network and regulate the first and second phase of insulin secretion by controlling the plasma membrane localization of the SNARE protein SNAP25. Downregulation of both GOPC and ARFRP1 in Min6 cells interferes with the plasma membrane localization of SNAP25 and enhances its degradation, thereby impairing glucose-stimulated insulin release from 13-cells. In turn, overexpression of SNAP25 as well as GOPC restores insulin secretion in islets from 13-cell-specific Arfrp1 knockout mice. <br /> Conclusion: Our results identify a hitherto unrecognized pathway required for insulin secretion at the level of trans-Golgi sorting. (c) 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Epigenetische Mechanismen spielen eine entscheidende Rolle bei der Pathogenese von Colitis ulcerosa (CU). Ihr Einfluss auf das beobachtete Ungleichgewicht zwischen pro- und anti-inflammatorischen Cytokinen ist hingegen weitgehend unerforscht. Einige der wichtigsten immunmodulatorischen Cytokine sind die Mitglieder der heterodimeren Interleukin- (IL-) 12-Familie, die durch das Kombinieren einer der drei α-Ketten (IL-12p35, IL-27p28, IL-23p19) mit den ß-Untereinheiten IL-12p40 oder EBI3 (Epstein-Barr Virus-induziertes Gen 3) charakterisiert sind. IL-35 (IL-12p35/EBI3) spielt eine bedeutende anti-inflammatorische Rolle bei verschiedenen Erkrankungen, wohingegen seine Level bei chronischen Entzündungen erniedrigt sind. Eine mögliche Ursache könnte eine transkriptionelle Stilllegung über epigenetische Modifikationen sein. Tatsächlich konnte durch die Stimulation mit dem DNA-Methyltransferase-Inhibitor (DNMTi) Decitabin (DAC; Dacogen®) eine Induktion von EBI3 in humanen Epithelzellen aus gesundem Colon (HCEC) erreicht werden, die als Modell für ein lokales Entzündungsgeschehen dienten. Diese Regulation über DNA-Methylierung konnte in weiteren humanen Zellen unterschiedlichen Ursprungs sowie durch Stimulation von HCEC-Zellen mit zwei weiteren DNMTi, dem Cytosin-Analogon Azacytidin (AZA; Vidaza®) und dem natürlich vorkommenden, epigenetisch wirksamen Polyphenol Epigallocatechingallat (EGCG), verifiziert werden. Die kombinierte Inkubation mit Tumor-Nekrose-Faktor α (TNFα) resultierte jeweils in einer über-additiven Induktion von EBI3.
Weiterführende Untersuchungen zeigten, dass TNFα trotz Beeinflussung der epigenetischen DNMT- und Ten-eleven Translocation- (TET-) Enzyme keinen Einfluss auf die globalen Methylierungs- oder Hydroxymethylierungslevel hatte, jedoch eine genspezifische DNA-Hypomethylierung im EBI3-Promotor induzierte. Durch Nutzung verschiedener Inhibitoren konnte darüber hinaus nachgewiesen werden, dass der beobachtete synergistische Effekt der gemeinsamen DAC und TNFα-Stimulation hauptsächlich über NFκB (Nuclear factor “kappa-light-chain-enhancer” of activated B-cells) vermittelt wird. Ein Teil verläuft dabei über p38 MAPK (mitogen-activated protein kinases), während die JNK- (c-Jun N-terminale Kinasen-) und ERK- (extracellular-signal-regulated kinases) Signalwege keine Rolle spielen.
In der vorliegenden Arbeit wurde zudem gezeigt, dass die DNA-Hypomethylierung während eines entzündlichen Zustandes auch in einer erhöhten EBI3-Proteinexpression resultiert. Die Höhe der immunologisch detektierten Banden wies auf eine Dimerbildung sowohl im Zelllysat als auch im Überstand hin. Humane Colonepithelzellen sind demnach in der Lage, Cytokine zu bilden und zu sezernieren, was die Bedeutung von Nicht-Immunzellen bei der lokalen Immunantwort unterstreicht. Mittels Genexpressionsanalysen wurden IL-12p35 und IL-23p19 als mögliche Bindungspartner identifiziert. Aufgrund kreuzreaktiver Antikörper ist ein direkter Nachweis der EBI3-Dimere derzeit nicht möglich. Die stattdessen genutzte Kombination verschiedener Methoden dient als geeigneter Ersatz für die problematischen Antikörper-basierten Analysen wie Immunpräzipitation oder ELISA. Durch molekularbiologische, immunologische und massenspektrometrische Methoden konnte IL-35 identifiziert werden, während IL-39 (IL-23p19/EBI3) nicht detektiert wurde. Dies ist in Einklang mit den Erkenntnissen mehrerer Forschungsgruppen, die eine Bildung des nativen humanen Dimers aus IL-23p19 und EBI3 bezweifeln. Des Weiteren wurde die biologische Aktivität des behandlungsinduzierten IL 35-Proteins durch einen Funktionsassay nachgewiesen.
Neben einer DNMTi-bedingten transkriptionellen Aktivierung konnte eine Regulation von EBI3 über Histonacetylierungen gezeigt werden. Der EBI3-induzierende Effekt des Histondeacetylasen-Inhibitors (HDACi) Trichostatin A (TSA) wurde durch SAHA (suberoylanilide hydroxamic acid (Vorinostat; Zolinza®)) verifiziert. Ähnlich zu der Stimulation mit den hypomethylierenden Substanzen wurde ein synergistischer Effekt bei paralleler Inkubation mit TNFα beobachtet, der in einer gesteigerten Bildung des EBI3-Proteins resultierte.
Um die Befunde in einem komplexeren in vivo-Modell zu untersuchen, wurde eine chronische Colitis in Ebi3-defizienten Mäusen und dem dazugehörigen Wildtypstamm C57BL/6 durch zyklische Applikation von Natriumdextransulfat (Dextran sodium sulfate (DSS)) induziert. Der Vergleich klinischer Parameter wie Mortalitätsrate und Körper- sowie Milzgewicht wies bei Abwesenheit von Ebi3 signifikant stärkere colitische Symptome auf. Dies bestätigte die zentrale Rolle von Ebi3 in der Colitisentwicklung und deutete auf eine bevorzugte Bildung des anti-inflammatorisch wirkenden IL-35 statt des pro-inflammatorischen IL-39 in den Wildtyptieren hin. Durch zusätzliche therapeutische Behandlung der C57BL/6-Mäuse nach der DSS-Gabe konnte die in der Literatur beschriebene positive Wirkung von SAHA auf die Colitismanifestation bestätigt werden. Im Gegensatz dazu war der HDACi in den Ebi3-defizienten Tieren nicht in der Lage, die colitischen Parameter zu verbessern beziehungsweise verschlimmerte den Krankheitsphänotyp. Expressionsanalysen von Up- und Downstream-Target-Genen lieferten weitere Hinweise darauf, dass bei Anwesenheit von Ebi3 IL-35 statt IL-39 gebildet wird, was in Einklang mit den in vitro-Untersuchungen steht.
Die vorliegende Arbeit konnte durch den Vergleich der C57BL/6-Mäuse mit den Ebi3-defizienten Tieren neue Erkenntnisse über die Wirkungsweise von SAHA erbringen. Histonacetylierende Bedingungen verbessern colitische Symptome über einen Mechanismus, der die epigenetische Induktion von Ebi3 mit nachfolgender IL-35-Bildung involviert. Durch Kooperation der epigenetischen Mechanismen Hypomethylierung und Histonacetylierung wurde der stärkste Effekt auf die EBI3-Induktion bewirkt.
Insgesamt konnte in der vorliegenden Arbeit durch in vitro- und in vivo-Analysen die epigenetische und NFκB-vermittelte Induktion von EBI3 über DNA-Demethylierung und Histonacetylierung mit nachfolgender IL-35-Bildung und –Sezernierung nachgewiesen werden. Da IL-35 in der Lage ist, colitische Symptome zu mildern, stellt die epigenetische Reaktivierbarkeit von EBI3 durch DNMTi und HDACi eine vielversprechende Alternative für die derzeit genutzten, oft nicht oder nur kurzfristig wirksamen Therapien bei der Behandlung einer CU dar. Einer übermäßigen Immunantwort während schubweiser entzündlicher Phasen könnte entgegengewirkt und Komplikationen wie die Bildung Colitis-assoziierter Karzinome verhindert werden.
OBJECTIVE: Higher plasma vitamin C levels are associated with lower type 2 diabetes risk, but whether this association is causal is uncertain. To investigate this, we studied the association of genetically predicted plasma vitamin C with type 2 diabetes.
RESEARCH DESIGN AND METHODS: We conducted genome-wide association studies of plasma vitamin C among 52,018 individuals of European ancestry to discover novel genetic variants. We performed Mendelian randomization analyses to estimate the association of genetically predicted differences in plasma vitamin C with type 2 diabetes in up to 80,983 case participants and 842,909 noncase participants. We compared this estimate with the observational association between plasma vitamin C and incident type 2 diabetes, including 8,133 case participants and 11,073 noncase participants.
RESULTS: We identified 11 genomic regions associated with plasma vitamin C (P < 5 x 10(-8)), with the strongest signal at SLC23A1, and 10 novel genetic loci including SLC23A3, CHPT1, BCAS3, SNRPF, RER1, MAF, GSTA5, RGS14, AKT1, and FADS1. Plasma vitamin C was inversely associated with type 2 diabetes (hazard ratio per SD 0.88; 95% CI 0.82, 0.94), but there was no association between genetically predicted plasma vitamin C (excluding FADS1 variant due to its apparent pleiotropic effect) and type 2 diabetes (1.03; 95% CI 0.96, 1.10).
CONCLUSIONS: These findings indicate discordance between biochemically measured and genetically predicted plasma vitamin C levels in the association with type 2 diabetes among European populations. The null Mendelian randomization findings provide no strong evidence to suggest the use of vitamin C supplementation for type 2 diabetes prevention.
The knowledge of transformation pathways and transformation products of veterinary drugs is important for health, food and environmental matters. Residues, consisting of original veterinary drug and transformation products, are found in food products of animal origin as well as the environment (e.g., soil or surface water). Several transformation processes can alter the original veterinary drug, ranging from biotransformation in living organism to environmental degradation processes like photolysis, hydrolysis, or microbial processes. In this thesis, four veterinary drugs were investigated, three ionophore antibiotics Monensin, Salinomycin and Lasalocid and the macrocyclic lactone Moxidectin. Ionophore antibiotics are mainly used to cure and prevent coccidiosis in poultry especially prophylactic in broiler farming. Moxidectin is an antiparasitic drug that is used for the treatment of internal and external parasites in food-producing and companion animals. The main objective of this work is to employ different laboratory approaches to generate and identify transformation products. The identification was conducted using high-resolution mass spectrometry (HRMS). A major focus was placed on the application of electrochemistry for simulation of transformation processes. The electrochemical reactor – equipped with a three-electrode flow-through cell – enabled the oxidation or reduction by applying a potential. The transformation products derived were analyzed by online coupling of the electrochemical reactor and a HRMS and offline by liquid chromatography (LC) combined with HRMS. The main modification reaction of the identified transformation products differed for each investigated veterinary drug. Monensin showed decarboxylation and demethylation as the main modification reactions, for Salinomycin mostly decarbonylation occurred and for Lasalocid methylation was prevalent. For Moxidectin, I observed an oxidation (hydroxylation) reaction and adduct formation with solvent. In general, for Salinomycin and Lasalocid, more transient transformation products (online measurement) than stable transformation products (offline measurements) were detected. By contrast, the number of transformation products using online and offline measurements were identical for Monensin and Moxidectin. As a complementary approach, metabolism tests with rat or human liver microsomes were conducted for the ionophore antibiotics. Monensin was investigated by using rat liver microsomes and the transformation products identified were based on decarboxylation and demethylation. Salinomycin and Lasalocid were converted by human and rat liver microsomes. For both substances, more transformation products were found by using human liver microsomes. The transformation products of the rat liver microsome conversion were redundant, and the transformation products were also found at the human liver microsome assay. Oxidation (hydroxylation) was found to be the main modification reaction for both. In addition, a frequent ion exchange between sodium and potassium was identified. The final two experiments were performed for one substance each, whereby the hydrolysis of Monensin and the photolysis of Moxidectin was investigated. The transformation products of the pH-dependent hydrolysis were based on ring-opening and dehydration. Moxidectin formed several transformation products by irradiation with UV-C light and the main modification reactions were isomeric changes, (de-)hydration and changes of the methoxime moiety. In summary, transformation products of the four investigated veterinary drugs were generated by the different laboratory approaches. Most of the transformation products were identified for the first time. The resulting findings provide an improved understanding of clarifying the transformation behavior.
By using mouse outcross populations in combination with bioinformatic approaches, it was possible to identify and characterize novel genes regulating body weight, fat mass and β-cell function, which all contribute to the pathogenesis of obesity and T2D. In detail, the presented studies identified 1. Ifi202b/IFI16 as adipogenic gene involved in adipocyte commitment, maintenance of white adipocyte identity, fat cell size and the inflammatory state of adipose tissue. 2. Pla2g4a/PLA2G4A as gene linked to increased body weight and fat mass with a higher expression in adipose tissue of obese mice and pigs as well as in obese human subjects. 3. Ifgga2/IRGM as novel regulator of lipophagy protecting from excess hepatic lipid accumulation. 4. Nidd/DBA as a diabetogenic locus containing Kti12, Osbpl9, Ttc39a and Calr4 with differential expression in pancreatic islets and/or genetic variants. 5. miR-31 to be higher expressed in adipose tissue of obese and diabetic mice and humans targeting PPARy and GLUT4 and thereby involved in adipogenesis and insulin signaling. 6. Gjb4 as novel gene triggering the development of T2D by reducing insulin secretion, inducing apoptosis and inhibiting proliferation. The performed studies confirmed the complexity and strong genetic heritability character of obesity and T2D. A high number of genetic variations, each with a small effect, are collectively influencing the degree and severity of the disease. The use of mouse outcross populations is a valid tool for disease gene identification; however, to facilitate and accelerate the process of gene identification the combination of mouse cross data with advanced sequencing resources and the publicly available data sets are essential. The main goal for future studies should be the translation of these novel molecular discoveries to useful treatment therapies. More recently, several classes of novel unimolecular combination therapeutics have emerged with superior efficacy than currently prescribed options and pose the potential to reverse obesity and T2D (Finan et al., 2015). The glucagon-like peptide-1 (GLP-1)- estrogen conjugate, which targets estrogen into cells expressing GLP-1 receptors, was shown to improve energy, glucose and lipid metabolism as well as to reduce food reward (Finan et al., 2012; Schwenk et al., 2014; Vogel et al., 2016). Another possibility is the development of miRNA-based therapeutics to prevent obesity and T2D, such as miRNA mimetics, anti-miRNA oligonucleotides and exosomes loaded with miRNAs (Ji and Guo, 2019; Gottmann et al., 2020). As already described, genome-wide association studies for polygenic obesity and T2D traits in humans have also led to the identification of numerous gene variants with modest effect, most of them having an unknown function (Yazdi et al., 2015). These discoveries resulted in novel animal models and have illuminated new biologic pathways. Therefore, the integration of mouse-human genetic approaches and the utilization of the synergistic effects have the potential to lead to the identification of more genes responsible for common Mendelian forms of obesity and T2D, as well as gene × gene and gene × environment interactions (Yazdi et al., 2015; Ingelsson and McCarthy, 2018). This combination may help to unravel the missing heritability of obesity and T2D, to identify novel drug targets and to design more efficient and personalized obesity prevention and management programs.
Background & aims: Fibroblast growth factor 21 (FGF21) plays a pivotal role in glucose and lipid metabolism and has been proposed as a longevity hormone. However, elevated plasma FGF21 concentrations are paradoxically associated with mortality in higher age and little is known about the postprandial regulation of FGF21 in older adults. In this parallel group study, we investigated postprandial FGF21 dynamics and response in older (65-85 years) compared to younger (18-35 years) adults following test meals with varying macronutrient composition.
Methods: Participants (n = 60 older; n = 60 younger) were randomized to one of four test meals: dextrose, high carbohydrate (HC), high fat (HF) or high protein (HP). Blood was drawn before and 15, 30, 60, 120, 240 min after meal ingestion. Postprandial dynamics were evaluated using repeated measures ANCOVA. FGF21 response was assessed by incremental area under the curve.
Results: Fasting FGF21 concentrations were significantly higher in older adults. FGF21 dynamics were affected by test meal (p < 0.001) and age (p = 0.013), when adjusted for BMI and fasting FGF21. Postprandial FGF21 concentrations steadily declined over 240 min in both age groups after HF and HP, but not after dextrose or HC ingestion. At 240 min, FGF21 concentrations were significantly higher in older than in younger adults following dextrose (133 pg/mL, 95%CI: 103, 172 versus 91.2 pg/mL, 95%CI: 70.4, 118; p = 0.044), HC (109 pg/mL, 95%CI: 85.1, 141 versus 70.3 pg/mL, 95%CI: 55.2, 89.6; p = 0.014) and HP ingestion (45.4 pg/mL, 95%CI: 34.4, 59.9 versus 27.9 pg/mL 95%CI: 20.9, 37.1; p = 0.018). FGF21 dynamics and response to HF were similar for both age groups.
Conclusions: The age-specific differences in postprandial FGF21 dynamics and response in healthy adults, potentially explain higher FGF21 concentrations in older age. Furthermore, there appears to be a significant impact of acute and recent protein intake on FGF21 secretion.
Background Neurofibromatosis type 1 (NF1) is a multi-organ disease caused by mutations in neurofibromin 1 (NF1). Amongst other features, NF1 patients frequently show reduced muscle mass and strength, impairing patients' mobility and increasing the risk of fall. The role of Nf1 in muscle and the cause for the NF1-associated myopathy are mostly unknown. Methods To dissect the function ofNf1in muscle, we created muscle-specific knockout mouse models for NF1, inactivatingNf1in the prenatal myogenic lineage either under the Lbx1 promoter or under the Myf5 promoter. Mice were analysed during prenatal and postnatal myogenesis and muscle growth. Results Nf1(Lbx1)and Nf1(Myf5)animals showed only mild defects in prenatal myogenesis. Nf1(Lbx1)animals were perinatally lethal, while Nf1(Myf5)animals survived only up to approximately 25 weeks. A comprehensive phenotypic characterization of Nf1(Myf5)animals showed decreased postnatal growth, reduced muscle size, and fast fibre atrophy. Proteome and transcriptome analyses of muscle tissue indicated decreased protein synthesis and increased proteasomal degradation, and decreased glycolytic and increased oxidative activity in muscle tissue. High-resolution respirometry confirmed enhanced oxidative metabolism in Nf1(Myf5)muscles, which was concomitant to a fibre type shift from type 2B to type 2A and type 1. Moreover, Nf1(Myf5)muscles showed hallmarks of decreased activation of mTORC1 and increased expression of atrogenes. Remarkably, loss of Nf1 promoted a robust activation of AMPK with a gene expression profile indicative of increased fatty acid catabolism. Additionally, we observed a strong induction of genes encoding catabolic cytokines in muscle Nf1(Myf5)animals, in line with a drastic reduction of white, but not brown adipose tissue. Conclusions Our results demonstrate a cell autonomous role for Nf1 in myogenic cells during postnatal muscle growth required for metabolic and proteostatic homeostasis. Furthermore, Nf1 deficiency in muscle drives cross-tissue communication and mobilization of lipid reserves.
As of late, epidemiological studies have highlighted a strong association of dairy intake with lower disease risk, and similarly with an increased amount of odd-chain fatty acids (OCFA). While the OCFA also demonstrate inverse associations with disease incidence, the direct dietary sources and mode of action of the OCFA remain poorly understood.
The overall aim of this thesis was to determine the impact of two main fractions of dairy, milk fat and milk protein, on OCFA levels and their influence on health outcomes under high-fat (HF) diet conditions. Both fractions represent viable sources of OCFA, as milk fats contain a significant amount of OCFA and milk proteins are high in branched chain amino acids (BCAA), namely valine (Val) and isoleucine (Ile), which can produce propionyl-CoA (Pr-CoA), a precursor for endogenous OCFA synthesis, while leucine (Leu) does not. Additionally, this project sought to clarify the specific metabolic effects of the OCFA heptadecanoic acid (C17:0).
Both short-term and long-term feeding studies were performed using male C57BL/6JRj mice fed HF diets supplemented with milk fat or C17:0, as well as milk protein or individual BCAA (Val; Leu) to determine their influences on OCFA and metabolic health. Short-term feeding revealed that both milk fractions induce OCFA in vivo, and the increases elicited by milk protein could be, in part, explained by Val intake. In vitro studies using primary hepatocytes further showed an induction of OCFA after Val treatment via de novo lipogenesis and increased α-oxidation. In the long-term studies, both milk fat and milk protein increased hepatic and circulating OCFA levels; however, only milk protein elicited protective effects on adiposity and hepatic fat accumulation—likely mediated by the anti-obesogenic effects of an increased Leu intake. In contrast, Val feeding did not increase OCFA levels nor improve obesity, but rather resulted in glucotoxicity-induced insulin resistance in skeletal muscle mediated by its metabolite 3-hydroxyisobutyrate (3-HIB). Finally, while OCFA levels correlated with improved health outcomes, C17:0 produced negligible effects in preventing HF-diet induced health impairments.
The results presented herein demonstrate that the beneficial health outcomes associated with dairy intake are likely mediated through the effects of milk protein, while OCFA levels are likely a mere association and do not play a significant causal role in metabolic health under HF conditions. Furthermore, the highly divergent metabolic effects of the two BCAA, Leu and Val, unraveled herein highlight the importance of protein quality.
Type 2 diabetes (T2D) is a complex metabolic disease regulated by an interaction of genetic predisposition and environmental factors. To understand the genetic contribution in the development of diabetes, mice varying in their disease susceptibility were crossed with the obese and diabetes-prone New Zealand obese (NZO) mouse. Subsequent whole-genome sequence scans revealed one major quantitative trait loci (QTL),Nidd/DBAon chromosome 4, linked to elevated blood glucose and reduced plasma insulin and low levels of pancreatic insulin. Phenotypical characterization of congenic mice carrying 13.6 Mbp of the critical fragment of DBA mice displayed severe hyperglycemia and impaired glucose clearance at week 10, decreased glucose response in week 13, and loss of beta-cells and pancreatic insulin in week 16. To identify the responsible gene variant(s), further congenic mice were generated and phenotyped, which resulted in a fragment of 3.3 Mbp that was sufficient to induce hyperglycemia. By combining transcriptome analysis and haplotype mapping, the number of putative responsible variant(s) was narrowed from initial 284 to 18 genes, including gene models and non-coding RNAs. Consideration of haplotype blocks reduced the number of candidate genes to four (Kti12,Osbpl9,Ttc39a, andCalr4) as potential T2D candidates as they display a differential expression in pancreatic islets and/or sequence variation. In conclusion, the integration of comparative analysis of multiple inbred populations such as haplotype mapping, transcriptomics, and sequence data substantially improved the mapping resolution of the diabetes QTLNidd/DBA. Future studies are necessary to understand the exact role of the different candidates in beta-cell function and their contribution in maintaining glycemic control.
Background:
Epidemiological evidence indicates that diets rich in plant foods are associated with a lower risk of ischaemic heart disease (IHD), but there is sparse information on fruit and vegetable subtypes and sources of dietary fibre. This study examined the associations of major plant foods, their subtypes and dietary fibre with risk of IHD in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Methods:
We conducted a prospective analysis of 490 311 men and women without a history of myocardial infarction or stroke at recruitment (12.6 years of follow-up, n cases = 8504), in 10 European countries. Dietary intake was assessed using validated questionnaires, calibrated with 24-h recalls. Multivariable Cox regressions were used to estimate hazard ratios (HR) of IHD.
Results:
There was a lower risk of IHD with a higher intake of fruit and vegetables combined [HR per 200 g/day higher intake 0.94, 95% confidence interval (CI): 0.90-0.99, P-trend = 0.009], and with total fruits (per 100 g/day 0.97, 0.95-1.00, P-trend = 0.021). There was no evidence for a reduced risk for fruit subtypes, except for bananas. Risk was lower with higher intakes of nuts and seeds (per 10 g/day 0.90, 0.82-0.98, Ptrend = 0.020), total fibre (per 10 g/day 0.91, 0.85-0.98, P-trend = 0.015), fruit and vegetable fibre (per 4 g/day 0.95, 0.91-0.99, P-trend = 0.022) and fruit fibre (per 2 g/day 0.97, 0.95-1.00, P-trend = 0.045). No associations were observed between vegetables, vegetables subtypes, legumes, cereals and IHD risk.
Conclusions:
In this large prospective study, we found some small inverse associations between plant foods and IHD risk, with fruit and vegetables combined being the most strongly inversely associated with risk. Whether these small associations are causal remains unclear.
In order to improve a recently established cell-based assay to assess the potency of botulinum neurotoxin, neuroblastoma-derived SiMa cells and induced pluripotent stem-cells (iPSC) were modified to incorporate the coding sequence of a reporter luciferase into a genetic safe harbor utilizing CRISPR/Cas9. A novel method, the double-control quantitative copy number PCR (dc-qcnPCR), was developed to detect off-target integrations of donor DNA. The donor DNA insertion success rate and targeted insertion success rate were analyzed in clones of each cell type. The dc-qcnPCR reliably quantified the copy number in both cell lines. The probability of incorrect donor DNA integration was significantly increased in SiMa cells in comparison to the iPSCs. This can possibly be explained by the lower bundled relative gene expression of a number of double-strand repair genes (BRCA1, DNA2, EXO1, MCPH1, MRE11, and RAD51) in SiMa clones than in iPSC clones. The dc-qcnPCR offers an efficient and cost-effective method to detect off-target CRISPR/Cas9-induced donor DNA integrations.
In order to improve a recently established cell-based assay to assess the potency of botulinum neurotoxin, neuroblastoma-derived SiMa cells and induced pluripotent stem-cells (iPSC) were modified to incorporate the coding sequence of a reporter luciferase into a genetic safe harbor utilizing CRISPR/Cas9. A novel method, the double-control quantitative copy number PCR (dc-qcnPCR), was developed to detect off-target integrations of donor DNA. The donor DNA insertion success rate and targeted insertion success rate were analyzed in clones of each cell type. The dc-qcnPCR reliably quantified the copy number in both cell lines. The probability of incorrect donor DNA integration was significantly increased in SiMa cells in comparison to the iPSCs. This can possibly be explained by the lower bundled relative gene expression of a number of double-strand repair genes (BRCA1, DNA2, EXO1, MCPH1, MRE11, and RAD51) in SiMa clones than in iPSC clones. The dc-qcnPCR offers an efficient and cost-effective method to detect off-target CRISPR/Cas9-induced donor DNA integrations.
The intake of high-fat diets (HFDs) containing large amounts of saturated long-chain fatty acids leads to obesity, oxidative stress, inflammation, and insulin resistance. The trace element selenium, as a crucial part of antioxidative selenoproteins, can protect against the development of diet-induced insulin resistance in white adipose tissue (WAT) by increasing glutathione peroxidase 3 (GPx3) and insulin receptor (IR) expression. Whether selenite (Se) can attenuate insulin resistance in established lipotoxic and obese conditions is unclear. We confirm that GPX3 mRNA expression in adipose tissue correlates with BMI in humans. Cultivating 3T3-L1 pre-adipocytes in palmitate-containing medium followed by Se treatment attenuates insulin resistance with enhanced GPx3 and IR expression and adipocyte differentiation. However, feeding obese mice a selenium-enriched high-fat diet (SRHFD) only resulted in a modest increase in overall selenoprotein gene expression in WAT in mice with unaltered body weight development, glucose tolerance, and insulin resistance. While Se supplementation improved adipocyte morphology, it did not alter WAT insulin sensitivity. However, mice fed a SRHFD exhibited increased insulin content in the pancreas. Overall, while selenite protects against palmitate-induced insulin resistance in vitro, obesity impedes the effect of selenite on insulin action and adipose tissue metabolism in vivo.
The intake of high-fat diets (HFDs) containing large amounts of saturated long-chain fatty acids leads to obesity, oxidative stress, inflammation, and insulin resistance. The trace element selenium, as a crucial part of antioxidative selenoproteins, can protect against the development of diet-induced insulin resistance in white adipose tissue (WAT) by increasing glutathione peroxidase 3 (GPx3) and insulin receptor (IR) expression. Whether selenite (Se) can attenuate insulin resistance in established lipotoxic and obese conditions is unclear. We confirm that GPX3 mRNA expression in adipose tissue correlates with BMI in humans. Cultivating 3T3-L1 pre-adipocytes in palmitate-containing medium followed by Se treatment attenuates insulin resistance with enhanced GPx3 and IR expression and adipocyte differentiation. However, feeding obese mice a selenium-enriched high-fat diet (SRHFD) only resulted in a modest increase in overall selenoprotein gene expression in WAT in mice with unaltered body weight development, glucose tolerance, and insulin resistance. While Se supplementation improved adipocyte morphology, it did not alter WAT insulin sensitivity. However, mice fed a SRHFD exhibited increased insulin content in the pancreas. Overall, while selenite protects against palmitate-induced insulin resistance in vitro, obesity impedes the effect of selenite on insulin action and adipose tissue metabolism in vivo.
The prevalence of depression and anxiety is increased in obese patients compared to healthy humans, which is partially due to a shared pathogenesis, including insulin resistance and inflammation. These factors are also linked to intestinal dysbiosis. Additionally, the chronic consumption of diets rich in saturated fats results in body weight gain, hormonal resistances and unfavorable changes in the microbiome composition. The intake of Lactobacilli has already been shown to improve dysbiosis along with metabolism and mood. Yet, the beneficial role and the underlying mechanism of Lactobacillus rhamnosus GG (LGG) to improve emotional behavior in established diet-induced obese conditions are, so far, unknown. To characterize the role of LGG in diet-induced obesity, female and male C57BL/6N mice were fed a semi-synthetic low-fat diet (LFD, 10 % kcal from fat) or a conventional high-fat diet (HFD, 45 % kcal from fat) for initial 6 weeks, which was followed by daily oral gavage of vehicle or 1x10^8 CFU of LGG until the end of the experiment. Mice were subjected to basic metabolic and extensive behavioral phenotyping, with a focus on emotional behavior. Moreover, composition of cecal gut microbiome, metabolomic profile in plasma and cerebrospinal fluid was investigated and followed by molecular analyses. Both HFD-feeding and LGG application resulted in sex-specific differences. While LGG prevented the increase of plasma insulin, adrenal gland weight and hyperactivity in diet-induced obese female mice, there was no regulation of anxiodepressive-like behavior. In contrast, metabolism of male mice did not benefit from LGG application, but strikingly, LGG decreased specifically depressive-like behavior in the Mousetail Suspension Test which was confirmed by the Splash Test characterizing motivation for ’self-care’. The microbiome analysis in male mice revealed that HFD-feeding, but not LGG application, altered cecal microbiome composition, indicating a direct effect of LGG on behavioral regulation. However, in female mice, both HFD-feeding and LGG application resulted in changes of microbiome composition, which presumably affected metabolism. Moreover, as diet-induced obese female mice unexpectedly did not exhibit anxiodepressive-like behavior, follow-up analyses were conducted in male mice. Here, HFD-feeding significantly altered abundance of plasma lipids whereas LGG decreased branched chain amino acids which associated with improved emotional behavior. In nucleus accumbens (NAcc) and VTA/SN, which belong to the dopaminergic system, LGG restored HFD-induced decrease of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, on gene expression level. Lastly, transcriptome analysis in the NAcc identified gene expression of cholecystokinin as a potential mediator of the effect of LGG on HFD-induced emotional alterations. In summary, this thesis revealed the beneficial effects of LGG application on emotional alterations in established diet-induced obesity. Furthermore, both HFD-feeding and LGG treatment exhibited sex-specific effects, resulting in metabolic improvements in female mice while LGG application mitigated depressive-like behavior in obese male mice along with a molecular signature of restored dopamine synthesis and neuropeptide signaling.
Background/Aims:
The ET system might be involved in the pathogenesis of hypertensive disorders during pregnancy. The objective is to analyse the impact of ET-1 in hypertensive pregnant women by a strict meta-analysis of published human clinical studies.
Methods:
Based on the principle of Cochrane systematic reviews, Cohort studies in PubMed (Medline), Google Scholar and China Biological Medicine Database (CBM-disc) designed to identify the role of endothelin-1 (ET-1) in the pathophysiology of gestational hypertension and preeclampsia were screened. Review Manager Version 5.0 (Rev-Man 5.0) was applied for statistical analysis. Mean difference and 95% confidence interval (CI) were shown in inverse variance (IV) fixed-effects model or IV random-effects model.
Results:
Sixteen published cohort studies including 1739 hypertensive cases and 409 controls were used in the meta-analysis. ET-1 plasma concentrations were higher in hypertensive pregnant women as compared to the controls (mean difference between groups: 19.02 [15.60~22.44], P < 0.00001,). These finding were driven by severity of hypertension and/or degree of proteinuria.
Conclusion:
Plasma ET-1 concentrations are elevated in hypertensive disorders during human pregnancy. In particular women with preeclampsia (hypertensive pregnant women with proteinuria) have substantially elevated plasma ET-1 concentration as compared to pregnant women with normal blood pressure.
Background/Aims:
Obesity is a main risk factor for the development of hepatic insulin resistance and it is accompanied by adipocyte hypertrophy and an elevated expression of different adipokines such as autotaxin (ATX). ATX converts lysophosphatidylcholine to lysophosphatidic acid (LPA) and acts as the main producer of extracellular LPA. This bioactive lipid regulates a broad range of physiological and pathological responses by activation of LPA receptors (LPA1-6).
Methods:
The activation of phosphatidylinositide 3-kinases (PI3K) signaling (Akt and GSK-3ß) was analyzed via western blotting in primary rat hepatocytes. Incorporation of glucose into glycogen was measured by using radio labeled glucose. Real-time PCR analysis and pharmacological modulation of LPA receptors were performed. Human plasma LPA levels of obese (BMI > 30, n = 18) and normal weight individuals (BMI 18.5-25, n = 14) were analyzed by liquid chromatography tandem-mass spectrometry (LC-MS/MS).
Results:
Pretreatment of primary hepatocytes with LPA resulted in an inhibition of insulin-mediated Gck expression, PI3K activation and glycogen synthesis. Pharmacological approaches revealed that the LPA3-receptor subtype is responsible for the inhibitory effect of LPA on insulin signaling. Moreover, human plasma LPA concentrations (16: 0 LPA) of obese participants (BMI > 30) are significantly elevated in comparison to normal weight individuals (BMI 18.5-25).
Conclusion:
LPA is able to interrupt insulin signaling in primary rat hepatocytes via the LPA3 receptor subtype. Moreover, the bioactive lipid LPA (16: 0) is increased in obesity.
Within the last few decades, liquid chromatography-mass spectrometry (LC-MS) has become a preferred method for manifold issues in analytical biosciences, given its high selectivity and sensitivity. However, the analysis of fatty aldehydes, which are important components of cell metabolism, remains challenging. Usually, chemical derivatization prior to MS detection is required to enhance ionization efficiency. In this regard, the coupling of fatty aldehydes to hydrazines like 2,4-dinitrophenylhydrazine (DNPH) is a common approach. Additionally, hydrazones readily react with fatty aldehydes to form stable derivatives, which can be easily separated using high-performance liquid chromatography (HPLC) and subsequently detected by MS. Here, we exemplarily present the quantification of the long-chain fatty aldehyde (2E)-hexadecenal, a break-down product of the bioactive lipid sphingosine 1-phosphate (S1P), after derivatization with 2-diphenylacetyl-1,3-indandione-1-hydrazone (DAIH) via isotope-dilution HPLC-electrospray ionization-quadrupole/time-of-flight (ESI-QTOF) MS. Moreover, we show that the addition of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC hydrochloride) as a coupling agent allows for simultaneous determination of fatty aldehydes and fatty acids as DAIH derivatives. Taking advantage of this, we describe in detail how to monitor the degradation of (2E)-hexadecenal and the concurrent formation of its oxidation product (2E)-hexadecenoic acid in lysates of human hepatoblastoma (HepG2) cells within this chapter.
A balanced sphingolipid rheostat is indispensable for dendritic cell function and survival and thus initiation of an immune response. Sphingolipid levels are dynamically maintained by the action of sphingolipid enzymes of which sphingosine kinases, S1P phosphatases (SGPP-1/2) and S1P lyase (SGPL-1), are pivotal in the balance of S1P and sphingosine levels. In this study, we present that SGPP-1 and SGPL-1 are regulated in inflammatory dendritic cells and contribute to S1P fate. TLR-dependent activation caused SGPL-1 protein downregulation with subsequent decrease of enzymatic activity by two-thirds. In parallel, confocal fluorescence microscopy revealed that endogenous SGPP-1 was expressed in nuclei of naive dendritic cells and was translocated into the cytoplasmatic compartment upon inflammatory stimulation resulting in dephosphorylation of S1P. Mass spectrometric determination showed that a part of the resulting sphingosine was released from the cell, increasing extracellular levels. Another route of diminishing intracellular S1P was possibly taken by its export via ATP-binding cassette transporter C1 which was upregulated in array analysis, while the S1P transporter, spinster homolog 2, was not relevant in dendritic cells. These investigations newly describe the sequential expression and localization of the endogenous S1P regulators SGPP-1 and SGPL-1 and highlight their contribution to the sphingolipid rheostat in inflammation.
Objective: We aimed to identify the role of the enzyme acid sphingomyelinase in the aging of stored units of packed red blood cells (pRBCs) and subsequent lung inflammation after transfusion.
Summary Background Data: Large volume pRBC transfusions are associated with multiple adverse clinical sequelae, including lung inflammation. Microparticles are formed in stored pRBCs over time and have been shown to contribute to lung inflammation after transfusion.
Methods: Human and murine pRBCs were stored with or without amitriptyline, a functional inhibitor of acid sphingomyelinase, or obtained from acid sphingomyelinase-deficient mice, and lung inflammation was studied in mice receiving transfusions of pRBCs and microparticles isolated from these units.
Results: Acid sphingomyelinase activity in pRBCs was associated with the formation of ceramide and the release of microparticles. Treatment of pRBCs with amitriptyline inhibited acid sphingomyelinase activity, ceramide accumulation, and microparticle production during pRBC storage. Transfusion of aged pRBCs or microparticles isolated from aged blood into mice caused lung inflammation. This was attenuated after transfusion of pRBCs treated with amitriptyline or from acid sphingomyelinase-deficient mice.
Conclusions: Acid sphingomyelinase inhibition in stored pRBCs offers a novel mechanism for improving the quality of stored blood.
Starch is one of the most popular nutritional sources for both human and animals. Due to the variation of its nutritional traits and biochemical specificities, starch has been classified into rapidly digestible, slowly digestible and resistant starch. Resistant starch has its own unique chemical structure, and various forms of resistant starch are commercially available. It has been found being a multiple-functional regulator for treating metabolic dysfunction. Different functions of resistant starch such as modulation of the gut microbiota, gut peptides, circulating growth factors, circulating inflammatory mediators have been characterized by animal studies and clinical trials. In this mini-review, recent remarkable progress in resistant starch on gut microbiota, particularly the effect of structure, biochemistry and cell signaling on nutrition has been summarized, with highlights on its regulatory effect on gut microbiota.
Background/Aims: Impaired pregnancy outcomes, such as low birth weight are associated with increased disease risk in later life, however little is known about the impact of common infectious diseases during pregnancy on birth weight. The study had two aims: a) to investigate risk factors of influenza virus infection during pregnancy, and b) to analyze the impact of influenza virus infection on pregnancy outcome, especially birth weight.
Methods: Prospective and retrospective observational studies found in PubMed, MEDLINE, Embase, Google Scholar, and WangFang database were included in this meta analysis. Data of included studies was extracted and analyzed by the RevMan software.
Results: Pregnant women with anemia (P=0.004, RR=1.46, 95% CI: 1.13-1.88), obesity (P<0.00001, RR=1.35, 95% CI: 1.25-1.46) and asthma (P<0.00001, RR=1.99, 95% CI: 1.67-2.37) had higher rates of influenza virus infection. Regarding birth outcomes, influenza A virus infection did not affect the likelihood for cesarean section. Mothers with influenza had a higher rate of stillbirth (P=0.04, RR=2.36, 95% CI: 1.05-5.31), and their offspring had low 5-minute APGR Scores (P=0.009, RR=1.39, 95% CI: 1.08-1.79). Furthermore, the rate for birth weight < 2500g (P=0.04, RR=1.71, 95% CI: 1.03-2.84) was increased.
Conclusion: Results of this study showed that anemia, asthma and obesity during pregnancy are risk factors influenza A virus infection during pregnancy. Moreover, gestational influenza A infection impairs pregnancy outcomes and increases the risk for low birth weight, a known risk factor for later life disease susceptibility.
Background/Aims: Contrast induced acute kidney injury (CI-AKI) remains a serious complication of contrast media enhanced procedures like coronary angiography. There is still a lack of established biomarkers that help to identify patients at high risk for short and long-term complications. The aim of the current study was to evaluate plasma kynurenine as a predictive biomarker for CI-AKI and long-term complications, measured by the combined endpoint "major adverse kidney events" (MAKE) up to 120 days after CM application.
Methods: In this prospective cohort study 245 patients undergoing coronary angiography were analyzed. Blood samples were obtained at baseline, 24h and 48h after contrast media (CM) application to diagnose CI-AKI. Patients were followed for 120 days for adverse clinical events including death, the need for dialysis, and a doubling of plasma creatinine. Occurrence of any of these events was summarized in the combined endpoint MAKE.
Results: Preinterventional plasma kynurenine was not associated with CI-AKI. Patients who later developed MAKE displayed significantly increased preinterventional plasma kynurenine levels (p<0.0001). ROC analysis revealed that preinterventional kynurenine is highly predictive for MAKE (AUC=0.838; p<0.0001). The optimal cutoff was found at >= 3.5 mu mol/L. Using this cutoff, the Kaplan-Meier estimator demonstrated that concentrations of plasma kynurenine >= 3.5 mu mol/L were significantly associated with a higher prevalence of MAKE until follow up (p<0.0001). This association remained significant in multivariate Cox regression models adjusted for relevant factors of long-term renal outcome.
Conclusion: Preinterventional plasma kynurenine might serve as a highly predictive biomarker for MAKE up to 120 days after coronary angiography.
Background/Aims: A recent study revealed that global overexpression of ET-1 causes a slight reduction in systemic blood pressure. Moreover, heterozygous ET-1 knockout mice are hypertensive. The role of ET-1 in human hypertension was so far not addressed by a strict meta-analysis of published human clinical studies.
Methods: We included studies published between January 1, 1990 and February 28, 2017. We included case control studies analyzing untreated essential hypertension or hypertensive patients where antihypertensive medication was discontinued for at least two weeks. Based on the principle of Cochrane systematic reviews, case control studies (CCSs) in PubMed (Medline) and Google Scholar designed to identify the role of endothelin-1 (ET-1) in the pathophysiological of hypertension were screened. Review Manager Version 5.0 (Rev-Man 5.0) was applied for statistical analysis. Mean difference and 95% confidence interval (CI) were shown in inverse variance (IV) fixed-effects model or IV random-effects models.
Results: Eleven studies fulfilling our in-and exclusion criteria were eligible for this meta-analysis. These studies included 450 hypertensive patients and 328 controls. Our meta-analysis revealed that ET-1 plasma concentrations were higher in hypertensive patients as compared to the control patients [mean difference between groups 1.57 pg/mL, 95%Ci [0.47 similar to 2.68, P = 0.005]. These finding were driven by patients having systolic blood pressure higher than 160 mmHg and diastolic blood pressure higher than 100 mmHg.
Conclusions: This meta-analysis showed that hypertensive patients do have elevated plasma ET-1 concentrations. This finding is driven by those patients with high systolic/diastolic blood pressure. Given that the ET-1 gene did not appear in any of the whole genome association studies searching for hypertension associated gene loci, it is very likely that the elevated plasma ET-1 concentrations in hypertensive patients are secondary to hypertension and may reflect endothelial cell damage.
Countries processing raw coffee beans are burdened with low economical incomes to fight the serious environmental problems caused by the by-products and wastewater that is generated during the wet-coffee processing. The aim of this work was to develop alternative methods of improving the waste by-product quality and thus making the process economically more attractive with valorization options that can be brought to the coffee producers.
The type of processing influences not only the constitution of green coffee but also of by-products and wastewater. Therefore, coffee bean samples as well as by-products and wastewater collected at different production steps of were analyzed. Results show that the composition of wastewater is dependent on how much and how often the wastewater is recycled in the processing. Considering the coffee beans, results indicate that the proteins might be affected during processing and a positive effect of the fermentation on the solubility and accessibility of proteins seems to be probable. The steps of coffee processing influence the different constituents of green coffee beans which, during roasting, give rise to aroma compounds and express the characteristics of roasted coffee beans. Knowing that this group of compounds is involved in the Maillard reaction during roasting, this possibility could be utilized for the coffee producers to improve the quality of green coffee beans and finally the coffee cup quality.
The valorization of coffee wastes through modification to activated carbon has been considered as a low-cost option creating an adsorbent with prospective to compete with commercial carbons. Activation protocol using spent coffee and parchment was developed and prepared to assess their adsorption capacity for organic compounds. Spent coffee grounds and parchment proved to have similar adsorption efficiency to commercial activated carbon.
The results of this study document a significant information originating from the processing of the de-pulped to green coffee beans. Furthermore, it showed that coffee parchment and spent coffee grounds can be valorized as low-cost option to produce activated carbons. Further work needs to be directed to the optimization of the activation methods to improve the quality of the materials produced and the viability of applying such experiments in-situ to bring the coffee producer further valorization opportunities with environmental perspectives.
Coffee producers would profit in establishing appropriate simple technologies to improve green coffee quality, re-use coffee by-products, and wastewater valorization.
Wheat alpha-amylase/trypsin inhibitors remain a subject of interest considering the latest findings showing their implication in wheat-related non-celiac sensitivity (NCWS). Understanding their functions in such a disorder is still unclear and for further study, the need for pure ATI molecules is one of the limiting problems. In this work, a simplified approach based on the successive fractionation of ATI extracts by reverse phase and ion exchange chromatography was developed. ATIs were first extracted from wheat flour using a combination of Tris buffer and chloroform/methanol methods. The separation of the extracts on a C18 column generated two main fractions of interest F1 and F2. The response surface methodology with the Doehlert design allowed optimizing the operating parameters of the strong anion exchange chromatography. Finally, the seven major wheat ATIs namely P01083, P17314, P16850, P01085, P16851, P16159, and P83207 were recovered with purity levels (according to the targeted LC-MS/MS analysis) of 98.2 ± 0.7; 98.1 ± 0.8; 97.9 ± 0.5; 95.1 ± 0.8; 98.3 ± 0.4; 96.9 ± 0.5, and 96.2 ± 0.4%, respectively. MALDI-TOF-MS analysis revealed single peaks in each of the pure fractions and the mass analysis yielded deviations of 0.4, 1.9, 0.1, 0.2, 0.2, 0.9, and 0.1% between the theoretical and the determined masses of P01083, P17314, P16850, P01085, P16851, P16159, and P83207, respectively. Overall, the study allowed establishing an efficient purification process of the most important wheat ATIs. This paves the way for further in-depth investigation of the ATIs to gain more knowledge related to their involvement in NCWS disease and to allow the absolute quantification in wheat samples.
Wheat alpha-amylase/trypsin inhibitors remain a subject of interest considering the latest findings showing their implication in wheat-related non-celiac sensitivity (NCWS). Understanding their functions in such a disorder is still unclear and for further study, the need for pure ATI molecules is one of the limiting problems. In this work, a simplified approach based on the successive fractionation of ATI extracts by reverse phase and ion exchange chromatography was developed. ATIs were first extracted from wheat flour using a combination of Tris buffer and chloroform/methanol methods. The separation of the extracts on a C18 column generated two main fractions of interest F1 and F2. The response surface methodology with the Doehlert design allowed optimizing the operating parameters of the strong anion exchange chromatography. Finally, the seven major wheat ATIs namely P01083, P17314, P16850, P01085, P16851, P16159, and P83207 were recovered with purity levels (according to the targeted LC-MS/MS analysis) of 98.2 ± 0.7; 98.1 ± 0.8; 97.9 ± 0.5; 95.1 ± 0.8; 98.3 ± 0.4; 96.9 ± 0.5, and 96.2 ± 0.4%, respectively. MALDI-TOF-MS analysis revealed single peaks in each of the pure fractions and the mass analysis yielded deviations of 0.4, 1.9, 0.1, 0.2, 0.2, 0.9, and 0.1% between the theoretical and the determined masses of P01083, P17314, P16850, P01085, P16851, P16159, and P83207, respectively. Overall, the study allowed establishing an efficient purification process of the most important wheat ATIs. This paves the way for further in-depth investigation of the ATIs to gain more knowledge related to their involvement in NCWS disease and to allow the absolute quantification in wheat samples.
Botulinum neurotoxin (BoNT) is used for the treatment of a number of ailments. The activity of the toxin that is isolated from bacterial cultures is frequently tested in the mouse lethality assay. Apart from the ethical concerns inherent to this assay, species-specific differences in the affinity for different BoNT serotypes give rise to activity results that differ from the activity in humans. Thus, BoNT/B is more active in mice than in humans. The current study shows that the stimulus-dependent release of a luciferase from a differentiated human neuroblastoma–based reporter cell line (SIMA-hPOMC1-26-Gluc) was inhibited by clostridial and recombinant BoNT/A to the same extent, whereas both clostridial and recombinant BoNT/B inhibited the release to a lesser extent and only at much higher concentrations, reflecting the low activity of BoNT/B in humans. By contrast, the genetically modified BoNT/B-MY, which has increased affinity for human synaptotagmin, and the BoNT/B protein receptor inhibited luciferase release effectively and with an EC50 comparable to recombinant BoNT/A. This was due to an enhanced uptake into the reporter cells of BoNT/B-MY in comparison to the recombinant wild-type toxin. Thus, the SIMA-hPOMC1-26-Gluc cell assay is a versatile tool to determine the activity of different BoNT serotypes providing human-relevant dose-response data.
Botulinum neurotoxin (BoNT) is used for the treatment of a number of ailments. The activity of the toxin that is isolated from bacterial cultures is frequently tested in the mouse lethality assay. Apart from the ethical concerns inherent to this assay, species-specific differences in the affinity for different BoNT serotypes give rise to activity results that differ from the activity in humans. Thus, BoNT/B is more active in mice than in humans. The current study shows that the stimulus-dependent release of a luciferase from a differentiated human neuroblastoma–based reporter cell line (SIMA-hPOMC1-26-Gluc) was inhibited by clostridial and recombinant BoNT/A to the same extent, whereas both clostridial and recombinant BoNT/B inhibited the release to a lesser extent and only at much higher concentrations, reflecting the low activity of BoNT/B in humans. By contrast, the genetically modified BoNT/B-MY, which has increased affinity for human synaptotagmin, and the BoNT/B protein receptor inhibited luciferase release effectively and with an EC50 comparable to recombinant BoNT/A. This was due to an enhanced uptake into the reporter cells of BoNT/B-MY in comparison to the recombinant wild-type toxin. Thus, the SIMA-hPOMC1-26-Gluc cell assay is a versatile tool to determine the activity of different BoNT serotypes providing human-relevant dose-response data.
The protein fraction, important for coffee cup quality, is modified during post-harvest treatment prior to roasting. Proteins may interact with phenolic compounds, which constitute the major metabolites of coffee, where the processing affects these interactions. This allows the hypothesis that the proteins are denatured and modified via enzymatic and/or redox activation steps. The present study was initiated to encompass changes in the protein fraction. The investigations were limited to major storage protein of green coffee beans. Fourteen Coffea arabica samples from various processing methods and countries were used. Different extraction protocols were compared to maintain the status quo of the protein modification. The extracts contained about 4–8 µg of chlorogenic acid derivatives per mg of extracted protein. High-resolution chromatography with multiple reaction monitoring was used to detect lysine modifications in the coffee protein. Marker peptides were allocated for the storage protein of the coffee beans. Among these, the modified peptides K.FFLANGPQQGGK.E and R.LGGK.T of the α-chain and R.ITTVNSQK.I and K.VFDDEVK.Q of β-chain were detected. Results showed a significant increase (p < 0.05) of modified peptides from wet processed green beans as compared to the dry ones. The present study contributes to a better understanding of the influence of the different processing methods on protein quality and its role in the scope of coffee cup quality and aroma. View Full-Text
The protein fraction, important for coffee cup quality, is modified during post-harvest treatment prior to roasting. Proteins may interact with phenolic compounds, which constitute the major metabolites of coffee, where the processing affects these interactions. This allows the hypothesis that the proteins are denatured and modified via enzymatic and/or redox activation steps. The present study was initiated to encompass changes in the protein fraction. The investigations were limited to major storage protein of green coffee beans. Fourteen Coffea arabica samples from various processing methods and countries were used. Different extraction protocols were compared to maintain the status quo of the protein modification. The extracts contained about 4–8 µg of chlorogenic acid derivatives per mg of extracted protein. High-resolution chromatography with multiple reaction monitoring was used to detect lysine modifications in the coffee protein. Marker peptides were allocated for the storage protein of the coffee beans. Among these, the modified peptides K.FFLANGPQQGGK.E and R.LGGK.T of the α-chain and R.ITTVNSQK.I and K.VFDDEVK.Q of β-chain were detected. Results showed a significant increase (p < 0.05) of modified peptides from wet processed green beans as compared to the dry ones. The present study contributes to a better understanding of the influence of the different processing methods on protein quality and its role in the scope of coffee cup quality and aroma. View Full-Text
High-salt (HS) diets have recently been linked to oxidative stress in the brain, a fact that may be a precursor to behavioral changes, such as those involving anxiety-like behavior. However, to the best of our knowledge, no study has evaluated the amygdala redox status after consuming a HS diet in the pre- or postweaning periods. This study aimed to evaluate the amygdala redox status and anxiety-like behaviors in adulthood, after inclusion of HS diet in two periods: preconception, gestation, and lactation (preweaning); and only after weaning (postweaning). Initially, 18 females and 9 male Wistar rats received a standard (n = 9 females and 4 males) or a HS diet (n = 9 females and 5 males) for 120 days. After mating, females continued to receive the aforementioned diets during gestation and lactation. Weaning occurred at 21-day-old Wistar rats and the male offspring were subdivided: control-control (C-C)—offspring of standard diet fed dams who received a standard diet after weaning (n = 9–11), control-HS (C-HS)—offspring of standard diet fed dams who received a HS diet after weaning (n = 9–11), HS-C—offspring of HS diet fed dams who received a standard diet after weaning (n = 9–11), and HS-HS—offspring of HS diet fed dams who received a HS diet after weaning (n = 9–11). At adulthood, the male offspring performed the elevated plus maze and open field tests. At 152-day-old Wistar rats, the offspring were euthanized and the amygdala was removed for redox state analysis. The HS-HS group showed higher locomotion and rearing frequency in the open field test. These results indicate that this group developed hyperactivity. The C-HS group had a higher ratio of entries and time spent in the open arms of the elevated plus maze test in addition to a higher head-dipping frequency. These results suggest less anxiety-like behaviors. In the analysis of the redox state, less activity of antioxidant enzymes and higher levels of the thiobarbituric acid reactive substances (TBARS) in the amygdala were shown in the amygdala of animals that received a high-salt diet regardless of the period (pre- or postweaning). In conclusion, the high-salt diet promoted hyperactivity when administered in the pre- and postweaning periods. In animals that received only in the postweaning period, the addition of salt induced a reduction in anxiety-like behaviors. Also, regardless of the period, salt provided amygdala oxidative stress, which may be linked to the observed behaviors.
High-salt (HS) diets have recently been linked to oxidative stress in the brain, a fact that may be a precursor to behavioral changes, such as those involving anxiety-like behavior. However, to the best of our knowledge, no study has evaluated the amygdala redox status after consuming a HS diet in the pre- or postweaning periods. This study aimed to evaluate the amygdala redox status and anxiety-like behaviors in adulthood, after inclusion of HS diet in two periods: preconception, gestation, and lactation (preweaning); and only after weaning (postweaning). Initially, 18 females and 9 male Wistar rats received a standard (n = 9 females and 4 males) or a HS diet (n = 9 females and 5 males) for 120 days. After mating, females continued to receive the aforementioned diets during gestation and lactation. Weaning occurred at 21-day-old Wistar rats and the male offspring were subdivided: control-control (C-C)—offspring of standard diet fed dams who received a standard diet after weaning (n = 9–11), control-HS (C-HS)—offspring of standard diet fed dams who received a HS diet after weaning (n = 9–11), HS-C—offspring of HS diet fed dams who received a standard diet after weaning (n = 9–11), and HS-HS—offspring of HS diet fed dams who received a HS diet after weaning (n = 9–11). At adulthood, the male offspring performed the elevated plus maze and open field tests. At 152-day-old Wistar rats, the offspring were euthanized and the amygdala was removed for redox state analysis. The HS-HS group showed higher locomotion and rearing frequency in the open field test. These results indicate that this group developed hyperactivity. The C-HS group had a higher ratio of entries and time spent in the open arms of the elevated plus maze test in addition to a higher head-dipping frequency. These results suggest less anxiety-like behaviors. In the analysis of the redox state, less activity of antioxidant enzymes and higher levels of the thiobarbituric acid reactive substances (TBARS) in the amygdala were shown in the amygdala of animals that received a high-salt diet regardless of the period (pre- or postweaning). In conclusion, the high-salt diet promoted hyperactivity when administered in the pre- and postweaning periods. In animals that received only in the postweaning period, the addition of salt induced a reduction in anxiety-like behaviors. Also, regardless of the period, salt provided amygdala oxidative stress, which may be linked to the observed behaviors.
Growth differentiation factor 15 (GDF15) is a stress-induced cytokine secreted into the circulation by a number of tissues under different pathological conditions such as cardiovascular disease, cancer or mitochondrial dysfunction, among others. While GDF15 signaling through its recently identified hindbrain-specific receptor GDNF family receptor alpha-like (GFRAL) has been proposed to be involved in the metabolic stress response, its endocrine role under chronic stress conditions is still poorly understood. Mitochondrial dysfunction is characterized by the impairment of oxidative phosphorylation (OXPHOS), leading to inefficient functioning of mitochondria and consequently, to mitochondrial stress. Importantly, mitochondrial dysfunction is among the pathologies to most robustly induce GDF15 as a cytokine in the circulation.
The overall aim of this thesis was to elucidate the role of the GDF15-GFRAL pathway under mitochondrial stress conditions. For this purpose, a mouse model of skeletal muscle-specific mitochondrial stress achieved by ectopic expression of uncoupling protein 1 (UCP1), the HSA-Ucp1-transgenic (TG) mouse, was employed. As a consequence of mitochondrial stress, TG mice display a metabolic remodeling consisting of a lean phenotype, an improved glucose metabolism, an increased metabolic flexibility and a metabolic activation of white adipose tissue.
Making use of TG mice crossed with whole body Gdf15-knockout (GdKO) and Gfral-knockout (GfKO) mouse models, this thesis demonstrates that skeletal muscle mitochondrial stress induces the integrated stress response (ISR) and GDF15 in skeletal muscle, which is released into the circulation as a myokine (muscle-induced cytokine) in a circadian manner. Further, this work identifies GDF15-GFRAL signaling to be responsible for the systemic metabolic remodeling elicited by mitochondrial stress in TG mice. Moreover, this study reveals a daytime-restricted anorexia induced by the GDF15-GFRAL axis under muscle mitochondrial stress, which is, mechanistically, mediated through the induction of hypothalamic corticotropin releasing hormone (CRH). Finally, this work elucidates a so far unknown physiological outcome of the GDF15-GFRAL pathway: the induction of anxiety-like behavior.
In conclusion, this study uncovers a muscle-brain crosstalk under skeletal muscle mitochondrial stress conditions through the induction of GDF15 as a myokine that signals through the hindbrain-specific GFRAL receptor to elicit a stress response leading to metabolic remodeling and modulation of ingestive- and anxiety-like behavior.
Novel nanogels that possess the capacity to change their physico-chemical properties in response to external stimuli are promising drug-delivery candidates for the treatment of severe skin diseases. As thermoresponsive nanogels (tNGs) are capable of enhancing penetration through biological barriers such as the stratum corneum and are taken up by keratinocytes of human skin, potential adverse consequences of their exposure must be elucidated. In this study, tNGs were synthesized from dendritic polyglycerol (dPG) and two thermoresponsive polymers. tNG_dPG_tPG are the combination of dPG with poly(glycidyl methyl ether-co-ethyl glycidyl ether) (p(GME-co-EGE)) and tNG_dPG_pNIPAM the one with poly(N-isopropylacrylamide) (pNIPAM). Both thermoresponsive nanogels are able to incorporate high amounts of dexamethasone and tacrolimus, drugs used in the treatment of severe skin diseases. Cellular uptake, intracellular localization and the toxicological properties of the tNGs were comprehensively characterized in primary normal human keratinocytes (NHK) and in spontaneously transformed aneuploid immortal keratinocyte cell line from adult human skin (HaCaT). Laser scanning confocal microscopy revealed fluorescently labeled tNGs entered into the cells and localized predominantly within lysosomal compartments. MTT assay, comet assay and carboxy-H2DCFDA assay, demonstrated neither cytotoxic or genotoxic effects, nor any induction of reactive oxygen species of the tNGs in keratinocytes. In addition, both tNGs were devoid of eye irritation potential as shown by bovine corneal opacity and permeability (BCOP) test and red blood cell (RBC) hemolysis assay. Therefore, our study provides evidence that tNGs are locally well tolerated and underlines their potential for cutaneous drug delivery.
pH-sensitive nanoparticles have a great potential for dermal and transfollicular drug delivery. In this study, pH-sensitive, dexamethasone-loaded Eudragit (R) L 100, Eudragit (R) L 100-55, Eudragit (R) S 100, HPMCP-50, HPMCP-55 and cellulose acetate phthalate nanoparticles were prepared by nanoprecipitation and characterized. The pH-dependent swelling, erosion, dissolution and drug release kinetics were investigated in vitro using dynamic light scattering and Franz diffusion cells, respectively. Their toxicity potential was assessed by the ROS and MTT assays. 100-700 nm nanoparticles with high drug loading and entrapment efficiency were obtained. The nanoparticles bear no toxicity potential. Cellulose phthalates nanoparticles were more sensitive to pH than acrylates nanoparticles. They dissolved in 10 mM pH 7.5 buffer and released > 80% of the drug within 7 h. The acrylate nanoparticles dissolved in 40 mM pH 7.5 buffer and released 65-70% of the drug within 7 h. The nanoparticles remained intact in 10 and 40 mM pH 6.0 buffers (HPMCP nanoparticles dissolved in 40 mM pH 6.0 buffer) and released slowly. The nanoparticles properties could be modulated by blending the different polymers. In conclusion, various pH-sensitive nanoparticles that could release differently on the skin surface and dissolve and release in the hair follicles were obtained.
Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of the nitric oxide (NO)-synthase and a biomarker of endothelial dysfunction (ED). ED plays an important role in the pathogenesis of contrast-induced nephropathy (CIN). The aim of our study was to evaluate serum ADMA concentration as a biomarker of an acute renal damage during the follow-up of 90 days after contrast medium (CM) application. Blood samples were obtained from 330 consecutive patients with diabetes mellitus or mild renal impairment immediately before, 24 and 48 hours after the CM application for coronary angiography. The patients were followed for 90 days. The composite endpoints were major adverse renal events (MARE) defined as occurrence of death, initiation of dialysis, or a doubling of serum creatinine concentration. Overall, ADMA concentration in plasma increased after CM application, although, there was no differences between ADMA levels in patients with and without CIN. ADMA concentration 24 hours after the CM application was predictive for dialysis with a specificity of 0.889 and sensitivity of 0.653 at values higher than 0.71 mu mol/L (area under the curve: 0.854, 95% confidential interval: 0.767-0.941, P<0.001). This association remained significant in multivariate Cox regression models adjusted for relevant factors of long-term renal outcome. 24 hours after the CM application, ADMA concentration in plasma was predictive for MARE with a specificity of 0.833 and sensitivity of 0.636 at a value of more than 0.70 mu mol/L (area under the curve: 0.750, 95% confidence interval: 0.602-0.897, P=0.004). Multivariate logistic regression analysis confirmed that ADMA and anemia were significant predictors of MARE. Further analysis revealed that increased ADMA concentration in plasma was highly significant predictor of MARE in patients with CIN. Moreover, patients with CIN and MARE had the highest plasma ADMA levels 24 hours after CM exposure in our study cohort. The impact of ADMA on MARE was independent of such known CIN risk factors as anemia, pre-existing renal failure, pre-existing heart failure, and diabetes. ADMA concentration in plasma is a promising novel biomarker of major contrast-induced nephropathy-associated events 90 days after contrast media exposure.
Seafood, including finfish, shellfish, and seaweed, is the largest contributor to arsenic (As) exposure in many human populations. In contrast to the predominance of inorganic As in water and many terrestrial foods, As in marine-derived foods is present primarily in the form of organic compounds. To date, human exposure and toxicological assessments have focused on inorganic As, while organic As has generally been considered to be nontoxic. However, the high concentrations of organic As in seafood, as well as the often complex As speciation, can lead to complications in assessing As exposure from diet. In this report, we evaluate the presence and distribution of organic As species in seafood, and combined with consumption data, address the current capabilities and needs for determining human exposure to these compounds. The analytical approaches and shortcomings for assessing these compounds are reviewed, with a focus on the best practices for characterization and quantitation. Metabolic pathways and toxicology of two important classes of organic arsenicals, arsenolipids and arsenosugars, are examined, as well as individual variability in absorption of these compounds. Although determining health outcomes or assessing a need for regulatory policies for organic As exposure is premature, the extensive consumption of seafood globally, along with the preliminary toxicological profiles of these compounds and their confounding effect on assessing exposure to inorganic As, suggests further investigations and process-level studies on organic As are needed to fill the current gaps in knowledge.
Small selenium (Se) species play a major role in the metabolism, excretion and dietary supply of the essential trace element selenium. Human cells provide a valuable tool for investigating currently unresolved issues on the cellular mechanisms of Se toxicity and metabolism. In this study, we developed two isotope dilution inductively coupled plasma tandem-mass spectrometry based methods and applied them to human hepatoma cells (HepG2) in order to quantitatively elucidate total cellular Se concentrations and cellular Se species transformations in relation to the cytotoxic effects of four small organic Se species. Species-and incubation time-dependent results were obtained: the two major urinary excretion metabolites trimethylselenonium (TMSe) and methyl-2-acetamido-2-deoxy-1-seleno-beta- D-galactopyranoside (SeSugar 1) were taken up by the HepG2 cells in an unmodified manner and did not considerably contribute to the Se pool. In contrast, Se-methylselenocysteine (MeSeCys) and selenomethionine (SeMet) were taken up in higher amounts, they were largely incorporated by the cells (most likely into proteins) and metabolized to other small Se species. Two new metabolites of MeSeCys, namely gamma-glutamyl-Se-methylselenocysteine and Se-methylselenoglutathione, were identified by means of HPLC-electrospray-ionization-Orbitrap-MS. They are certainly involved in the (de-) toxification modes of Se metabolism and require further investigation.
Preclinical assessment of penetration not only in intact, but also in barrier‐disrupted skin is important to explore the surplus value of novel drug delivery systems, which can be specifically designed for diseased skin. Here, we characterized physical and chemical barrier disruption protocols for short‐term ex vivo skin cultures with regard to structural integrity, physiological and biological parameters. Further, we compared the penetration of dexamethasone (Dex) in different nanoparticle‐based formulations in stratum corneum, epidermis and dermis extracts of intact vs. barrier‐disrupted skin as well as by dermal microdialysis at 6, 12 and 24 hours after topical application. Dex was quantified by liquid‐chromatography ‐ tandem‐mass spectrometry (LC‐MS/MS). Simultaneously, we investigated the Dex efficacy by interleukin (IL) analysis. Tape‐stripping (TS) and 4 hours sodium lauryl sulfate 5 % (SLS) exposure were identified as highly effective barrier disruption methods assessed by reproducible transepidermal water loss (TEWL) changes and IL‐6/8 increase which was more pronounced in SLS‐treated skin. The barrier state has also a significant impact on the Dex penetration kinetics: for all formulations, TS highly increased dermal Dex concentration despite the fact that nanocrystals quickly and effectively penetrated both, intact and barrier‐disrupted skin reaching significantly higher dermal Dex concentration after 6 hours compared to Dex cream. The surplus value of encapsulation in ethyl cellulose nanocarriers could mostly be observed when applied on intact skin, in general showing a delayed Dex penetration. Estimation of cytokines was limited due to the trauma caused by probe insertion. In summary, ex vivo human skin is a highly interesting short‐term preclinical model for the analysis of penetration and efficacy of novel drug delivery systems.
Adulteration of food and mislabeled products in global market is a major financial and reputational risk for food manufacturers and trade companies. Consequently, there is a necessity to develop analytical methods to meet these issues. An analytical strategy to check the authenticity of wheat, spelt and rye addition in bread products was developed based on database research, in silico digestion confirming peptide specificity and finally quantification by liquid chromatography-tandem mass spectrometry analysis. Peptide markers for wheat (SQQQISQQPQQLPQQQQIPQQPQQF; QQHQIPQQPQQFPQQQQF and QPHQPQQPYPQQ), spelt (ASIVVGIGGQ; SQQPGQIIPQQPQQPSPL) and rye (LPQSHKQHVGQGAL; AQVQGIIQPQQL and QQFPQQPQQSFPQQPQQPVPQQPL) were identified, verified by protein Basic Local Alignment Search Tool and database research and used for quantification in bread. The specific use of multi-reaction monitoring transitions of selected peptides permitted the identification of closely related species wheat and spelt. Other cereal species (emmer, einkorn, barley, maize, rye and oat) were also checked. The target peptides were quantified at different levels using own reference baked products (bread) after in-solution chymotryptic digestion. Sensitivity of the identification was 0.5-1% using flour-based (0-25%) matrix calibration and the analytical recovery in bread was 80-125%. The analytical strategy described here supplies an emerging, independent and flexible tool in controlling the labeling of bread.
Controlled delivery of corticosteroids using nanoparticles to the skin and corneal epithelium may reduce their side effects and maximize treatment effectiveness. Dexamethasone-loaded ethyl cellulose, Eudragit® RS and ethyl cellulose/Eudragit® RS nanoparticles were prepared by the solvent evaporation method. Dexamethasone release from the polymeric nanoparticles was investigated in vitro using Franz diffusion cells. Drug penetration was also assessed ex vivo using excised human skin. Nanoparticle toxicity was determined by MTT and H2DCFDA assays. Eudragit® RS nanoparticles were smaller and positively charged but had a lower dexamethasone loading capacity (0.3–0.7%) than ethyl cellulose nanoparticles (1.4–2.2%). By blending the two polymers (1:1), small (105 nm), positively charged (+37 mV) nanoparticles with sufficient dexamethasone loading (1.3%) were obtained. Dexamethasone release and penetration significantly decreased with decreasing drug to polymer ratio and increased when Eudragit® RS was blended with ethyl cellulose. Ex vivo, drug release and penetration from the nanoparticles was slower than a conventional cream. The nanoparticles bear no toxicity potentials except ethyl cellulose nanoparticles had ROS generation potential at high concentration. In conclusion, the nanoparticles showed great potential to control the release and penetration of corticosteroids on the skin and mucus membrane and maximize treatment effectiveness.
Acid sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets
(2017)
Pulmonary complications from stored blood products are the leading cause of mortality related to transfusion. Transfusion-related acute lung injury is mediated by antibodies or bioactive mediators, yet underlying mechanisms are incompletely understood. Sphingolipids such as ceramide regulate lung injury, and their composition changes as a function of time in stored blood. Here, we tested the hypothesis that aged platelets may induce lung injury via a sphingolipid-mediated mechanism. To assess this hypothesis, a two-hit mouse model was devised. Recipient mice were treated with 2 mg/kg intraperitoneal lipopolysaccharide (priming) 2 h before transfusion of 10 ml/kg stored (1-5 days) platelets treated with or without addition of acid sphingomyelinase inhibitor ARC39 or platelets from acid sphingomyelinase-deficient mice, which both reduce ceramide formation. Transfused mice were examined for signs of pulmonary neutrophil accumulation, endothelial barrier dysfunction, and histological evidence of lung injury. Sphingolipid profiles in stored platelets were analyzed by mass spectrophotometry. Transfusion of aged platelets into primed mice induced characteristic features of lung injury, which increased in severity as a function of storage time. Ceramide accumulated in platelets during storage, but this was attenuated by ARC39 or in acid sphingomyelinase-deficient platelets. Compared with wild-type platelets, transfusion of ARC39-treated or acid sphingomyelinase-deficient aged platelets alleviated lung injury. Aged platelets elicit lung injury in primed recipient mice, which can be alleviated by pharmacological inhibition or genetic deletion of acid sphingomyelinase. Interventions targeting sphingolipid formation represent a promising strategy to increase the safety and longevity of stored blood products.
To study the role of the TTR-RBP4-ROH complex components (transthyretin, serum retinol binding protein, retinol) and of angiogenic factors PlGF (placental growth factor) and sFlt-1 (soluble fms-like tyrosine kinase-1) in pregnancies complicated by small for gestational age infants (SGA). Case control study conducted on maternal serum collected between 11 + 0 to 13 + 6 weeks of gestation. TTR, RBP4, ROH, PlGF and sFlt-1 were measured in SGA patients (birth weight < 10%) who delivered at term (n = 37) and before 37 weeks of gestation (n = 17) and in a matched control group with uneventful pregnancies (n = 37). We found decreased RBP4 in SGA patients that delivered fetuses < 3% and in fetuses delivered after the 37 weeks of gestation compared to controls [1.50 (95% CI 1.40-1.75) vs 1.62 (95% CI 1.47-1.98), p < 0.05]. Further, we found lower PlGF and sFlt-1 concentrations in SGA that delivered before 37 weeks of gestation compared to controls (respectively, PIGF and sFlt-1: 39.7 pg/ml (95% CI 32.3-66.3) vs 62.9 pg/ml (95% CI 45.2-78.4) and 906 pg/ml (95% CI 727-1626) vs 1610 pg/ml (95% CI 1088-212), p < 0.05). First trimester maternal serum RBP4 and angiogenic factors PlGF and sFlt-1 can differently predict the timing of delivery of pregnancies complicated by SGA fetuses.
Background: Abdominal aortic aneurysm (AAA) is a deadly irreversible weakening and distension of the abdominal aortic wall. The pathogenesis of AAA remains poorly understood. Investigation into the physical and molecular characteristics of perivascular adipose tissue (PVAT) adjacent to AAA has not been done before and is the purpose of this study.
Methods and Results: Human aortae, periaortic PVAT, and fat surrounding peripheral arteries were collected from patients undergoing elective surgical repair of AAA. Control aortas were obtained from recently deceased healthy organ donors with no known arterial disease. Aorta and PVAT was found in AAA to larger extent compared with control aortas. Immunohistochemistry revealed neutrophils, macrophages, mast cells, and T-cells surrounding necrotic adipocytes. Gene expression analysis showed that neutrophils, mast cells, and T-cells were found to be increased in PVAT compared with AAA as well as cathepsin K and S. The concentration of ceramides in PVAT was determined using mass spectrometry and correlated with content of T-cells in the PVAT.
Conclusions: Our results suggest a role for abnormal necrotic, inflamed, proteolytic adipose tissue to the adjacent aneurysmal aortic wall in ongoing vascular damage.
Strong experimental evidence in animal and cellular models supports a pivotal role of sphingosine kinase-1 (SK1) in oncogenesis. In many human cancers, SK1 levels are upregulated and these increases are linked to poor prognosis in patients. Here, by employing untargeted NMR- based metabolomic profiling combined with functional validations, we report the crucial role of SK1 in the metabolic shift known as the Warburg effect in A2780 ovarian cancer cells. Indeed, expression of SK1 induced a high glycolytic rate, characterized by increased levels of lactate along with increased expression of the proton/monocarboxylate symporter MCT1, and decreased oxidative metabolism, associated with the accumulation of intermediates of the tricarboxylic acid cycle and reduction in CO2 production. Additionally, SK1-expressing cells displayed a significant increase in glucose uptake paralleled by GLUT3 transporter upregulation. The role of SK1 is not limited to the induction of aerobic glycolysis, affecting metabolic pathways that appear to support the biosynthesis of macromolecules. These findings highlight the role of SK1 signaling axis in cancer metabolic reprogramming, pointing out innovative strategies for cancer therapies.
Objective
Insulin regulates mitochondrial function, thereby propagating an efficient metabolism. Conversely, diabetes and insulin resistance are linked to mitochondrial dysfunction with a decreased expression of the mitochondrial chaperone HSP60. The aim of this investigation was to determine the effect of a reduced HSP60 expression on the development of obesity and insulin resistance.
Methods
Control and heterozygous whole-body HSP60 knockout (Hsp60+/−) mice were fed a high-fat diet (HFD, 60% calories from fat) for 16 weeks and subjected to extensive metabolic phenotyping. To understand the effect of HSP60 on white adipose tissue, microarray analysis of gonadal WAT was performed, ex vivo experiments were performed, and a lentiviral knockdown of HSP60 in 3T3-L1 cells was conducted to gain detailed insights into the effect of reduced HSP60 levels on adipocyte homeostasis.
Results
Male Hsp60+/− mice exhibited lower body weight with lower fat mass. These mice exhibited improved insulin sensitivity compared to control, as assessed by Matsuda Index and HOMA-IR. Accordingly, insulin levels were significantly reduced in Hsp60+/− mice in a glucose tolerance test. However, Hsp60+/− mice exhibited an altered adipose tissue metabolism with elevated insulin-independent glucose uptake, adipocyte hyperplasia in the presence of mitochondrial dysfunction, altered autophagy, and local insulin resistance.
Conclusions
We discovered that the reduction of HSP60 in mice predominantly affects adipose tissue homeostasis, leading to beneficial alterations in body weight, body composition, and adipocyte morphology, albeit exhibiting local insulin resistance.
Objective
Insulin regulates mitochondrial function, thereby propagating an efficient metabolism. Conversely, diabetes and insulin resistance are linked to mitochondrial dysfunction with a decreased expression of the mitochondrial chaperone HSP60. The aim of this investigation was to determine the effect of a reduced HSP60 expression on the development of obesity and insulin resistance.
Methods
Control and heterozygous whole-body HSP60 knockout (Hsp60+/−) mice were fed a high-fat diet (HFD, 60% calories from fat) for 16 weeks and subjected to extensive metabolic phenotyping. To understand the effect of HSP60 on white adipose tissue, microarray analysis of gonadal WAT was performed, ex vivo experiments were performed, and a lentiviral knockdown of HSP60 in 3T3-L1 cells was conducted to gain detailed insights into the effect of reduced HSP60 levels on adipocyte homeostasis.
Results
Male Hsp60+/− mice exhibited lower body weight with lower fat mass. These mice exhibited improved insulin sensitivity compared to control, as assessed by Matsuda Index and HOMA-IR. Accordingly, insulin levels were significantly reduced in Hsp60+/− mice in a glucose tolerance test. However, Hsp60+/− mice exhibited an altered adipose tissue metabolism with elevated insulin-independent glucose uptake, adipocyte hyperplasia in the presence of mitochondrial dysfunction, altered autophagy, and local insulin resistance.
Conclusions
We discovered that the reduction of HSP60 in mice predominantly affects adipose tissue homeostasis, leading to beneficial alterations in body weight, body composition, and adipocyte morphology, albeit exhibiting local insulin resistance.
Quantitative determination of the sulfur-containing antioxidant ergothioneine by HPLC/ICP- QQQ-MS
(2017)
Interest in the sulfur-containing antioxidant ergothioneine calls for reliable analytical methods for its quantification. In this work, a method based on reversed-phase high performance liquid chromatography (RP-HPLC) coupled with elemental mass spectrometry detection in mass shift mode (inductively coupled plasma triple quadrupole mass spectrometry, ICP-QQQ-MS) using oxygen as the reaction gas was developed for the element-selective determination of ergothioneine in complex biological matrices. Application of an instrumental setup using a 6-port-valve and the introduction of a methanol gradient allowed the time-efficient analysis of samples containing strongly retained sulfur species besides ergothioneine without compromising ICPMS detection. In aqueous solution, limits of detection and quantification (LOD and LOQ) of the optimized method for m/z 32 -> 48 (SO+) were 0.23 mu g S per L and 0.80 mu g S per L, respectively; measurements in a complex matrix (human hepatocyte carcinoma cells, HepG2) resulted in an LOD of 0.6 mu g S per L and an LOQ of 2.3 mu g S per L. Recoveries of ergothioneine from cell pellets spiked with the analyte before cell lysis (97 +/- 3%) matched those obtained for cell culture medium spiked before syringe filtration (96 +/- 9%) demonstrating that sample preparation did not impair the quantitative determination of ergothioneine. When HepG2 cells were exposed to ergothioneine via the culture medium, they showed low absorption; approximately 3% of the added ergothioneine was found in cell lysates, while most of it (>= 85%) remained in the cell culture medium. The method is capable of separating ergothioneine from other biologically relevant sulfur-containing species and is expected to be of broad future use. Furthermore, the potential use for the simultaneous separation of selenium species, thereby extending the scope of possible applications, was demonstrated by applying it to water extracts of oyster mushrooms.
Fibroblast growth differentiation factor 21 (FGF21) is known as a pivotal regulator of the glucose and lipid metabolism. As such, it is considered beneficial and has even been labelled a longevity hormone. Nevertheless, recent observational studies have shown that FGF21 is increased in higher age with possible negative effects such as loss of lean and bone mass as well as decreased survival. Hepatic FGF21 secretion can be induced by various nutritional stimuli such as starvation, high carbohydrate and fat intake as well as protein deficiency.. So far it is still unclear whether the FGF21 response to different macronutrients is altered in older age. An altered response would potentially contribute to explain the higher FGF21 concentrations found in older age. In this publication-based doctoral dissertation, a cross-sectional study as well as a dietary challenge were conducted to investigate the influence of nutrition on FGF21 concentrations and response in older age. In a cross-sectional study, FGF21 concentrations were assessed in older patients with and without cachexia anorexia syndrome anorexia syndrome compared to an older community-dwelling control group. Cachexia anorexia syndrome is a multifactorial syndrome frequently occurring in old age or in the context of an underlying disease. It is characterized by a severe involuntary weight loss, loss of appetite (anorexia) and reduced food intake, therefore representing a state of severe nutrient deficiency, in some aspects similar to starvation. The highest FGF21 concentrations were found in patients with cachexia anorexia syndrome. Moreover, FGF21 was positively correlated with weight loss and loss of appetite. In addition, cachexia anorexia syndrome itself was associated with FGF21 independent of sex, age and body mass index. As cachectic patients presumably exhibit protein malnutrition and FGF21 has been proposed a marker for protein insufficiency, the higher levels of FGF21 in patients with cachexia anorexia syndrome might be partly explained by insufficient protein intake. In order to investigate the acute response of FGF21 to different nutritional stimuli, a dietary challenge with a parallel group design was conducted. Here, healthy older (65-85 years) and younger (18-35 years) adults were randomized to one of four test meals: a dextrose drink, a high carbohydrate, high fat or high protein meal. Over the course of four hours, postprandial FGF21 concentrations (dynamics) were assessed and the FGF21 response (incremental area under the curve) to each test meal was examined.. In a sub-group of older and younger women, also the adiponectin response was investigated, as adiponectin is a known mediator of FGF21 effects on glucose and lipid metabolism. The dietary meal challenge revealed that dextrose and high carbohydrate intake result in higher FGF21 concentrations after four hours in older adults. This was partly explained by higher postprandial glucose concentrations in the old. For high fat ingestion no age differences were found. For the first time, acute FGF21 response to high protein intake was shown. Here, protein ingestion resulted in lower FGF21 concentrations in younger compared to older adults. Furthermore, sufficient protein intake, according to age-dependent recommendations, of the previous day, was associated with lower FGF21 concentrations in both age groups. The higher FGF21 response to dextrose ingestion resulted in a higher adiponectin response in older women, independent of fat mass, insulin resistance, triglyceride concentrations, inflammation and oxidative stress. Following the high fat meal, adiponectin concentrations declined in older women. Adiponectin response was not affected by meal composition in younger women. In summary, this thesis showed a positive association of FGF21 and cachexia anorexia syndrome with concomitant anorexia in older patients. Regarding the acute FGF21 response, a higher response following dextrose and carbohydrate ingestion was found in older compared with younger subjects. This might be attributed to a higher glucose response in older age. Furthermore, it was shown that the higher FGF21 response after dextrose ingestion possibly contributes to a higher adiponectin response in older women, independent of potential metabolic and inflammatory confounders. Acute protein ingestion resulted in a significant decrease in FGF21 concentrations. Moreover, protein intake of the previous day was inversely associated with fasting FGF21 concentrations. This might explain why FGF21 concentrations are higher in cachexia anorexia syndrome. These results therefore support the role of FGF21 as a sensor of protein restriction.
Pannexin 1
(2022)
Hypoxic pulmonary vasoconstriction is an active alveolar hypoxia-caused physiological response redirecting pulmonary blood flow from poorly ventilated areas to better oxygenated lung regions in order to optimize oxygen supply. However, the signaling pathways underlying this pulmonary vascular response remain an area under investigation. In the present study I investigated the functional relevance of Pannexin 1 (Panx1)-mediated ATP release in hypoxic pulmonary vasoconstriction and chronic hypoxic pulmonary hypertension using murine isolated perfused lungs, chronic hypoxic mice, and pulmonary artery smooth muscle cell culture. In isolated mouse lungs, switch to hypoxic gas induced a marked increase in pulmonary artery pressure. Pharmacological inhibition of Panx1 using probenecid, Panx1 specific inhibitory peptide (10Panx1) or spironolactone as well as genetic deletion of Panx1 in smooth muscle cells diminished hypoxic pulmonary vasoconstriction in isolated perfused mouse lungs. Fura-2 imaging revealed a reduced Ca2+ response to hypoxia in pulmonary artery smooth muscle cells treated with spironolactone or 10Panx1. Although these findings suggested an important role of Panx1 in HPV, neither smooth muscle cell nor endothelial cell specific genetic deletion of Panx1 prevented the development of pulmonary hypertension in chronic hypoxic mice. Surprisingly, hypoxia did not induce ATP release and inhibition of purinergic receptors or ATP degradation by ATPase failed to decrease the pulmonary vasoconstriction response to hypoxia in isolated perfused mouse lungs. However, Panx1 antagonism as well as TRPV4 inhibition prevented the hypoxia-induced increase in intracellular Ca2+ concentration in pulmonary artery smooth muscle cells in an additive manner suggesting that Panx1 might modulate intracellular Ca2+ signaling independently of the ATP-P2-TRPV4 signaling axis. In line with this assumption, overexpression of Panx1 in HeLa cells increased intracellular Ca2+ concentrations in response to acute hypoxia. Conclusion: In this study I identifiy Panx1 as novel regulator of HPV.. Yet, the role of Panx1 was not attributable to the release of ATP and downstream P2 signaling pathways or activation of TRPV4 but rathter relates to a role of Panx1 as indirect or direct modulator of the Ca2+ response to hypoxia in PASMCs. Genetic deletion of Panx1 did not influence the development of chronic hypoxic pulmonary hypertension in mice.
Single-cell analysis by ICP-MS/MS as a fast tool for cellular bioavailability studies of arsenite
(2017)
Single-cell inductively coupled plasma mass spectrometry (SC-ICP-MS) has become a powerful and fast tool to evaluate the elemental composition at a single-cell level. In this study, the cellular bioavailability of arsenite (incubation of 25 and 50 mu M for 0-48 h) has been successfully assessed by SC-ICP-MS/MS for the first time directly after re-suspending the cells in water. This procedure avoids the normally arising cell membrane permeabilization caused by cell fixation methods (e.g. methanol fixation). The reliability and feasibility of this SC-ICP-MS/MS approach with a limit of detection of 0.35 fg per cell was validated by conventional bulk ICP-MS/MS analysis after cell digestion and parallel measurement of sulfur and phosphorus.
A growing number of health-conscious individuals supplements their diet with protein-rich plant-based products to reduce their meat consumption. Analytical methods are needed to authenticate these new vegetarian products not only for the correct labelling of ingredients according to European legislation but also to discourage food fraud. This paper presents new biomarkers for a targeted proteomics LC-MS/MS work-flow that can simultaneously prove the presence/absence of garden pea, a protein-rich legume, meat and honey and quantify their content in processed vegan food. We show a novel rapid strategy to identify biomarkers for species authentication and the steps for the multi-parameter LC-MS/MS method validation and quantification. A high resolution triple time of flight mass spectrometer (HRMS) with SWATH Acquisition was used for the rapid discovery of all measurable trypsin-digested proteins in the individual ingredients. From these proteins, species-selective biomarkers were identified with BLAST and Skyline. Vicilin and convicilin (UniProt: D3VND9, Q9M3X6) allow pea authentication with regard to other legume species. Myostatin (UniProt: 018831) is a single biomarker for all meat types. For honey, we identified three selective proteins (UniProt: C6K481, C6K482, Q3L6329). The final LC-MS/MS method can identity and quantify these markers simultaneously. Quantification occurs via external matrix calibration.
Background
Coronavirus disease (COVID-19) has a severe impact on all aspects of patient care. Among the numerous biomarkers of potential validity for diagnostic and clinical management of COVID-19 are biomarkers at the interface of iron metabolism and inflammation.
Methods
The follow-up study included 54 hospitalized patients with laboratory-confirmed COVID-19 with a moderate and severe/critical form of the disease. Iron deficiency specific biomarkers such as iron, ferritin, transferrin receptor, hepcidin, and zinc protoporphyrin (ZnPP) as well as relevant markers of inflammation were evaluated twice: in the first five days when the patient was admitted to the hospital and during five to 15 days; and their validity to diagnose iron deficiency was further assessed. The regression and Receiver Operating Characteristics (ROC) analyses were performed to evaluate the prognosis and determine the probability for predicting the severity of the disease in the first five days of COVID-19.
Results
Based on hemoglobin values, anemia was observed in 21 of 54 patients. Of all iron deficiency anemia-related markers, only ZnPP was significantly elevated (P<0.001) in the anemic group. When patients were grouped according to the severity of disease, slight differences in hemoglobin or other anemia-related parameters could be observed. However, the levels of ZnPP were significantly increased in the severely ill group of patients. The ratio of ZnPP to lymphocyte count (ZnPP/L) had a discrimination power stronger than the neutrophil to lymphocyte count ratio (N/L) to determine disease severity. Additionally, only two markers were independently associated with the severity of COVID-19 in logistic regression analysis; D-dimer (OR (5.606)(95% CI 1.019–30.867)) and ZnPP/L ratio (OR (74.313) (95% CI 1.081–5108.103)).
Conclusions
For the first time ZnPP in COVID-19 patients were reported in this study. Among all iron-related markers tested, ZnPP was the only one that was associated with anemia as based on hemoglobin. The increase in ZnPP might indicate that the underlying cause of anemia in COVID-19 patients is not only due to the inflammation but also of nutritional origin. Additionally, the ZnPP/L ratio might be a valid prognostic marker for the severity of COVID-19.
Background
Coronavirus disease (COVID-19) has a severe impact on all aspects of patient care. Among the numerous biomarkers of potential validity for diagnostic and clinical management of COVID-19 are biomarkers at the interface of iron metabolism and inflammation.
Methods
The follow-up study included 54 hospitalized patients with laboratory-confirmed COVID-19 with a moderate and severe/critical form of the disease. Iron deficiency specific biomarkers such as iron, ferritin, transferrin receptor, hepcidin, and zinc protoporphyrin (ZnPP) as well as relevant markers of inflammation were evaluated twice: in the first five days when the patient was admitted to the hospital and during five to 15 days; and their validity to diagnose iron deficiency was further assessed. The regression and Receiver Operating Characteristics (ROC) analyses were performed to evaluate the prognosis and determine the probability for predicting the severity of the disease in the first five days of COVID-19.
Results
Based on hemoglobin values, anemia was observed in 21 of 54 patients. Of all iron deficiency anemia-related markers, only ZnPP was significantly elevated (P<0.001) in the anemic group. When patients were grouped according to the severity of disease, slight differences in hemoglobin or other anemia-related parameters could be observed. However, the levels of ZnPP were significantly increased in the severely ill group of patients. The ratio of ZnPP to lymphocyte count (ZnPP/L) had a discrimination power stronger than the neutrophil to lymphocyte count ratio (N/L) to determine disease severity. Additionally, only two markers were independently associated with the severity of COVID-19 in logistic regression analysis; D-dimer (OR (5.606)(95% CI 1.019–30.867)) and ZnPP/L ratio (OR (74.313) (95% CI 1.081–5108.103)).
Conclusions
For the first time ZnPP in COVID-19 patients were reported in this study. Among all iron-related markers tested, ZnPP was the only one that was associated with anemia as based on hemoglobin. The increase in ZnPP might indicate that the underlying cause of anemia in COVID-19 patients is not only due to the inflammation but also of nutritional origin. Additionally, the ZnPP/L ratio might be a valid prognostic marker for the severity of COVID-19.
Lipid-soluble arsenicals, so-called arsenolipids, have gained a lot of attention in the last few years because of their presence in many seafoods and reports showing substantial cytotoxicity emanating from arsenic-containing hydrocarbons (AsHCs), a prominent subgroup of the arsenolipids. More recent in vivo and in vitro studies indicate that some arsenolipids might have adverse effects on brain health. In the present study, we focused on the effects of selected arsenolipids and three representative metabolites on the blood-cerebrospinal fluid barrier (B-CSF-B), a brain-regulating interface. For this purpose, we incubated an in vitro model of the B-CSF-B composed of porcine choroid plexus epithelial cells (PCPECs) with three AsHCs, two arsenic-containing fatty acids (AsFAs) and three representative arsenolipid metabolites (dimethylarsinic acid, thio/oxo-dimethylpropanoic acid) to examine their cytotoxic potential and impact on barrier integrity. The toxic arsenic species arsenite was also tested in this way and served as a reference substance. While AsFAs and the metabolites showed no cytotoxic effects in the conducted assays, AsHCs showed a strong cytotoxicity, being up to 1.5-fold more cytotoxic than arsenite. Analysis of the in vitro B-CSF-B integrity showed a concentration dependent disruption of the barrier within 72 h. The correlation with the decreased plasma membrane surface area (measured as capacitance) indicates cytotoxic effects. These findings suggest exposure to elevated levels of certain arsenolipids may have detrimental consequences for the central nervous system.
Multi-element determination in human samples is very challenging. Especially in human intervention studies sample volumes are often limited to a few microliters and due to the high number of samples a high-throughput is indispensable. Here, we present a state-of-the-art ICP-MS/MS-based method for the analysis of essential (trace) elements, namely Mg, Ca, Fe, Cu, Zn, Mo, Se and I, as well as food-relevant toxic elements such as As and Cd. The developed method was validated regarding linearity of the calibration curves, method LODs and LOQs, selectivity and trueness as well as precision. The established reliable method was applied to quantify the element serum concentrations of participants of a human intervention study (LeguAN). The participants received isocaloric diets, either rich in plant protein or in animal protein. While the serum concentrations of Mg and Mo increased in participants receiving the plant protein-based diet (above all legumes), the Se concentration in serum decreased. In contrast, the animal protein-based diet, rich in meat and dairy products, resulted in an increased Se concentration in serum.
The Maillard reaction generates protein modifications which can accumulate during hyperglycemia or aging and may have inflammatory consequences. The proteasome is one of the major intracellular systems involved in the proteolytic degradation of modified proteins but its role in the degradation of glycated proteins is scarcely studied. In this study, chemical and structural changes of glycated myoglobin were analyzed and its degradation by 20S proteasome was studied. Myoglobin was incubated with physiological (5-10 mM), moderate (50-100 mM) and severe levels (300 mM) of glucose or methylglyoxal (MGO, 50 mM). Glycation increased myoglobin's fluorescence and surface hydrophobicity. Severe glycation generated crosslinked proteins as shown by gel electrophoresis. The concentration of advanced glycation endproducts (AGEs) N-epsilon-carboxymethyl lysine (CML), N-epsilon-carboxyethyl lysine (CEL), methylglyoxal-derived hydroimidazolone-1 (MG-H1), pentosidine and pyrraline was analyzed after enzymatic hydrolysis followed by UPLC-MS/MS. Higher concentrations of glucose increased all analyzed AGEs and incubation with MGO led to a pronounced increase of CEL and MG-H1. The binding of the heme group to apo-myoglobin was decreased with increasing glycation indicating the loss of tertiary protein structure. Proteasomal degradation of modified myoglobin compared to native myoglobin depends on the degree of glycation: physiological conditions decreased proteasomal degradation whereas moderate glycation increased degradation. Severe glycation again decreased proteolytic cleavage which might be due to crosslinking of protein monomers. The activity of the proteasomal subunit beta 5 is influenced by the presence of glycated myoglobin. In conclusion, the role of the proteasome in the degradation of glycated proteins is highly dependent on the level of glycation and consequent protein unfolding.
Enhanced topical delivery of dexamethasone by beta-cyclodextrin decorated thermoresponsive nanogels
(2018)
Highly hydrophilic, responsive nanogels are attractive as potential systems for the topical delivery of bioactives encapsulated in their three-dimensional polymeric scaffold. Yet, these drug carrier systems suffer from drawbacks for efficient delivery of hydrophobic drugs. Addressing this, β-cyclodextrin (βCD) could be successfully introduced into the drug carrier systems by exploiting its unique affinity toward dexamethasone (DXM) as well as its role as topical penetration enhancer. The properties of βCD could be combined with those of thermoresponsive nanogels (tNGs) based on dendritic polyglycerol (dPG) as a crosslinker and linear thermoresponsive polyglycerol (tPG) inducing responsiveness to temperature changes. Electron paramagnetic resonance (EPR) studies localized the drug within the hydrophobic cavity of βCD by differences in its mobility and environmental polarity. In fact, the fabricated carriers combining a particulate delivery system with a conventional penetration enhancer, resulted in an efficient delivery of DXM to the epidermis and the dermis of human skin ex vivo (enhancement compared to commercial DXM cream: ∼2.5 fold in epidermis, ∼30 fold in dermis). Furthermore, DXM encapsulated in βCD tNGs applied to skin equivalents downregulated the expression of proinflammatory thymic stromal lymphopoietin (TSLP) and outperformed a commercially available DXM cream.
Arsenic-containing hydrocarbons (AsHCs), a subgroup of arsenolipids (AsLs) occurring in fish and edible algae, possess a substantial neurotoxic potential in fully differentiated human brain cells. Previous in vivo studies indicating that AsHCs cross the blood–brain barrier of the fruit fly Drosophila melanogaster raised the question whether AsLs could also cross the vertebrate blood–brain barrier (BBB). In the present study, we investigated the impact of several representatives of AsLs (AsHC 332, AsHC 360, AsHC 444, and two arsenic-containing fatty acids, AsFA 362 and AsFA 388) as well as of their metabolites (thio/oxo-dimethylpropionic acid, dimethylarsinic acid) on porcine brain capillary endothelial cells (PBCECs, in vitro model for the blood–brain barrier). AsHCs exerted the strongest cytotoxic effects of all investigated arsenicals as they were up to fivefold more potent than the toxic reference species arsenite (iAsIII). In our in vitro BBB-model, we observed a slight transfer of AsHC 332 across the BBB after 6 h at concentrations that do not affect the barrier integrity. Furthermore, incubation with AsHCs for 72 h led to a disruption of the barrier at sub-cytotoxic concentrations. The subsequent immunocytochemical staining of three tight junction proteins revealed a significant impact on the cell membrane. Because AsHCs enhance the permeability of the in vitro blood–brain barrier, a similar behavior in an in vivo system cannot be excluded. Consequently, AsHCs might facilitate the transfer of accompanying foodborne toxicants into the brain.
Fortsetzung aus Ernährungs Umschau Heft 9/2017
Fettsäurenverteilung
Die Gehalte an den wichtigsten Fettsäuren (FS) sind in • Tabelle 4 und 5 aufgeführt, in g/100 g sowie in Prozent des Fettanteils (Etherextrakt bzw. g FS-Methylester pro 100 g der Summe der FS-Methylester). Erbsen und Ackerbohnen spielen als Fett- und FS-Quelle praktisch keine Rolle. Sojabohnen sind eine wesentliche Quelle für Linolsäure, die häufigste n-6-FS. An zweiter Stelle steht die Ölsäure. Aber auch der Gehalt an der n-3-FS α-Linolensäure (ALA) ist hoch, womit sich Sojaöl in die Reihe der Fette mit mittlerem ALA-Gehalt, wie Raps- und Walnussöl einreiht. Im Gegensatz zu Rapsöl entspricht jedoch das Linolsäure/α-Linolensäure- Verhältnis nicht dem empfohlenen Verhältnis von 5:1 in der Gesamt- Diät [13]. Zum Ausgleich für die Fette aus der übrigen Nahrung (Getreide, Lebensmittel tierischer Herkunft) sollten Pflanzenöle besser noch ein engeres Verhältnis als 5:1 aufweisen. Das trifft für Lupinen-Öl schon eher zu, wenngleich der absolute Beitrag an ALA hier eher gering ist.
DPP4 inhibition prevents AKI
(2017)
Lifestyle-related disorders, such as the metabolic syndrome, have become a primary risk factor for the development of liver pathologies that can progress from hepatic steatosis, hepatic insulin resistance, steatohepatitis, fibrosis and cirrhosis, to the most severe condition of hepatocellular carcinoma (HCC). While the prevalence of liver pathologies is steadily increasing in modern societies, there are currently no approved drugs other than chemotherapeutic intervention in late stage HCC. Hence, there is a pressing need to identify and investigate causative molecular pathways that can yield new therapeutic avenues. The transcription factor p53 is well established as a tumor suppressor and has recently been described as a central metabolic player both in physiological and pathological settings. Given that liver is a dynamic tissue with direct exposition to ingested nutrients, hepatic p53, by integrating cellular stress response, metabolism and cell cycle regulation, has emerged as an important regulator of liver homeostasis and dysfunction. The underlying evidence is reviewed herein, with a focus on clinical data and animal studies that highlight a direct influence of p53 activity on different stages of liver diseases. Based on current literature showing that activation of p53 signaling can either attenuate or fuel liver disease, we herein discuss the hypothesis that, while hyper-activation or loss of function can cause disease, moderate induction of hepatic p53 within physiological margins could be beneficial in the prevention and treatment of liver pathologies. Hence, stimuli that lead to a moderate and temporary p53 activation could present new therapeutic approaches through several entry points in the cascade from hepatic steatosis to HCC.